Focus on Fundamentals: Driving Operational Performance
VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare
Properties Management Limited
Page 1 of 4
MARKET RELEASE
13 August 2025
Focus on Fundamentals: Driving Operational Performance
Northwest Healthcare Properties Management Limited (the Manager), the manager of Vital
Healthcare Property Trust (Vital), has today released its results for the 12 months ended 30 June
2025 (FY25).
Vital is pleased to report that distributions of 9.75 cents per unit (cpu) were paid to Unit Holders
in FY25, consistent with guidance, funded from Adjusted Funds from Operations (AFFO) of
10.41cpu.
Strong progress was made during the year at a portfolio level. New and renewal leasing
successes lifted occupancy to 98.6% (from 98.0%). In addition, the profitability of Vital’s diverse
underlying hospital tenants continued to improve. Vital’s strong balance sheet was further
enhanced as improved terms and pricing from a major debt refinance were secured. Vital’s
next debt maturity is now not until March 2027.
Chris Adams Co Head of the A/NZ Region said: “We continue to drive further enhancement in
the quality of the Vital portfolio; the result of developments having completed, disposal of non-
core assets and asset management initiatives. The major refinancing of debt facilities is also a
testament to the quality of the Vital portfolio, banking relationships and strength of defensive
cashflows from a high quality and diversified tenant base.”
FY25 outcomes:
Financial
Vital’s pre-tax operating earnings were up 4.8% to $77.4 million versus the year ended 30 June
2024 (FY24), driven by strong like-for-like rental growth, additional income from completed
developments and lower management fees. In FY25 Unit Holders received distributions of
9.75cpu, consistent with FY24. Net Tangible Assets (NTA) were $2.47 per unit as at 30 June
2025, impacted by unrealised property valuation changes, the mark-to-market of interest rate
swaps and a weaker Australian Dollar exchange rate.
Key outcomes include:
• Operating earnings (pre-tax) up 4.8% to $77.4 million
• AFFO of 10.41cpu versus 10.90cpu in the prior comparative period (pcp)
• Distributions of 9.75cpu, consistent with guidance, on a 93.6% AFFO pay-out ratio
• NTA per unit of $2.47, down from $2.69 in the pcp
VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare
Properties Management Limited
Page 2 of 4
Operational performance
The underlying property portfolio performance was pleasing, with strong leasing outcomes
achieved – an endorsement of Vital’s high quality and well-located properties, accompanied
by a proactive leasing strategy. Occupancy further improved to 98.6% with this momentum
carrying over into positive early leasing outcomes for the year ended 30 June 2026 (FY26).
Together with leasing renewals and extensions, like-for-like Net Property Income
1
(NPI)
increased by 3.7% and Weighted Average Lease Expiry (WALE) was up to 18.5 years.
Key outcomes include:
• Like-for-like NPI up 3.7% versus FY24
• Occupancy further increased to 98.6%, up 0.6% versus pcp, reflecting over 9,400sqm of
new leasing executed
• WALE up from 18.3 years to 18.5 years
• Diversified and high-quality tenant mix maintained,
• Key hospital operator profitability (portfolio basis) further improved versus pcp, to almost
two times rent cover
2
• Weighted average capitalisation rate of the property portfolio softened 23bps to 5.54%,
resulting in an unrealised value reduction of $96.7 million - signs are now emerging that
property valuations have begun to stabilise
Development
Good progress was made in delivering Vital’s committed development pipeline with two
projects totalling $108.8 million being completed, substantially on time and budget. At 30
June 2025 only $36.9m remains to be deployed.
Subject to achieving hurdle earnings and value accretion outcomes for Unit Holders and
available capital, the focus for FY26 and beyond is the activation of the embedded value in
Vital’s robust development pipeline.
Key outcomes include:
• Completed the delivery of the:
o A$16.0 million expansion of Maitland Private Hospital (NSW), on a project yield of
6.0%; and
o $91.5 million Stage 2 of the $141.4m redevelopment of Wakefield Hospital
(WGN), on a project yield of 5.7%
• Initiated a $11.5 million capacity expansion project at Wakefield Hospital in June 2025,
on a project yield of ~7.0%
• Awarded Sector Leader by GRESB for ESG in healthcare for listed entities globally for
developments
Capital management
With strong support from Vital’s banking group in FY25, Vital extended $1.1 billion of debt
facilities (75% of total facility limits) on enhanced terms and pricing. Vital’s defensive,
diversified and long dated cashflows support current gearing at 42.1%, with material
headroom to bank covenants.
1
Determined on a constant currency basis
2
Measured as Rent/EBITDAR (earnings before interest, tax, depreciation, amortisation and rent) for the last twelve months to
31 March
VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare
Properties Management Limited
Page 3 of 4
The continued focus on disciplined capital management and deployment resulted in select
non-core asset recycling initiatives totalling $50 million, with the proceeds deployed to fund
Vital’s remaining committed development projects.
Key outcomes include:
• $1.1 billion debt refinance completed, delivering improved terms, pricing and an
extended maturity profile
• Strong balance sheet maintained – Gearing
3
at 42.1%, up from 39.1% in the pcp
• Weighted average debt duration extended to 3.8 years with no debt maturing until
March 2027
• Interest rate hedging cover increased to 82% with a weighted average duration of 3.2
years and weighted average hedged rate of 3.55% for FY26
• $50 million realised from non-core asset sales, with the proceeds reinvested into funding
Vital’s high quality committed development projects.
Outlook and guidance:
Vital is well placed for FY26 and beyond as a number of the headwinds that have impacted
healthcare property and the real estate sector more generally begin to abate, including
higher interest rates, operator challenges in Australia, and a risk off position from investors.
The recovery in New Zealand is further advanced than Australia, with continued strong
operator performance and a stabilisation of property valuations and moderation in
construction costs observed.
The continuation of this trend will allow the fundamentals of the Vital business to again emerge
including strong demand for health services, an attractive income return from a high-quality
diversified tenant base and opportunities to leverage the embedded value within the Vital
portfolio.
The Board and management are confident with Vital’s strategy to deliver attractive risk
adjusted returns over the medium to long term for our Unit Holders.
Distributions totalling 9.75cpu (payable quarterly) are forecast for FY26.
Conference call and webcast:
A conference call and webcast are scheduled for 10:00 am (NZST) on Wednesday, 13 August
2025. Participants are encouraged to pre-register for the event to avoid delays.
Conference call
Participants can register for the conference call by navigating to: https://s1.c-
conf.com/diamondpass/10043436-iyn8gk.html
Please note that registered participants will receive a pin upon registration allowing direct
entry to the call.
3
Trust Deed Gearing Ratio – calculated as total borrowings to gross asset value of the Trust. Bank Loan to Value ratio was
43.6% (covenant: 55.0%) at 30 June 2025.
VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare
Properties Management Limited
Page 4 of 4
Webcast
Presentation slides and audio can be viewed by copying the following URL into your internet
browser: https://event.choruscall.com/mediaframe/webcast.html?webcastid=LzAZ47i2
You will be required to input your name, email address and company name to register for the
webcast.
A copy of the webcast will be available on Vital’s website later in the day at: www.vhpt.co.nz
– ENDS –
ENQUIRIES
Chris Adams
Co-Head, A/NZ, Northwest Healthcare Properties Management Limited
Tel +61 408 665 332, Email chris.adams@nwhreit.com
Michael Groth
Chief Financial Officer, Northwest Healthcare Properties Management Limited
Tel +61 409 936 104, Email michael.groth@nwhreit.com
About Vital (NZX code VHP):
Vital Healthcare Property Trust is an NZX-listed fund that invests in high-quality healthcare
properties in New Zealand and Australia including private hospitals (~78%* of portfolio value),
ambulatory care facilities (~18%* of portfolio value) and life science facilities (~4%* of portfolio
value).
Vital is the leading specialist listed landlord of healthcare property in Australasia.
Vital is managed by Northwest Healthcare Properties Management Limited, a subsidiary of
Toronto Stock Exchange listed Northwest Healthcare Properties REIT (TSX: NWH-UN.TO), a global
investor and manager of healthcare infrastructure.
For more information, please visit our website: www.vhpt.co.nz
For more information about Northwest, please visit: www.nwhreit.com
__________________________________
* All figures are as at 30 June 2025, NZD/AUD exchange rate of 0.9275.
---
Annual Report
2025
Driving operational performance
F Y 2 5
OUTCOMES
9. 75cpu
Distributions paid to Unit Holders
3.7%
Like-for-like Net Property Income (NPI) growth
$2.47
Net Tangible Assets (NTA) per unit
98.6%
Occupancy
Contents
AWARDS AND RECOGNITION
As part of its sustainability efforts, hard copy Annual Reports will no
longer be mailed unless specifically requested by Unit Holders. As
with previous results, the full Annual Report will be emailed to Unit
Holders and will be available on the NZX and be posted on Vital’s
website: https://www.vitalhealthcareproperty.co.nz/financial-
results/. This initiative will save approximately 252,000 pages of
printing per annum and reduce our greenhouse gas emissions both
through reducing printing and mailing.
Investors who would like to receive a printed Annual Report can
request one by calling Computershare on +64 9 488 8777,
emailing enquiry@computershare.co.nz or mailing a request
to: Computershare Investor Services Limited, Private Bag 92119,
Auckland 1142.
2025 NEW ZEALAND COMMERCIAL
PROJECT AWARDS – GOLD | ORMISTON
HOSPITAL STAGE 1 EXPANSION
GOLD AWARD FOR VITAL’S
ANNUAL REPORT
About Vital and Northwest 4
Overview of Vital 6
FY25 Key Events 10
Manager’s Report 12
Financial Summary
and Portfolio Metrics 16
Asset Allocation 17
Australian Portfolio Overview 18
New Zealand Portfolio Overview 20
Completed Developments 22
Committed Developments 28
Sustainability 34
Our Board 54
Our Executive Team 56
Corporate Governance 58
Financial Statements 68
Vital’s Structure 11 6
Directory 11 8
CIVIC, HEALTH AND ARTS PROPERTY AWARD
ORMISTON HOSPITAL STAGE 1 EXPANSION
DEVELOPMENT EXCELLENCE AWARDS 2025
– WINNER – HIGHLY COMMENDED HEALTH
SOCIAL INFRASTRUCTURE | MACARTHUR
HEALTH PRECINCT STAGE 1 (GENESISCARE,
CAMPBELLTOWN)
MBA NSW 2024 AWARDS - EXCELLENCE IN
SUSTAINABILITY – COMMERCIAL CATEGORY
| MACARTHUR HEALTH PRECINCT STAGE 1
(GENESISCARE, CAMPBELLTOWN)
GRESB SECTOR LEADER IN DEVELOPMENTS
FOR LISTED HEALTHCARE GLOBALLY
All values in this report are in NZ dollars
unless stated otherwise.
ANNUAL REPORT 2025
|
3
TSX listed owner and manager of
NZ$10.3b of healthcare infrastructure
across four continents.
EXCELLENCE
Delivering exceptional outcomes
INTEGRITY
Doing what’s right
PARTNERSHIP
Succeeding together
Northwest (Australia and New Zealand)
is the manager of Vital, with over 50
professionals in the region. We have offices
in Auckland, Melbourne and Sydney.
Be the leading global diversified healthcare real estate entity.
Vision
Provide best in-class real estate solutions to the healthcare industry
and deliver exceptional shareholder value to investors.
Mission
Values
4
|
VITAL HEALTHCARE PROPERTY TRUST
Vital is an NZX listed
property trust which
owns ~$3.2b of
healthcare property in
New Zealand
and Australia.
To be Australia and New Zealand’s leading listed healthcare property fund.
Deliver stable and growing total Unit Holder returns, including an attractive
risk-adjusted income distribution, sourced from healthcare real estate.
Vision
Mission
ANNUAL REPORT 2025
|
5
WESTERN
AUSTRALIA
NORTHERN
TERRITORY
SOUTH
AUSTRALIA
NEW SOUTH
WALES
TASMANIA
VICTORIA
QUEENSLAND
Overview of Vital
1
1
All numbers quoted on this page relate to income producing properties only and exclude strategic land holdings.
4%
8%
22%
12 %
21 %
6
|
VITAL HEALTHCARE PROPERTY TRUST
18.5 years
WALE
$148.8m
NET PROPERTY
INCOME
Avive Clinic, Melbourne
30%
3%
SOUTH
ISLAND
NORTH
ISLAND
5.5%
$3.2
b
WEIGHTED
AVE CAP RATE
PORTFOLIO
VALUE
ANNUAL REPORT 2025
|
7
Acute Hospitals 58.1%
Ambulatory Care 22.2%
Specialty Hospitals
(mental health and rehabilitation) 19.7%
Sub-sector diversification
% of Value
Key Numbers
Healthe Care 16.4%
Allevia 3.0%
Epworth HealthCare 13.7%
Evolution Healthcare 13.9%
Burnside 3.0%
Southern Cross 4.2%
GenesisCare 2.3%
Endoscopy Auckland
1
1.5%
Boulcott Hospital 1.7%
Other 21.9%
Aurora Healthcare 18.4%
Tenant diversification
% of Rent
18.4%
21 . 9 %
16.4%
2.3%
1.7%
1.5%
4.2%
3.0%
3.0%
13.9%
13.7%
A
M
B
U
L
A
T
O
R
Y
C
A
R
E
2
2
.
2
%
AMBULATORY
CARE
SPECIALTY
HOSPITAL
ACUTE
HOSPITAL
58.1%
H
O
S
P
I
T
A
L
7
7
.
8
%
22.2%
19.7%
1
Joint venture between Evolution Healthcare and Allevia
8
|
VITAL HEALTHCARE PROPERTY TRUST
2.0%
42.1%
BALANCE SHEET GEARING
DISTRIBUTION 10-YEAR CAGR
PER ANNUM FY15 - FY25
$4.9m
LIKE-FOR-LIKE NET PROPERTY
INCOME GROWTH OVER FY25
9. 75cpu
FY26 DISTRIBUTION
GUIDANCE
~$2.2b
COMMITTED AND POTENTIAL
DEVELOPMENT PIPELINE
Maitland Private Hospital, Maitland
ANNUAL REPORT 2025
|
9
AUGUST 2024
• Grace Hospital Oropi Day Unit (Stage 4
of 5) reached practical completion.
SEPTEMBER 2024
• Vital marked 25 years of being listed on
the NZX.
• A$16.0m Maitland Private Hospital
expansion reached practical completion.
• PCNZ Property Conference
delegates tour of Wakefield
Hospital’s redevelopment.
OCTOBER 2024
• A$57.4m Macarthur Health Precinct Stage 1
(GenesisCare Integrated Cancer and Health Centre)
achieved Excellence in Sustainability – Commercial
Category at the Master Builder’s Association NSW
2024 Awards.
• GRESB – Vital was again recognised as a Global
Sector Leader for ESG in Developments for listed
healthcare globally.
• Prime Minister Rt Hon. Christopher Luxon opened
the $38.1m Ormiston Hospital Stage 1 Expansion,
operated by Southern Cross Healthcare.
• Inaugural Climate Related Disclosure was released.
JULY 2024
FY25 Key Events
QUARTER 1
QUARTER 2
Prime Minister Rt Hon. Christopher Luxon opened
the Ormiston Hospital Stage 1 Expansion
South Australia’s Minister for Health and Wellbeing,
Hon. Chris Picton MP officially opened Playford Health Hub Stage 2
10
|
VITAL HEALTHCARE PROPERTY TRUST
JANUARY 2025
• GenesisCare Integrated Cancer and Health Centre awarded
6 Star Green Star Design & As Built v1.3 certified rating.
• $11.5m Level 5 expansion at Wakefield Hospital commenced.*
FEBRUARY 2025
• Health Minister Simeon Brown officially opened Wakefield
Hospital Stage 2 redevelopment, which is operated by
Evolution Healthcare.
• South Australia’s Minister for Health and Wellbeing,
Hon. Chris Picton MP officially opened the A$43.4m Playford
Health Hub Stage 2 tenanted by Calvary, Sonic Healthcare,
GenesisCare, SA Health and Radiology SA.
• Keystone Trust Student awarded the 2025 Vital Healthcare
Property Trust Keystone Scholarship.
MAY 2025
• Ormiston Hospital Stage 1 Expansion achieved
Gold in the Health category at the New Zealand
Commercial Project Awards.
• Playford Health Hub Stage 2 awarded 6 Star Green
Star Design & As Built v1.3 certified rating.
JUNE 2025
• Ormiston Hospital Stage 1 Expansion achieved an
Excellence award in Civic, Health and Arts Category
at the PCNZ Awards.
• $1.1b debt refinancing – Vital extended debt maturity
to 3.83 years with improved terms and no maturities
until March 2027.
JUNE 2025
QUARTER 3
QUARTER 4
*Funding approved in May 2025.
Award-winning Ormiston Hospital Stage 1 Expansion
Health Minister Simeon Brown officially
opened Wakefield Hospital Stage 2
ANNUAL REPORT 2025
|
11
Manager’s Report
Tēnā koutou,
Northwest Healthcare Properties Management Limited (Northwest),
the Manager of Vital Healthcare Property Trust (Vital), is pleased to
report Vital’s results for the year ended 30 June 2025 (FY25).
FY25 highlights included:
• Like-for-like net property income (NPI) up 3.7%
1
.
• Enhanced occupancy of 98.6% with over 9,400sqm of vacancy
leased, primarily space at recently completed developments.
• Distributions of 9.75cpu (consistent with guidance) delivered on
a 93.6% AFFO pay-out ratio.
• Completed $1.1b debt refinance, delivering improved terms and
longer duration.
• Delivered two value enhancing developments:
–A$16.0m expansion of Maitland Private Hospital (NSW),
completed in September 2024. This expansion provided
additional mental health and surgical beds, day oncology
chairs, consulting suites and car parking.
–Stage 2 ($91.5m) of Vital’s $141.4m investment into the
redevelopment of Wakefield Hospital (WGN). This state-
of-the-art facility was officially opened by the Hon. Simeon
Brown, Minster of Health in February 2025.
• Commenced an $11.5m capacity expansion of Wakefield
Hospital in June 2025.
• Awarded Sector Leader (the highest possible achievement)
by GRESB for ESG in healthcare for listed entities globally
for development.
• Profitability of our underlying hospital tenants improved with
key rental affordability metric increasing to 57% from 51%.
2
Our commitment to sustainability
Vital’s approach to sustainability is grounded in understanding
and addressing the ways our operations affect both people and
the environment. We remain committed to actively enhancing our
long term sustainability outcomes, both commercially and for the
communities in which we operate.
In FY25 we released our first climate-related disclosure,
aligned with the Aotearoa New Zealand Climate Standards
developed by the External Reporting Board (XRB). This sets out
our climate governance, strategic priorities, risk approach and
performance measures.
Key highlights this year include:
• Submission to GRESB for the fifth consecutive year,
demonstrating continued transparency and performance
benchmarking. Results are expected in October 2025.
• Commenced climate-resiliency property assessments to better
understand and manage physical climate risks.
• Achieved 6 Star Green Star Design & As Built certifications at
Playford Health Hub Stage 2 and the GenesisCare Integrated
Cancer Centre, seeking to deliver sustainable design,
construction and resilient properties.
• Continued implementation of our Reflect Reconciliation
Action Plan (RAP), tracking against key initiatives that support
reconciliation and cultural awareness.
• Leveraged an industry-leading modern slavery platform,
with suppliers actively participating in risk assessments and
transparency efforts.
Portfolio overview
Active asset management remained a high priority throughout FY25.
Over 51,000sqm of space were leased, extended or renewed
during the year, representing 22% of Vital’s total income and 20%
of the portfolio's lettable area, locking in secure, defensive and
long term cashflows for Unit Holders.
These strong leasing outcomes, including over 9,400sqm of
new leasing activity, lifted portfolio occupancy from 98.0% to
98.6% and increased weighted average lease expiry (WALE)
by 0.2 years to 18.5 years, despite the passage of time.
It is worth noting that Vital’s WALE was 18.1 years in FY20,
increasing despite five years passing reflecting leasing,
developments, divestments, acquisitions and other initiatives
undertaken during this time.
The weighted average valuation capitalisation rate on Vital's
property portfolio softened to 5.54% at 30 June 2025, resulting
in an unrealised value reduction of $96.7m. Signs have emerged
that valuations are stabilising.
1
On a like-for-like, constant currency basis
2
Rent cover ratio = Rent / EBITDAR (Earnings before interest, tax, depreciation, amortisation and rent) for last twelve months to 31 March 2025.
Distributions of 9.75cpu delivered, underpinned by occupancy increasing to 98.6% and
structured rent reviews.
12
|
VITAL HEALTHCARE PROPERTY TRUST
3.7%
INCREASE IN LIKE-FOR-LIKE
NET PROPERTY INCOME
~$3.2b
PROPERTY
PORTFOLIO
2024 GRESB SECTOR
LEADER - DEVELOPMENTS
Developments
Good progress was made during the financial year in completing
Vital’s committed developments.
The projects at Maitland Private Hospital and Wakefield Hospital
totalling $108.8m were successfully operationalised in FY25.
New opportunities are being considered on a selective value
adding basis and include the commencement of a new $11.5m
capacity expansion project at Wakefield Hospital.
At 30 June 2025, Vital had $249.9m of developments under way in
New Zealand and Australia, with approximately $36.9m remaining
to spend (excluding land costs).
Acquisitions
No significant acquisitions were made during FY25.
Divestments
Over FY25, the following assets were divested, realising gross
proceeds of $49.7m:
1. In October 2024, the sale of Hirondelle Private Hospital
(NSW) to a private investor settled for A$24.0m.
2. In December 2024, Epworth Rehabilitation (VIC) was sold
with vacant possession to Arcare for A$19.3m as services
ceased at this facility. This sale included two adjacent
residential houses.
3. In May 2025, a residential house in Sydney no longer
required for expansion of a nearby Vital asset was sold for
A$1.7m.
The above sales were achieved at an average 7.0% discount to
book value.
Playford Health Hub, Adelaide
In conjunction with our highly
supportive banking group, $1.1b of
debt extensions were completed in
the year resulting in:
• Improved terms, multicurrency flexibility and
pricing enhancements
• Weighted average debt duration extended to
3.8 years with no debt maturing until March
2027
• Interest rate hedging cover increased to 82%,
with a weighted average duration of 3.2 years
ANNUAL REPORT 2025
|
13
GenesisCare Integrated Cancer and Health Centre, Sydney
Net property income
Net property income increased by 3.7% over FY25 (on a
like-for-like, constant currency basis), reflecting contributions
from the structured rent reviews from the portfolio, improved
occupancy and leasing outcomes.
In FY25, approximately 83% of Vital's rent was linked to CPI,
with 75% of this having a weighted average annual cap of
~3.6% with the balance being uncapped. This rent review
structure is designed to provide Vital’s Unit Holders with
sustainable income growth opportunities.
Financial results
Cash from operations (measured by AFFO) was $70.4m
(down 3.5%) and 10.41cpu (down 4.5%). This outcome
reflects increased tax expense, following law changes, and
interest expense versus growth in net property income after
taking into account the impact of completed developments and
divested property.
Expenses were $71.4m, 1.1% higher than FY24 reflecting
higher borrowings costs and strategic transaction costs,
offset by lower management fees.
Vital’s NTA per unit decreased by 7.9% to $2.47 primarily
due to $96.7m of unrealised property revaluation losses
attributable to +23bps portfolio capitalisation rate softening,
partially offset by development margin gains, rental growth
and leasing. Additionally there were $28.7m of unrealised fair
value losses on the value of derivatives driven by the declining
interest rate environment.
Capital management
Vital’s strong balance sheet was maintained throughout
FY25, with gearing as at 30 June 2025 of 42.1%, well below
financial covenants.
During FY25, with the strong support from Vital’s banking
partners, over $1.1b of debt facilities were extended on
improved terms and flexibility resulting in a weighted average
duration of 3.8 years at 30 June 2025 and no debt maturing
until March 2027. 82% of Vital’s borrowings were hedged at
an average fixed rate of 3.32% at 30 June 2025.
Vital’s distribution reinvestment plan remained active for FY25
raising $6.2m to fund Vital’s development opportunities. A
2.0% issue price discount applied on and from the third quarter
distribution payment.
FY26 guidance
The Board and management are pleased to provide FY26
distribution guidance of 9.75cpu (payable quarterly),
consistent with FY25 distributions.
Refer to disclaimer on back page of this report for limitations
to this guidance.
14
|
VITAL HEALTHCARE PROPERTY TRUST
New Zealand healthcare sector
New Zealand’s private healthcare sector continues to perform
well, with strong underlying demand for services being
experienced by our key hospital tenants.
Signs have recently emerged of the stabilisation in property
valuations and construction costs, although still high, are
moderating. We expect demand for new private healthcare
infrastructure to emerge over the coming year.
Australian healthcare sector
The broader Australian healthcare sector is showing signs of
emerging from its recent short-term challenges, as pressures
from health inflation, private health insurance funding dynamics
and higher interest rates begin to moderate.
Hospital operator profitability continues to improve as the
impact of recently renegotiated private health insurance rates
takes effect, however this has yet to fully translate into broader
confidence in the sector.
Longer term healthcare sector thematics
Over the long-term, sector thematics for New Zealand and
Australian healthcare services are unchanged and positive.
A strong and viable private healthcare sector remains
fundamental to the delivery of healthcare services across both
countries.
Ageing and growing populations, rising life expectancies and
continued technological advancements in health solutions,
combined with public funding capacity constraints underpin
Vital’s confidence in the sector and its ability to deliver long-
term risk adjusted returns for Unit Holders.
Vital’s strategic positioning
Vital’s property portfolio is characterised by high-quality, well
located healthcare properties with embedded development
opportunities that can be activated over time.
This, combined with high income security afforded by a long
weighted average lease term (WALE) to a high-quality and
diversified tenant mix, provides the expectation for Vital to
deliver long term Unit Holder value.
Graham Stuart
Independent Chair
13 August 2025
Northwest Healthcare Properties Management Limited,
the Manager of Vital Healthcare Property Trust
Chris Adams
Co-Head A/NZ Region
Vital has completed over $272m of capital
recycling initiatives since FY23, including
~$50m in FY25, investing the proceeds from
the sale of these non-core properties into
high-quality developments like the recently
completed Maitland Private Hospital
expansion and the redeveloped
Wakefield Hospital. This focus on actively
curating the property portfolio, offers the
potential for enhanced Unit Holder return
benefits over the medium term, reflecting
enhanced property quality, resilience
and performance.
FY26 outlook
We believe the Vital business is well placed for FY26 and beyond
as we begin to see many of the headwinds that have impacted
healthcare property and the real estate sector more generally
begin to abate, including higher interest rates, operator challenges
in Australia and a risk off position from investors.
The recovery in New Zealand is further advanced than Australia,
with continued strong operator performance and a stabilisation of
property valuations and moderation in construction costs observed.
The continuation of this trend will allow the fundamentals of the
Vital business to again emerge including strong demand for health
services, an attractive income return from a diversified tenant base
and opportunities to leverage the embedded value in the Vital
portfolio.
The Board and management remain confident around Vital’s
strategy for delivering medium-long term returns for our
Unit Holders.
We encourage you to join us and look forward to welcoming you
to our Annual General Meeting being held on 6 November 2025.
Nā māua noa, nā
ANNUAL REPORT 2025
|
15
Financial summary
Portfolio metrics
All figures are in New Zealand dollars (NZD) unless otherwise stated
All figures are in New Zealand dollars (NZD) unless otherwise stated
1
Excludes properties held for development
FY21FY22FY23FY24FY25
Financial Performance
Net property income109,66312 3 , 018145,224144,533148,834
Revaluation gain/(loss) on investment properties235,383244,239(208,553)(165,244)(96,722)
Net interest expense27,68428,9833 7, 7 7 040,60645,169
AFFO and distributions
Adjusted Funds From Operations (AFFO)
1
57,457 6 7, 8 2 473, 33572,89970,369
AFFO (cpu)11 . 5 411 . 9 211 . 1 810.9010.41
Cash distribution to Unit Holders (cpu)8.889.639. 759. 759. 75
Financial Position
Total assets2,662,5603,399,8343,429,7123,304,7593,248,092
Borrowings929,3001,018,7771,239,1561,287,4771,363,639
Total equity1,503,4512,165,8761,957,3831,805,1261,679,515
Debt to total assets ratio (%)35.030.036.33 9 .14 2 .1
Net tangible assets ($ per unit)2.893.342.962.692.47
20212022202320242025
Investment properties ($m)2,634.03,339.03,381.03,240.03,212.0
Number of investment properties
1
4146453634
Occupancy (%)99.298.898.998.098.6
Weighted average lease term to expiry (years)18 . 717. 617. 818.318.5
12 month lease expiry (% of income)1. 71. 71.81.21. 7
Financial Summary
16
|
VITAL HEALTHCARE PROPERTY TRUST
1
Healthcare precinct = area or hub for healthcare delivery typically including at least two of a public hospital, major private hospital, health teaching facility or health research facility
Comprises
Public, private, speciality,
rehabilitation and mental
health hospitals
Targeting
Government supported
or high private health
insurance catchments with
growing populations
Comprises
Residential aged care
facilities (excluding
retirement facilities)
Targeting
High quality operators with
substantial balance sheets
and <45.0% rent/EBITDAR
and high-quality infrastructure
Indicative target portfolio weighting
50 - 70%
(30 June 2025: 78%)
Indicative target portfolio weighting
10 - 20%
(30 June 2025: 0%)
HOSPITALS
AGED CARE
OUT-PATIENT/AMBULATORY
CARE
LIFE SCIENCES/RESEARCH
Comprises
Administration, diagnostic
services and specialist
consulting, primary care
out-patient facilities
Targeting
Facilities located in a
healthcare precinct
1
and/or from where
healthcare is delivered
Comprises
Biotechnology,
pharmaceutical, biomedical,
university, health education
and other research facilities
Targeting
Specialised facilities and/
or facilities located in a
healthcare precinct
1
Indicative target portfolio weighting
10 - 20%
(30 June 2025: 18%)
Indicative target portfolio weighting
5 - 15%
(30 June 2025: 4%)
Asset Allocation
Hospitals are expected to remain
the core of Vital's portfolio.
Ageing population in Australia and New
Zealand presents continued investment
opportunity in aged care. The asset class
remains a growth target for Vital subject to
identification of suitable opportunities of scale.
Ambulatory care is expected to be a key growth
area in Australia and New Zealand reflecting shifts
in healthcare delivery models in both countries.
Expected to increase
on completion of RDX.
The indicative target asset allocations listed below
provide an indication of how we could move the portfolio
over time subject to appropriate acquisition and /
or development opportunities becoming available.
ANNUAL REPORT 2025
|
17
PRIVATE
HOSPITALS
AMBULATORY
CARE
• 14 hospitals (acute and specialty
– mental health, rehabilitation)
•5 hospital operators
• 83.0% of AUS portfolio value;
86.0% of AUS portfolio rent
• WALE: 20.7 years
• 6 assets, multiple tenants
• 17.0% of AUS portfolio value;
14.0% of AUS portfolio rent
• WALE: 9.5 years
WESTERN
AUSTRALIA
SOUTH
AUSTRALIA
NEW SOUTH
WALES
VICTORIA
QUEENSLAND
2
3
6
2
7
Australian Portfolio
Overview
18
|
VITAL HEALTHCARE PROPERTY TRUST
VICTORIA
QUEENSLANDNEW SOUTH WALES
WESTERN AUSTRALIA
SOUTH AUSTRALIA
• Belmont Private Hospital
• Currumbin Clinic
• GenesisCare Integrated
Cancer and Health Centre
• Hurstville Private Hospital
• Kellyville Private Hospital
• Lingard Day Centre
• Lingard Private Hospital
• Maitland Private Hospital
• Toronto Private Hospital
• Abbotsford Private Hospital
• Marian Centre
• Burnside Hospital - Stepney
• Playford Health Hub – MOB,
Retail and Carpark
• Tennyson Centre
• 120 Thames Street
• Avive Clinic Mornington Peninsula
• Ekera Medical Centre
• Epworth Camberwell
• Epworth Eastern Hospital
• South Eastern Private Hospital
~$2.1b
20
1
PROPERTIES (AUS)
1
Income Producing Property (excludes strategic assets)
www.vitalhealthcareproperty.co.nz/portfolio/
Full details of individual
properties are available at:
ANNUAL REPORT 2025
|
19
New Zealand
Portfolio Overview
NORTH
ISLAND
SOUTH
ISLAND
12
2
PRIVATE
HOSPITALS
AMBULATORY
CARE
•9 hospitals (all acute)
•6 hospital operators
• 84.1% of NZ portfolio value;
84.3% of NZ portfolio rent
•WALE: 19.2 years
• 5 assets, multiple tenants
• 15.9% of NZ portfolio value;
15.7% of NZ portfolio rent
• WALE: 10.2 years
• Ascot
• Ascot Carpark (Right of Use)
• Ascot Central
• Boulcott Hospital
• Bowen Hospital
• Endoscopy Auckland
• Grace Hospital
• Hutt Valley Health Hub
• Kensington Hospital
• Ormiston Hospital
• Royston Hospital
• Wakefield Hospital
• 68 Saint Asaph Street
• Kawarau Park Health Hub
NORTH ISLAND
SOUTH ISLAND
20
|
VITAL HEALTHCARE PROPERTY TRUST
Ormiston Hospital Stage 1 Expansion, Auckland
~$1.1b
14 PROPERTIES (NZ)
www.vitalhealthcareproperty.co.nz/portfolio/
Full details of individual
properties are available at:
ANNUAL REPORT 2025
|
21
Completed
Developments
During FY25, Vital completed
two developments with a total
development cost of $108.8m.
Details of the completed
developments follow on pages
24-25 of this report.
Playford Health Hub, Adelaide
22
|
VITAL HEALTHCARE PROPERTY TRUST
ANNUAL REPORT 2025
|
23
Wakefield Hospital has undergone a major
transformation to deliver leading healthcare services
and is the largest private hospital in Wellington. Vital’s
contribution capped at a total of $141.4m all in cost
for Stage 1 and 2, was reached in June 2024 with the
balance funded by operator Evolution Healthcare.
Wakefield Hospital - Stage 2
Spanning 6 storeys across multiple buildings and connected via a spacious
atrium, this redevelopment provides a seismically resilient facility with 7 fully
digital operating theatres, 2 cardiac catheterisation labs, 10 ICU/ HDU beds,
a 37-bed inpatient ward, 3,000sqm specialist medical consulting suite, full
radiology unit and new administration and front of house areas.
NLA STAGE 2 ONLY
~10,000sqm
TO WELLINGTON
PUBLIC HOSPITAL
1km
OPERATIONS
COMMENCED
January 2025
% OF VITAL'S
PORTFOLIO
5.9%
~$141. 4 m
TOTAL DEVELOPMENT COST
(INCLUDING $91.5M FOR STAGE 2)
NEW BEDS INCLUDING
10 HDU/ ICU BEDS
47
SUSTAINABILITY
FEATURES
Passive design,
thermal performance
and energy efficient
systems
24
|
VITAL HEALTHCARE PROPERTY TRUST
Located in NSW, servicing the Maitland and
greater Hunter region, the two stage expansion
increased services capacity for mental health and
oncology for operator Healthe Care.
Maitland Private Hospital
The initial stage of the redevelopment built a new level above the existing
mental health ward supporting an increase in the mental health service
capacity by 24 beds, including high quality consulting suites, communal
areas, group rooms and gymnasium.
The second stage relocated the day oncology unit, providing an increase of
5 chairs to 12, creating an improved space for the provision of services, whilst
leveraging the views of the Hunter region.
An additional 67 car parks and improvements to the hospital entry interface
and roadways were also completed as part of Stage 2.
NLA
1,155sqm
TO MAITLAND
HOSPITAL
1.8km
PRACTICAL COMPLETION
ACHIEVED
September 2024
% OF VITAL'S
PORTFOLIO
4.7%
NEW MENTAL HEALTH
BEDS + 4 SURGICAL
BEDS REFURBISHED
24
~ A$16 .0 m
DEVELOPMENT COST
SUSTAINABILITY
FEATURE
Utilisation of existing
common plant to
minimise additional
infrastructure
ANNUAL REPORT 2025
|
25
Wakefield Hospital, acquired by Vital in 2017, has been transformed to provide high quality healthcare
in a state-of-the-art private hospital and specialist facility, in partnership with Evolution Healthcare.
• Vital has contributed a total of $141.4m to the major
redevelopment of Wakefield Hospital (Stage 1 and 2).
• The asset is strategically located ~1km from the Wellington
Public Hospital.
• A 30-year lease term will commence from Stage 2b
practical completion, forecast for late 2025.
• Level 5 expansion commenced in January 2025 to fitout 34
additional surgical beds, unlocking existing shell space, with
a blended net yield of ~7.0%.
• Future operating theatre expansion planning is already
under way to meet healthcare demand.
Under Vital’s ownership, the
redevelopment has transformed
the facility, delivering improved
sustainability and seismic resilience,
increased rental income, lease
duration and property valuation.
4 MAY 2017
(AT ACQUISITION)
30 JUNE 2025IMPROVEMENT
Rental Income~$1.4m~$11.1m693.0%
Asset Management Case Study
26
|
VITAL HEALTHCARE PROPERTY TRUST
1
Health Precinct = area or hub for healthcare delivery typically including at least two of a public hospital, major private hospital, health teaching facility or health research facility
Leasing Highlights
• Renewed car parking agreement - designed to
optimise operations and increase income
• New Lease to Basis, improving occupancy to 82%,
up from 71.1% in FY24
• Strong interest in remaining unlet space
• Strong tenant retention with all major tenants renewed,
maintaining asset occupancy at 100.0%
• WALE 6 years
• Strong tenant covenants including being anchored by
the South Australian Government (OPERA Clinic and
Lyell McEwin Renal Dialysis unit)
• Occupancy increased to 92% since practical
completion in May 2024
• Vacancies successfully leased
• Asset occupancy 100.0% post balance date, up from
75.7% in FY24
• Ascot Central
- ~4,800sqm GFA
- 100.0% leased, up from 96.9% in FY24
- 15 tenants, anchor tenant Fertility Associates
- WALE ~5.0 years
• Ascot
- ~11,400sqm GFA
- 100.0% leased, up from 98.4% in FY24
- 11 tenants, anchor tenant, Allevia Health
- WALE ~15 years
• Ascot Carpark
- 97.3% leased, up from 91.5% in FY24
68 ST ASAPH STREET
TENNYSON CENTRE
PLAYFORD HEALTH HUB
120 THAMES STREET
ASCOT HEALTH PRECINCT
1
ANNUAL REPORT 2025
|
27
Committed
Developments
Vital has five committed
developments under way at a
total projected cost of $249.9m
with $36.9m remaining to spend.
1
This potential development pipeline is expected to be delivered
over a long period of time (~10 years) and is subject to market
conditions being supportive and a range of other requirements
including minimum tenant precommitments.
Vital’s committed and potential
development pipeline of ~$2.2b
(assuming strategic land is fully
developed)
1
remains extensive with a
focus on asset resilience, quality and
portfolio growth.
RDX, Gold Coast (Artist’s Impression)
28
|
VITAL HEALTHCARE PROPERTY TRUST
SUSTAINABILITY FEATURES
Immediately adjacent to the public Hutt Valley
Hospital and Vital owned Hutt Valley Health Hub,
Boulcott Hospital is undergoing a refurbishment and
expansion to increase theatre capacity and support
services, whilst maintaining operational continuity.
An Importance Level 3
facility (building code
and seismic rating
compliance)
Reduced
embodied
carbon
Passive design and
thermal performance
Energy
efficient
systems
estimated
development cost
$24.8m
WALE
20.0 years
1
yield on cost
~6.0%
1
Estimated on practical completion
This complex refurbishment and expansion includes 2 additional
operating theatres, increased capacity within the day stay and
recovery units, a new kitchen and associated support services.
Master planning has commenced for future expansion at Boulcott
Hospital and Vital’s adjacent site at Hutt Valley Health Hub.
Boulcott Hospital, Wellington
forecast completion
Mid-25
Boulcott Hospital, Wellington (Theatre - under construction)
ANNUAL REPORT 2025
|
29
SUSTAINABILITY FEATURES
An Importance Level 3
facility (building code
and seismic rating
compliance)
Reduced embodied
carbon
Passive design and
thermal performance
5 Star Green Star
design review rating
has been lodged
Energy efficient
systems
Adjacent to the existing Vital owned Endoscopy Auckland
on Gillies Avenue in Epsom, this 1,400sqm new stand alone
endoscopy and day surgery facility at 22 Kipling Avenue
is under construction and will be operated by a joint
venture between Evolution Healthcare and Allevia Health.
1
From practical completion
This 3-storey facility will provide 4 procedure rooms, a sterile services
department, associated support services and basement parking. Construction
works are materially progressed with internal fitout works well under way.
Consent for an on grade car park at 24 Kipling Avenue to support the new
facility has been granted and works are expected to commence in August
2025.
estimated
development cost
$32.2m
WALE
20.0 years
1
forecast completion
Mid-late-25
yield on cost
~5.4%
Endoscopy Auckland, Epsom
Render
30
|
VITAL HEALTHCARE PROPERTY TRUST
SUSTAINABILITY FEATURES
An Importance Level 3 facility (building
code and seismic rating compliance)
with the addition of base isolators and
accelerometers designed to exceed the
latest seismic standards
Wakefield Hospital’s new acute services building
commenced operations in January 2025. Almost
immediately, demand for the future 34-bed ward within
the Level 5 shell space triggered the need for expansion.
1
From practical completion
Fitout works to the ward are under way and will increase the hospital
bed capacity to 81-beds (including 10 existing HUD/ ICU beds).
Expansion works are a reflection of the significant healthcare demands
at Wakefield Hospital and to enable future growth of the facility.
Beds will be commissioned in two phases with first 16-beds operational
in late 2025 and the remaining 18-beds operational in mid 2026.
estimated
development cost
$11 . 5 m
WALE
30.0 years
1
forecast completion
Late-25
fully let blended yield
~ 7.0%
Wakefield Hospital Level 5
Expansion, Wellington
Reduced embodied
carbon
Passive design and
thermal performance
Building services
designed around
stepped isolation
plane and
movement joints
Energy efficient
systems
ANNUAL REPORT 2025
|
31
total cost excl land
(A$7.2m)
A$134 . 2m
forecast completion
Early-26
forecast fully let
blended yield
~5.6%
RDX Lumina is a state-of-the-art health and research
focused facility under construction within the Gold
Coast Health and Knowledge Precinct (GCHKP).
By connecting place and possibility, our aim is to
provide real estate solutions for world-class life science
occupiers and innovators within RDX’s premier facility.
RDX, Gold Coast
Reduced embodied
carbon
Climate scenario
analysis and
adaptation
undertaken
End of trip facilities
and EV charging
All electric building
powered by
renewable energy
RDX spans 9 storeys and features sustainable design, targeting a 6 Star
Green Star rating, a first-in-precinct accomplishment. The building offers
a mix of clinical, research, laboratory and specialist consulting spaces,
with tenancies available for lease now. Construction is well progressed
with practical completion delayed to early 2026 due to inclement
weather (Cyclone Alfred) and to accommodate the rework of the feature
atrium. Located adjacent to the Gold Coast Private Hospital, RDX offers
attractive amenity and convenience for healthcare users and clinicians.
Artist’s Impression
Artist’s Impression
SUSTAINABILITY FEATURES
Targeting 6
Star Green Star
certification
32
|
VITAL HEALTHCARE PROPERTY TRUST
SEISMIC AND
SUSTAINABILITY FEATURES
In partnership with the hospital operator (a joint
venture between Evolution Healthcare and
Southern Cross), Grace Hospital continues to
undergo significant expansion.
estimated
development cost
$36. 7m
WALE
24.5 years
1
yield on cost
~5.5%
1
Estimated on practical completion
A multi staged redevelopment, 4 of 5 works packages are now complete.
Oropi Day Unit endoscopy expansion reached practical completion in
August 2024.
The final works package, a 10-bed inpatient unit expansion is currently
under construction with internal services and lining under way.
As the only private surgical hospital in the Bay of Plenty, this major
refurbishment and expansion of Grace Hospital responds to the healthcare
needs of the community.
Grace Hospital, Tauranga
forecast completion
Mid-26
An Importance Level 3
facility (building code
and seismic rating
compliance)
Reduced embodied
carbon
Passive design and
thermal performance
Energy efficient
systems
ANNUAL REPORT 2025
|
33
Sustainability
Whāia te iti kahurangi ki te
tūohu koe me he maunga teitei.
Seek the treasure you value most
dearly. If you bow your head, let
it be to a lofty mountain.
Whakataukī Māori proverb
Sustainability framework
Northwest acknowledges the Traditional Owners of Country
throughout Australia, especially the lands on which we live
and work, and recognises their continuing connection to lands,
waters and communities.
Northwest also acknowledges the Rangatiratanga of Māori as
Tangata Whenua and Treaty of Waitangi partners in Aotearoa
New Zealand. We pay our respects to all First Nations peoples
and to Elders past, present and emerging.
Ormiston Hospital (Stage 1), Auckland
Acknowledgement
of country
ENABLERS
Advancing our sustainability strategy through strong
governance structures and transparency.
Governance
Reporting and Disclosure
Through the development and revitalisation of healthcare
facilities, Vital and Northwest strive to deliver lasting value
for our tenants, support the wellbeing of our people,
protect the environment and strengthen our communities.
This purpose-driven approach informs how we invest and
act, underpinning our broader sustainability ambitions.
To support progress across each sustainability pillar, Northwest
has established a set of global Key Performance Indicators
(KPIs), which are monitored at the regional level. This report
outlines the A/NZ region’s performance against these KPIs,
with results disclosed under each corresponding pillar.
THRIVING
PARTNERS
Empowering healthcare
providers to deliver
better outcomes.
HEALTHY
PLANET
Contributing to a more
sustainable future.
STRONG
COMMUNITIES
Investing in the health and
vitality of our communities.
INCLUSIVE
COMPANY
Building a strong and
engaged workforce.
34
|
VITAL HEALTHCARE PROPERTY TRUST
Having established a clear sustainability framework and robust set of strategic pillars, the real test lies
in how these principles translate into day-to-day decision-making, investment choices and stakeholder
outcomes. For Vital and Northwest, sustainability is not a peripheral commitment, it is a fundamental
lens through which we manage risk, identify opportunities and seek to deliver long-term value for all
stakeholders, including our investors, tenants, employees and the communities we serve.
In this sustainability section, we demonstrate how our strategy is embedded into the practical realities of
our business operations. From integrating climate resilience into asset management plans, to seeking to
drive measurable reductions in energy use, to working closely with partners across our supply chain to
ensure ethical and responsible practices.
We also recognise that achieving genuine progress requires moving beyond ambition to accountability.
That means disclosing transparently against global reporting standards and holding ourselves to a higher
bar year over year. Whilst challenges remain, we continue to integrate sustainability considerations into
our business operations to improve risk management, operational performance and long-term planning.
The practicalities of ESG – from framework to action
Kapa Haka Group from South Wellington Intermediate School
performing during the Wakefield Hospital
Stage 2 redevelopment official opening
ANNUAL REPORT 2025
|
35
Targets and
Achievements
FY25 key ESG highlights
6 61
hours of staff volunteering
489.4 Mwh
solar generation across
Vital assets
98.1%
improvement in air quality
at Tennyson Centre
100%
100%
of landlord controlled
sites have emergency
preparedness plans in place
27
assets have a Green Star*
Performance rating
7
developments are
targeting a minimum of 5
Star Green Star* ratings
* Refer to page 49 for details on Green Star ratings
of landlord controlled base building
electricity contracts use renewable energy
36
|
VITAL HEALTHCARE PROPERTY TRUST
Playford Health Hub, Adelaide
GenesisCare Integrated Cancer and Health Centre, Sydney
Playford Health Hub - Stage 2
South Australia’s first 6 Star Green Star
certified medical office building
GenesisCare Integrated Cancer
and Health Centre, Sydney
6 Star Green Star
ANNUAL REPORT 2025
|
37
Materiality
Materiality process
In 2024, Northwest, as manager of the Vital
portfolio, undertook a comprehensive update of
its materiality assessment to ensure we remain
focused on the sustainability topics that are most
significant, both in terms of their impact on the
environment, people and communities, and their
financial relevance to our long-term performance.
This updated assessment adopts double materiality principles, recognising that
sustainability is multifaceted and requires consideration of:
1. Impact materiality – how our activities affect the environment and broader
society, and
2. Financial materiality – how sustainability-related risks and opportunities
may influence business performance and value creation.
The evaluation spanned actual and potential impacts—both positive and
negative—across Vital’s operations and value chain, including business
relationships and asset lifecycle activities.
This materiality assessment will
continue to guide Vital’s ESG
reporting and decision-making,
ensuring that our approach remains
evidence-based, stakeholder-
informed and strategically aligned
with global best practices and
long-term value creation.
TOPIC IDENTIFICATION
Priority topics were identified through alignment
with internationally recognised sustainability
frameworks and standards, including:
• Global Reporting Initiative (GRI)
• Sustainability Accounting Standards Board (SASB)
• European Sustainability Reporting
Standards (ESRS)
In addition, Northwest considered investor
expectations, emerging ESG themes and
priority issues identified in the previous
2021 materiality assessment.
STAKEHOLDER ENGAGEMENT
Engagement with stakeholders was a core part of
the process. Through a combination of interviews
and surveys, Northwest gathered input from:
• Management and employees across
both Northwest and Vital
• Tenants and healthcare operators
• Suppliers and service providers
• Investors and ESG analysts
This process helped ensure that our sustainability
priorities are reflective of the expectations
and insights of those most connected
to and impacted by our business.
2
1
Healthy Planet
Thriving Partners
Inclusive Company
Strong Communities
Enablers
Playford Health Hub, Adelaide
38
|
VITAL HEALTHCARE PROPERTY TRUST
PRIORITISATION OF TOPICS
Each of the 27 sustainability topics evaluated
were assessed for both impact and financial
significance, and scored using a structured rubric.
The topics were then plotted on a materiality
matrix to clearly map their relative priority.
Key outcomes
Nine topics emerged as Tier 1 priorities,
representing the highest significance due to their
potential for material impact on the environment,
society and financial performance.
Tier 2 topics were also recognised for their importance,
particularly where they ranked highly from either an impact
or financial materiality perspective, such as Climate
Adaptation and Corporate Philanthropy and Volunteerism.
INTEGRATION OF FINDINGS
Following completion of the assessment, the findings
were reviewed and validated by Northwest’s
Corporate Sustainability Team and Executive
Leadership Team. These insights were directly used to:
• Refresh our sustainability strategy
• Update our key performance indicators (KPIs)
• Inform new and evolving sustainability-
related commitments
• Restructure our sustainability reporting
framework based on the themes and
pillars that emerged as top priorities
3
4
Healthy PlanetThriving PartnersInclusive CompanyEnablers
TIER 1 PRIORITY TOPICS
Building certifications
Corporate ethics and governance
Diversity, equity and inclusion
Employee health and safety
Energy management
Regulatory compliance
Tenant safety, wellbeing and inclusivity
Tenant satisfaction and experience
Waste management
The nine Tier 1 topics identified represent our priority focus, providing clear
direction for targeted action and resource allocation. These priorities are subject
to review as stakeholder expectations and operating conditions evolve and are
supported by other important themes also embedded in our broader strategy.
ANNUAL REPORT 2025
|
39
Enablers
Governance of ESG
Vital operates under a robust governance framework that
integrates climate and sustainability considerations into decision-
making at all levels. The Board holds ultimate responsibility
for overseeing climate-related risks and opportunities,
ensuring that environmental objectives are embedded in
Vital's strategic direction. The Board reviews climate-related
disclosures and metrics, including progress toward Vital’s net
zero 2050 target and maintains visibility through structured
quarterly reports, updates from management and dedicated
climate-focused sessions held throughout the year. These
sessions included targeted training on climate disclosure
frameworks and evolving legal obligations for directors.
Supporting this oversight, the Operational Risk Committee
(ORC) and Climate Working Group (CWG) play central
roles in identifying, assessing and managing material climate
risks and opportunities. These bodies report into the Board
via Vital’s leadership team, which includes the Heads of the
A/NZ Region, CFO and Regional General Counsel. The
CWG also collaborates closely with Northwest’s Global
Sustainability Team to ensure that emerging issues are escalated
appropriately. The CWG meets quarterly to assess emerging
climate risks, including asset-level vulnerabilities and transition
risks, and escalates material issues to the ORC. These insights
are incorporated into key business processes, including
acquisitions, divestments and developments, where climate
considerations are embedded in due diligence checklists
and capital planning. Vital’s Audit Committee is tasked with
reviewing the integrity of climate-related disclosures, verifying
compliance with regulatory standards and ensuring that
appropriate internal controls and external assurances are in
place for climate reporting. This layered structure ensures that
sustainability remains a core focus of governance at Vital.
ESG working groups
In addition to the Climate Working
Group and Operational Risk Committee,
Vital has established dedicated working
groups focused on key ESG priorities,
including Modern Slavery, Sustainable
Development, Operations and Facilities
Management, and Reconciliation and
Māori Culture. These groups provide subject
matter expertise, support implementation
of initiatives and ensure cross-functional
alignment on sustainability-related matters.
Integrating sustainability
into investments
By embedding sustainability into our investment
processes, we seek to create long-term value and
mitigate risks related to environmental and social factors.
Leases
We have updated our leasing practices to ensure that new
leases and renewals involving negotiated terms now include
clauses in leases which govern the collaboration with tenants
on energy efficiency, data sharing and sustainability initiatives.
Given the long weighted average lease expiry across our
portfolio, the adoption of these clauses is expected to grow
progressively over time as leases come up for renewal.
40
|
VITAL HEALTHCARE PROPERTY TRUST
Quarterly agenda plus
at least 2 climate specific
sessions per annum
• Heads of A/NZ
• CFO
• Financial Controller
• Regional General Council
• Director of Operations
and Sustainability
• Sustainability Manager
• Development Managers
VITAL
BOARD
OVERSEE
INFORM
MANAGE
IDENTIFY
OPERATIONAL
RISK COMMITTEE
SUSTAINABILITY
WORKING GROUPS
A/NZ
SUSTAINABILITY
STEERING
COMMITTEE
CLIMATE
WORKING
GROUP
Governance structure
Ormiston Hospital Stage 1 Expansion, Auckland
ANNUAL REPORT 2025
|
41
Reporting and disclosure
CLIMATE CHANGE AND RISK MANAGEMENT
Vital is a Climate Reporting Entity (CRE) and is required to
provide Climate-Related Disclosure (CRD). Vital released
its inaugural CRD in October 2024, in alignment with the
Aotearoa New Zealand Climate Standards (CS1, CS2,
and CS3). This disclosure included detailed reporting
across governance, strategy, risk management and
emissions metrics. Vital is preparing to release its second
CRD before 31 October 2025, with an enhanced focus on
the transition plan aspects of our strategy.
To support transparent and credible reporting, limited
assurance has been achieved over Vital’s GHG inventories
since CY22, covering full Scope 1, Scope 2, and Scope
3 categories. For FY25, we are targeting reasonable
assurance for Scope 1 and 2, and limited assurance for
Scope 3. Inventories have been developed using the GHG
Protocol, with material Scope 3 categories determined
via a scoping boundary assessment aligned with a 1%
materiality threshold. The outcomes of our FY25 inventory
and related scenario analysis will be reflected in our
next disclosure.
Vital's Climate Related Disclosures can be found on
our website.
GRESB
Vital submitted to the Global Real Estate Sustainability
Benchmark (GRESB) for the fifth consecutive year in 2025,
reinforcing our ongoing commitment to transparency,
accountability and continuous improvement. GRESB
remains a key global standard for real estate sustainability
benchmarking, enabling Vital to evaluate and compare
our performance across key environmental, social and
governance indicators. Participation also helps identify
opportunities for enhancement across the portfolio.
2024 results saw Vital maintain Sector Leader status for
Developments against listed healthcare peers globally.
• 2024 Standing Investment Score: 82/100
(75 global average)
• 2024 Development Score: 99/100 (85
global average)
Results of the 2025 submission are expected to be released
in October 2025.
Sector Leader
GRESB
B
CDP
BBB
MSCI
Forsyth Barr
B
Sustainalytics
14 . 9
ISS ESG
C-
4 .1
Craigs Investment Partners
42
|
VITAL HEALTHCARE PROPERTY TRUST
Human rights and modern slaveryData privacy and cybersecurity
Industry engagement
Human rights represent the fundamental freedoms,
protections and standards of treatment that every individual
is entitled to. Vital and Northwest are committed to
respecting the human rights of all people and upholding
internationally recognised standards, including those
set out in the Universal Declaration of Human Rights, the
International Bill of Human Rights, and the International
Labour Organization’s Declaration on Fundamental
Principles and Rights at Work. These frameworks guide
our approach to ethical business conduct and responsible
engagement across our operations and supply chains.
In line with this commitment, we assess and manage
modern slavery and human rights-related risks, particularly
in high-risk areas such as construction. This includes
annual modern slavery training for all Australian and
New Zealand employees, with specialised training for
key staff and the Modern Slavery Working Group.
To support responsible sourcing, we have a Supplier
Code of Conduct which is issued at the commencement
of supplier engagement and use the Informed 365
platform to distribute supplier questionnaires, track
responses and assess modern slavery risk. Contracts
are regularly reviewed to ensure alignment with
modern slavery legislation. These efforts are part of a
broader approach to embed sustainable procurement
approaches, reinforce our governance practices and
uphold internationally recognised human rights standards.
Northwest’s Modern Slavery Statement
can be found on our website.
Northwest remains committed to protecting sensitive
information and strengthening our cybersecurity. In
FY25, Northwest enhanced system security through
improved identity verification, access controls, cloud-
based infrastructure and upgraded network protections.
Threat detection, data loss prevention and server security
were also strengthened, alongside the introduction
of new data retention and backup protocols.
To support ongoing readiness, Northwest expanded
its cybersecurity team, launched mandatory
employee training and conducted regular phishing
simulations. A new device tracking system and disaster
recovery framework have been implemented.
Vital continues memberships across relevant industry
bodies to ensure we are abreast of evolving regulatory
standards, sustainability frameworks and industry
best practices. In FY25, our team again actively
participated in working groups, roundtables and
committees facilitated by the Property Councils of New
Zealand and Australia, as well as the Green Building
Councils in both countries. These engagements support
collaboration on topics such as sustainable development,
climate disclosure and legislative preparedness.
We are also members of Sustainable Healthcare Aotearoa
(SHA), a national network of healthcare professionals
focused on advancing low-emission, environmentally
sustainable healthcare in Aotearoa New Zealand through
collaboration, knowledge sharing and advocacy.
ANNUAL REPORT 2025
|
43
Thriving Partners
Places for quality care program
AIR QUALITY TESTING
100% of landlord-controlled assets within
the Vital portfolio have completed air
quality testing, reinforcing our commitment
to maintaining healthy indoor environments
across our healthcare facilities. Air quality
testing is conducted every two years.
DISASTER AND RECOVERY
PLANNING
Vital maintains comprehensive emergency
preparedness plans across all landlord-
properties, tailored to the specific risks
and operational requirements of each
site. These plans address a broad range
of potential scenarios, including natural
disasters, utility outages and critical
incident responses. Each plan is monitored,
reviewed and updated to reflect new
information, operational changes or
emerging risks, ensuring they remain current
and effective. This proactive approach
supports business continuity, safeguards
tenant wellbeing and reinforces the
resilience of our healthcare infrastructure.
TENANT PORTAL
Northwest is currently exploring the
adoption of Prism, a digital tenant
engagement and building performance
portal, across the A/NZ portfolio,
following its successful implementation
across Northwest’s assets in Europe.
The platform streamlines maintenance
workflows, enhances tenant communication
and supports data-driven sustainability
management. Prism enables real-time
tracking of building performance,
document management and preventative
maintenance, whilst also helping to identify
opportunities for improved efficiency and
reduced environmental impact.
Formalise “Places for Quality Care” programMaterial topic(s)
Complete air quality testing at 100% of landlord-controlled portfolio.
Energy Pollution and Air Quality
Tenant Safety, Wellbeing,
and Inclusivity
Business Continuity
Tenant Satisfaction
and Experience
Update disaster and recovery planning at properties and business units.
Deploy online tenant engagement portal to one additional region.
Enhance tenant satisfaction
Deploy annual tenant satisfaction survey.
Complete property-specific action plans to address
survey results for 75% of properties.
In progressSubstantially completeOn trackComplete
Ormiston Hospital Stage 1 Expansion, Auckland
44
|
VITAL HEALTHCARE PROPERTY TRUST
Tenant satisfaction
Project revitalise -
Ascot lobby upgrade
Tenant advisory committees
TENANT ENGAGEMENT SURVEY
In 2024, Vital tenants participated in a refreshed tenant
satisfaction survey to better understand their perspectives on
property management, communication and sustainability
priorities. The survey uses a standardised metric to track
satisfaction year over year and provides valuable insights to
guide service improvements.
Informed by the results, we are working to develop targeted
action plans. The goal is to complete these plans across 75% of
properties by the end of 2025. Going forward, the survey will
be conducted annually towards the end of the year, supporting
our commitment to continuous improvement and an enhanced
tenant experience.
As part of our commitment to proactive tenant engagement, we
have introduced tenant engagement meetings across our medical
office buildings in Australia and New Zealand. These meetings,
held annually and often aligned with site visits, offer a structured
forum to address a range of operational and strategic matters
including cleaning, maintenance, security, leasing requirements
and capital works planning.
By inviting a representative cross-section of tenants, we ensure
a robust and inclusive dialogue. These meetings also present
an opportunity to go beyond traditional satisfaction surveys by
fostering deeper, recurring engagement that builds trust over time.
We will continue to adapt the format based on tenant feedback,
including rotating committee members periodically to maintain
fresh perspectives and high participation.
In Q3 and Q4 in collaboration with Allevia Hospital
Ascot and other valued tenants, Vital undertook a major
refurbishment of the main ground floor lobby at Ascot as
part of its ongoing commitment to elevating healthcare
environments. Branded as Project Revitalise, the initiative
aimed to enhance the comfort, functionality and aesthetics
of the shared space. The project was guided by core
priorities including minimising disruption, maintaining
cost certainty and delivering an inviting, sustainable and
well-connected environment for patients, visitors and staff.
The completed upgrade includes:
• repositioned admissions area for Allevia Hospital Ascot
• improved wayfinding and security services with
a new concierge desk near the main entry
• comprehensive interior refresh including new flooring,
ceiling features, acoustic treatments and feature lighting
• digital signage, in-built planting and
expanded soft seating areas
• new café operator, providing convenient, nutritious
and high-quality food and drink options
These improvements streamline the patient journey
whilst also creating a more welcoming and
efficient environment for tenants and staff.
ASCOT LOBBY UPGRADE PHOTOS
Ascot, Auckland
Ascot, Auckland
ANNUAL REPORT 2025
|
45
Healthy Planet
Building utility
performance metrics
Our new third-party data collection platform
streamlines data capture by extracting consumption
information directly from utility invoices, receiving
data from retail providers and integrating building
management systems into a centralised portal. This
transition builds on the data collection methods
developed in previous years; however, collecting
tenant utility data continues to present challenges. We
are actively engaging with tenants to reinforce the
importance of this data in supporting our sustainability
goals and regulatory reporting obligations.
Establish building utility performance metricsMaterial topic(s)
Efficiently collect, track, analyse and report energy
and utility data to meet and refine targets.
Energy Management
Waste Management
Water Management
Building Certifications
and Performance
Formalise energy management plan
Create regional specific 3-year capital budget roadmaps to implement energy
conservation measures identified from energy audits in line with reduction targets.
Establish environmental building certifications program
Evaluate development of global plan for pursuing certifications,
including for tenant-controlled properties.
In progressSubstantially completeOn trackComplete
Maitland Private Hospital, Maitland
46
|
VITAL HEALTHCARE PROPERTY TRUST
GREEN STAR
Vital is committed to delivering high-performing, sustainable
healthcare assets by pursuing Green Star certification through
both the New Zealand Green Building Council (NZGBC) and
the Green Building Council of Australia (GBCA). Green Star is a
leading internationally recognised rating system that evaluates the
environmental design, construction and operations of buildings.
GREEN STAR – PERFORMANCE RATINGS
In 2024, 31 assets within the Vital portfolio were eligible for
a Green Star Performance rating, a framework that evaluates
the operational sustainability of buildings on a scale from 1
Star (Minimum Practice) to 6 Star (World Leadership).
Of the assets assessed, 27 assets achieved the following ratings:
Green Star Performance certification renewals
are scheduled for Q1 of FY26.
GREEN STAR – DEVELOPMENTS
In alignment with our sustainability strategy and Board-approved
environmental targets, Vital is committed to a minimum 5
Star Green Star rating for all new developments and major
refurbishments, as defined by GRESB, reflecting our ambition to
deliver sustainable outcomes across energy, water, materials,
indoor environment quality and emissions. Some earlier projects
proceeded prior to this commitment and are therefore not rated.
All applicable future projects will target at least 5 Stars.
Vital has achieved 6 Star Green Star certification for:
• Playford Health Hub – Stage 2, Adelaide; and
• GensisCare Integrated Cancer Centre, Sydney.
• RDX Centre of Excellence, Gold Coast has
achieved a 6 Star Design certification.
Vital is targeting 5 Star Green Star deign and as built ratings for:
• Kipling Avenue, Auckland
• Coomera Health Precinct - Stage 1, Gold Coast
• Logan Private Hospital, Meadowbrook
• Buranda Health Hub, Woolloongabba
• St Asaph St, Christchurch
• 61-71 Park Road, Auckland
Environmental building
certifications program
After-hours operational
performance review
Decarbonisation
roadmap
14
assets
11
assets
2
assets
Our optimisation strategy is centred on reducing
energy consumption and carbon emissions by
targeting inefficiencies in building operations
during low-occupancy periods. One core
initiative is the implementation of after-hours
operational performance reviews to assess real-
time system behaviour against expected low-
load performance benchmarks. These reviews
are instrumental in uncovering unnecessary
overnight energy use such as excessive lighting,
non-scheduled air conditioning operation and
misconfigured BMS logic, contributing greater
insight into both avoidable costs and emissions.
Each finding is translated into practical
interventions such as lighting automation,
smarter ventilation schedules and BMS
reprogramming. This approach is designed
not only to seek measurable reductions
in electricity usage but also to contribute
to our decarbonisation roadmap.
As part of our commitment to reducing operational
emissions, we have undertaken a detailed analysis
of energy efficiency upgrade opportunities
across the portfolio. These upgrades have been
prioritised using a structured approach that
considers asset end-of-life timelines, emissions
reduction potential and alignment with key capital
projects. This ensures that decarbonisation efforts
are strategically sequenced and supported
by appropriate capital allocation, enabling
us to maximise environmental impact whilst
maintaining operational and financial efficiency.
1 S TA R -
MINIMUM
PRACTICE
2 S TA R -
AVERAGE
PRACTICE
2 S TA R -
GOOD
PRACTICE
ANNUAL REPORT 2025
|
47
Tennyson Centre Plasma
Shield Project – results
In 2024, a plasma air purification project was implemented at the
Tennyson Centre in Adelaide, South Australia. The initiative aimed to
enhance indoor air quality through advanced filtration technology.
As part of the project, the site permanently adopted the ASHRAE 241
Infection Risk Management Mode, a standard designed to minimise airborne
infection risks in shared spaces. Following implementation, testing confirmed
a 98.1% improvement in air quality, marking a significant outcome in terms of
environmental health and safety. The project has contributed to a cleaner indoor
environment for building occupants, including staff, tenants and visitors.
98.1%
Improvement in air quality
at Tennyson Centre
Tennyson Centre,
Adelaide
48
|
VITAL HEALTHCARE PROPERTY TRUST
Sustainable Development
Guidelines
In FY25, we undertook a comprehensive review and update
of our Sustainable Development Guidelines, which provide
a consistent framework for embedding environmentally
sustainable design (ESD) principles across all new
developments and major refurbishments. The revision aligns
the guidelines with the latest commitments in Northwest’s
Sustainability Policy, updated Green Star requirements
and GRESB definitions, ensuring our approach remains
both current and practical. The review process involved
extensive consultation across regional development,
asset management and facilities management teams.
GenesisCare Integrated Cancer and Health Centre, Sydney
Enhanced guidance
on climate resilience
Reaffirmation of our target to
achieve a minimum 5 Star Green
Star rating on all major projects
Revised project classification
system aligned with
GRESB standards
Key updates include enhanced guidance on climate
resilience, reaffirmation of our target to achieve a minimum
5 Star Green Star rating on all major projects, and a revised
project classification system aligned with GRESB standards.
The guidelines also reflect practical adjustments, such as
replacing the previously required NABERS certification—
currently not applicable to private healthcare facilities—with
alternative pathways through Green Star Performance
tools. Other changes clarify expectations around low-
emission technologies and consolidate ESG reporting
obligations into a single reference point for project teams.
A summary of our Sustainable Development
Guidelines can be found on our website.
ANNUAL REPORT 2025
|
49
Strong Communities
Keystone Trust
Vital is proud to continue its partnership with Keystone Trust, an
organisation dedicated to supporting young people pursuing
careers in property and construction. In FY25, we strengthened
this relationship through a range of initiatives aimed at fostering
industry talent and increasing access to professional opportunities.
This year, two internship placements were offered to Keystone
students across the Vital and Northwest teams, providing
valuable on-the-job experience and exposure to real-world
property management and development projects. We also
continued our annual scholarship support, helping alleviate
financial barriers for students pursuing tertiary education. In
addition, our team remains actively involved in mentoring
programmes, offering guidance and industry insight to help
students build confidence and prepare for successful careers.
Vital also hosted 22 Keystone students for a site visit to Endoscopy
Auckland, offering a unique behind-the-scenes look at both an
operational hospital and a major new development under way.
The students toured the existing facility and gained exposure
to the construction of a new 1,400 sqm endoscopy suite, a
$32.0m project scheduled for completion in late 2025.
Our engagement with Keystone Trust reflects Vital’s ongoing
commitment to investing in the next generation of property
professionals and promoting greater equity within the sector.
2024 Keystone Trust GalaKeystone Trust students visit Endoscopy Auckland
2025 Vital Keystone Scholarship
recipient Hannah (Chau) Nguyen
Strengthen community engagementMaterial topic(s)
Increase employee participation in community volunteering
programs to foster local engagement and support.
Corporate Philanthropy
and Volunteerism
Community Engagement
Human Rights
Urban Design and Impact
on Public Spaces
Biodiversity and Environmental
Rehabilitation
Develop and implement a Reconciliation Action Plan (RAP) in Australia to
promote partnerships, respect and opportunities with Indigenous communities.
Launch initiatives aimed at improving local biodiversity at existing assets.
In progressSubstantially completeOn trackComplete
50
|
VITAL HEALTHCARE PROPERTY TRUST
Biodiversity
Volunteering
Reconciliation and cultural awareness
In support of local biodiversity, Vital initiated
a beekeeping project at Ascot in Auckland.
The project was launched in 2023 to enhance
urban pollination and support New Zealand’s
bee population and involves the installation and
management of beehives on site. Following a
successful natural hive expansion during the 2024
swarming season, the site now hosts two active
beehives. In addition to fostering biodiversity, the hives
produce honey, which is shared with on-site tenants.
Following the success of this initiative, discussions
are under way to expand beehive installations
across additional Vital assets in New Zealand.
Throughout FY25, Northwest team members across Australia and
New Zealand actively participated in a range of volunteering
initiatives, supporting local communities and organisations aligned
with social wellbeing and equity. In Auckland, staff contributed to
the Middlemore Hospital Mental Health Unit, beginning the day
with a mihimihi in the marae before revitalising overgrown gardens
to help create a more calming outdoor space for patients.
In Australia, our Melbourne employees supported Foodbank
Australia, helping to combat food insecurity through food relief
programs that support over 2,800 frontline charities and more
than 3,300 school breakfast programs nationwide. Volunteers
also lent their time at the Magpie Nest Café in Melbourne, which
provides free meals and a welcoming space for individuals facing
homelessness, mental health challenges and social exclusion.
The Sydney team also joined forces with ReLove, a not-for-
profit that furnishes homes for people transitioning out of crisis.
Volunteers took on a variety of hands-on roles from assembling
and cleaning donated furniture, to walking alongside clients
as they selected household items and helping move and
set up furnishings in new homes. These full-day volunteering
sessions not only provided practical support but also offered
dignity and choice to people rebuilding their lives.
Northwest remains committed to reconciliation and has been progressing
commitments within our Reflect Reconciliation Action Plan (RAP) and
making a meaningful contribution. Throughout the year, our focus has
been on supporting First Nations peoples/ businesses' participation
on our construction projects and providing services to support our
standing investments. We have worked with our development team
to review our construction contract documentation and updated them
to incorporate minimum participation rate requirements across our
projects. We have also been working with our asset management and
facilities management team to identify opportunities to engage First
Nations suppliers across our standing asset portfolio. In addition, we
have explored ways and provided opportunities for our staff to engage
in cultural and knowledge sharing activities throughout the year.
The Reconciliation Working Group continues to work and deliver
on the goals we have set for ourselves within our RAP.
Bees Up Top rehomed a swarm with Sophie Benfell-Brinsden -
Asset Manager and Liz Ingram - Sustainability Manager
Melbourne employees volunteering at Foodbank Australia
Sydney team volunteering at ReLove
Bracelet weaving for National Reconciliation week
ANNUAL REPORT 2025
|
51
Employee engagement
pulse check
Throughout 2024, Northwest experienced significant organisational
changes, reinforcing the importance of employee engagement.
As part of an ongoing commitment towards an engaging
and responsive workplace, an employee pulse survey was
conducted in Q3 of FY25 in partnership with TalentMap, an
employee engagement and benchmarking specialist. The
survey provided valuable insights across five key dimensions:
Organisational Engagement, Leadership, Growth and
Development, Organisational Culture, and Change and
Transformation. Whilst Organizational Culture scored highest
(66), followed by Leadership (61), Engagement (54) and
Change and Transformation (55) showed room for improvement,
particularly when benchmarked against external comparators.
Encouragingly, the A/NZ team expressed strong confidence
in leadership visibility, recent change initiatives and career
development opportunities. Positive views were also shared
about the increased representation of women in leadership,
diverse project work and optimism tied to recent transitions.
The survey also highlighted communication from leadership as
the most significant opportunity for improvement, alongside
challenges in workload distribution and office environment.
These insights are helping shape targeted actions to strengthen
internal communications, support wellbeing and enhance
the employee experience across the organisation.
Inclusive Company
Enhance employee satisfaction and performanceMaterial topic(s)
Deploy employee satisfaction survey.
Employee Satisfaction
and Retention
Employee Training
and Development
Deploy sustainability education
Have a sustainability-engaged and educated workforce.
Enhance social connections and culture
Enhance employee engagement through actively connecting
people globally through both formal and informal programs.
In progressSubstantially completeOn trackComplete
Auckland team volunteering at Ambury Park Farm for Riding Therapy
52
|
VITAL HEALTHCARE PROPERTY TRUST
Training
Global mobility
and career growth
We are committed to fostering a culture of continuous
learning and professional growth across all levels of the
business. Our training framework includes both role-
specific development and organisation-wide programs,
ensuring employees are equipped with the knowledge
and tools needed to succeed in their roles whilst upholding
the company’s values and compliance obligations.
In 2024, we introduced mandatory onboarding training for
all new hires covering essential topics such as diversity and
inclusion, mental health and wellbeing and sustainability.
Through our partnership with LinkedIn Learning, employees
gained access to over 20,000 courses, enabling both
microlearning and formal certification on topics ranging
from technical skills to ESG fundamentals. A dedicated
sustainability module was required for all new employees,
focusing on the strategic importance of sustainability
and how individuals can contribute to our goals.
We also deliver region-wide training in critical areas such
as cybersecurity, modern slavery and privacy, alongside
ongoing access to industry webinars and events, particularly
for employees engaged in ESG-related reporting.
We are committed to creating a rewarding employee
experience that supports both personal and professional
growth. Our inclusive culture and global platform provide
opportunities for staff to thrive across regions and explore
diverse career pathways. In FY25, we were proud to
see two team members from the A/NZ region transfer
to Northwest offices abroad, reflecting our focus on
internal mobility and cross-regional development.
WORKFORCE BREAKDOWN
FY24FY25
Australia and New Zealand5653
Turnover rate (voluntary)11 . 1 %16.0%
Turnover rate (involuntary)4.7%12.5%
GENDER
FY24FY25
MFMF
Gender (workforce)43.0%57.0%47.0%53.0%
Middle management
1
47.0%53.0%72.0%29.0%
Senior leadership
2
67.0%33.0%60.0%40.0%
A G E
FY24FY25
>200.0%0.0%
21-3013.0%11.0%
31-4043.0%49.0%
41-5021.0%13.0%
51-6021.0%25.0%
61-642.0%2.0%
65+0.0%0.0%
HEALTH AND SAFETY
FY24FY25
Absentee Rate
3
0.7% 0.9%
Injury Rate 00
Fatalities 00
TRAINING
FY24FY25
ESG training completion rate100.0%100.0%
VOLUNTEERING
FY24FY25
Total hours of volunteer
time by employees
2586 61
1
People leader, VP and below
2
C-Suite, Regional Heads, SVP
3
The absentee rate is the ratio of
employees with absences to total
salaried employment
Auckland team volunteering at Tiaho Mai
- Adult Mental Health (Te Whatu Ora)
ANNUAL REPORT 2025
|
53
Our Board
Graham Stuart
Independent Chair and
Member of the Audit Committee
(68, Auckland)
Graham Stuart is an experienced
corporate director with an established
track record of performance in
governance and in prior executive
roles. He is currently a Director of
Ravensdown Limited and Director of
Dairy Goat Co-operative (N.Z.) Limited.
He was previously the CEO of Sealord
Group from 2007 to 2014 and Director,
Strategy and Growth and CFO of
Fonterra Co-operative Group from 2001
to 2007, Independent Chair of EROAD
Limited and an Independent Director
and Chair of the Audit Committee at
Tower Limited.
Graham is a Fellow of Chartered
Accountants Australia & New Zealand
(CAANZ) and has a Master of Science
degree from Massachusetts Institute
of Technology and a Bachelor of
Commerce with first class honours from
the University of Otago.
Mike Brady
Non-Independent Director
(58, Toronto)
Mike Brady was appointed global
President of Northwest Healthcare
Properties REIT (TSX: NWH.UN) in
2023 after serving as global Executive
Vice President, General Counsel and
Board Secretary since joining the REIT
in 2006. He has extensive experience
in real estate investments and finance,
transaction management, global
leadership, governance and legal
matters.
Mike has played a significant commercial
and legal role in the strategic direction
and growth of the REIT, most recently
leading the team to complete a €2.0
billion pan-European joint venture fund,
a $435 million UK hospital portfolio,
and a $2 billion joint venture fund and
acquisition of a $1.25 billion hospital
portfolio in Australia.
Prior to joining the corporate real estate
world, Mike was a corporate law
partner at two Toronto-based law firms,
where he developed his real estate
practice. He has a Bachelor of Arts
(Economics) and a joint LL.B./Masters of
Business Administration from Dalhousie
University, Halifax.
Angela Bull
Independent Director and
Member of the Audit Committee
(50, Auckland)
Angela Bull is an independent director
of Channel Infrastructure Ltd (NZX:
CHI), Property For Industry Limited
(NZX:PFI), Foodstuffs South Island Ltd
and Foodstuffs NZ Ltd. She is also on
the Trust Board of St Cuthbert’s College
and an independent director of Bayleys
Corporation Board (NZ) and recently
joined the Board of Fulton Hogan as an
independent director.
Angela is a former Chief Executive of
Tramco Group, a large New Zealand
owned property investment company
which specialises in large scale land
holdings, notably the Viaduct Harbour
precinct in Auckland and Wairakei Estate
in the Waikato; a former Board member
of the Property Council of New Zealand;
and a former independent director of the
Real Estate Institute of New Zealand and
realestate.co.nz.
She holds a Bachelor of Laws and a
Bachelor of Arts (Political Science) and
practised property and environmental law
prior to her executive career. Previously,
Angela held a number of senior positions
over a 10-year period with Foodstuffs
Auckland and Foodstuffs North Island Ltd,
most recently being General Manager
Property Development for Foodstuffs
North Island.
The Board comprises five highly qualified directors based in Auckland,
Toronto, Sydney
*
and Melbourne, three of whom are independent.
Their executive experience includes healthcare, property and finance.
54
|
VITAL HEALTHCARE PROPERTY TRUST
Craig Mitchell
Non-Executive Director and
Member of the Audit Committee
(57, Sydney)
(Zachary Vaughan replaced Craig
Mitchell on the Board effective 12
August 2025)
Craig Mitchell is a professional manager
with an inclusive leadership style, Craig
has more than 20 years of experience
specialising in the property industry. His
previous roles include Northwest CEO
(ceased 30 June 2025) and Executive
Director and Chief Operating Officer of
Dexus, an ASX top 50 listed REIT.
Craig has a Master of Business
Administration (Executive) from the
Australian Graduate School of
Management, a Bachelor of Commerce
and a Fellow of CPA Australia. He
has also completed the Advanced
Management Program at Harvard
University, Boston.
Zachary Vaughan
Non-Independent Director
(Appointed 12 August 2025)
(48, Toronto)
Zachary Vaughan was appointed
Chief Executive Officer of Northwest
Healthcare Properties REIT in July 2025.
He brings over 20 years of experience
in real estate investment and asset
management, with a strong track record
of leadership across global markets.
Prior to joining Northwest, Zachary
served as Global Head and Chief
Investment Officer of Real Estate at Arrow
Global, where he led the firm’s real estate
strategy. He remains a Non-Executive
Director at Arrow. Before Arrow, he held
several senior roles at Brookfield Asset
Management, including Managing
Partner and Head of European Real
Estate, Head of Multifamily Investments,
and CEO of Brookfield REIT.
Earlier in his career, Zachary was a
Director in the Real Estate Investment
team at the Canada Pension Plan
Investment Board (CPPIB), and Director
of Acquisitions at International Property
Corporation/Reichmann International.
Zachary holds an Honours Bachelor of
Economics from Western University. He
is now based in Toronto, where he leads
Northwest’s global healthcare real estate
platform spanning North America, Brazil,
Europe, and Australasia.
Zachary was appointed as a Non-
Independent Director to the board of the
Manager on 12 August 2025.
Dr Michael Stanford AM
Independent Director and Chair
of the Audit Committee
(66, Melbourne)
Dr Michael Stanford has more than 30
years’ experience in the health sector
in either Group CEO or Board roles.
Michael’s current Board roles include
Chair of Nexus Hospitals, a leading
provider of specialist day and short stay
private hospital based care; and Board
member of the Royal Australian College
of General Practitioners as well as Board
member of Healius (ASX:HLS).
Michael was the Group CEO of St
John of God Healthcare, Australasia’s
third largest private hospital provider,
for 16 years during which time the
company increased revenue fivefold
through organic and M&A growth plus
more than A$1 billion greenfield and
brownfield developments. Michael’s other
Managing Director roles included the
ASX listed Australian Hospital Care and
two public hospital networks in Victoria.
Michael holds an MBA from Macquarie
University and Bachelor of Medicine and
Bachelor of Surgery from UNSW. He
is a Fellow of the Australian Institute of
Company Directors.
In 2018 Michael was awarded a
Member of the Order of Australia for
significant service to the health sector
through executive roles, to tertiary
education and the WA community, in
2010 he received the WA Citizen of the
Year Award – Industry and Commerce
category.
Directors are based in
Auckland (x2), Toronto,
Sydney
*
and Melbourne.
Their current and prior
executive experience
includes healthcare,
property and finance.
Playford Health Hub,
Adelaide
* As of 12 August 2025, with the replacement of Craig Mitchell by Zachary Vaughan,
two directors are based in Toronto and no directors are based in Sydney
ANNUAL REPORT 2025
|
55
Chris Adams
Co-Head A/NZ Region
(55, Melbourne)
Chris Adams jointly leads the Northwest
business in Australia and New
Zealand, and manages Northwest’s
NZX-listed Vital Healthcare Property
Trust, which he has been part of
the leadership team since 2017.
He has extensive experience in the
property industry in Australia, New
Zealand and the United Kingdom,
including over 25 years’ direct
experience in health property.
Chris was one of the founding Executives
at ASX-listed Generation Healthcare
REIT which was acquired by Northwest
in 2017. Prior to that he established Vital
Healthcare Property Trust’s presence
in Australia in 1999 following various
roles with the group in New Zealand.
Chris holds a Bachelor of Property
from the University of Auckland.
Alex Belcastro
Senior Vice President,
Developments and Precincts
(37, Sydney)
Alex Belcastro, formerly the Chief
Business Development Officer at Ramsay
Health Care managing a multi-billion-
dollar hospital asset portfolio, joined our
team in 2021.
Alex leads precinct transactions, leasing
and developments. She also provides
strategic leadership to the development
and leasing divisions and heads our
Strategy and Research function.
With over 18 years of specialised
experience in social infrastructure, she
has facilitated large-scale transactions
and developments across public and
private sectors.
Her diverse background spans advisory,
operational and ownership roles,
adding valuable real estate expertise
to our platform.
Holding a Master of Construction
Management and a Bachelor of Planning
and Design from the University of
Melbourne, Alex has also honed her skills
through executive education at Harvard
Business School.
Kirsty Bowyer
Vice President, Development
(40, Auckland)
Kirsty Bowyer joined the team in New
Zealand in 2023 and is responsible
for overseeing the planning, design
and construction of Vital’s development
projects across New Zealand. With
more than 15 years of experience
in the construction and property
industry including major healthcare
infrastructure projects, Kirsty brings a
deep and practical understanding of the
complexities of healthcare development,
combining technical expertise with
strategic leadership.
Before joining Northwest, Kirsty spent
13 years at Johnstaff, one of Australia’s
leading property and construction
consultancies. During her time there, she
held various senior roles, leading the
end to end delivery of capital works
programmes across both Australia and
New Zealand.
Over the course of her career, Kirsty has
delivered more than $2.5 billion worth
of healthcare real estate. Her leadership
is characterised by a strong commitment
to clinical user engagement, operational
efficiency and design excellence.
Kirsty is also a committee member of the
New Zealand Health Design Council,
where she contributes to national discourse
on health infrastructure innovation.
Our Executive Team
Northwest has over 240 employees globally, including more than 50 real
estate professionals in New Zealand and Australia. The Vital Executive
Team is made up of property professionals with extensive experience in
New Zealand, Australia and beyond.
56
|
VITAL HEALTHCARE PROPERTY TRUST
Vanessa Flax
Vice President, Regional General
Counsel and Company Secretary
(54, Melbourne)
Vanessa Flax joined the team in 2019,
prior to which she was a special counsel
at Ashurst Australia.
Vanessa has 25 years of deep and
broad ranging property law experience
in Australia and New Zealand, including
acting as primary legal adviser (for
approximately 15 years) for Vital
and Northwest.
Vanessa’s legal experience covers
all aspects of real estate property
transactions, including acquisitions,
divestments and sales, leasing and
Crown leasing, development transactions
and due diligence.
Vanessa has a Bachelor of Arts and
Bachelor of Laws from the University
of Witwatersrand, South Africa.
Kawarau Park Health Hub, Queenstown
Michael Groth
Chief Financial Officer
(51, Melbourne)
Michael Groth has over 18 years’
experience as a senior finance executive
in the listed and unlisted property funds
and funds management industry. Prior
to joining the team in 2019, Michael’s
most recent position was as Group Chief
Financial Officer of the Melbourne based
and ASX-listed real estate fund manager,
APN Property Group Limited.
Michael has extensive experience in
financial management and reporting,
taxation, treasury and capital
management, corporate structuring,
acquisitions, disposals and equity raisings
in the listed and unlisted property and
funds management industry.
Michael holds a Bachelor of Commerce
and Bachelor of Science and has been
a member of the Chartered Accountants
Australia and New Zealand since 2000.
Richard Roos
Co-Head A/NZ Region
(60, Melbourne)
Richard Roos jointly leads the Northwest
business in Australia and New Zealand.
He has over 25 years’ experience
in commercial real estate financing,
acquisitions and property management,
of which the last 17 years have been in
healthcare real estate in senior roles for
Northwest in Canada and Australia.
Richard is responsible for asset
management, transactions, people
and culture, and ESG. He is also
focused on building and expanding
strong relationships with Northwest’s
operator partners.
Kawarau Park, Queenstown
ANNUAL REPORT 2025
|
57
Corporate Governance
Vital Healthcare Property Trust and Northwest Healthcare Properties Management
Limited. All information as at 30 June 2025, unless otherwise stated.
The Board of Directors
The role of the Board of Directors is to set the strategic direction
of Vital and to support management in monitoring the delivery
of this against specific performance objectives. The Board
also ensures all business risks are appropriately identified and
managed and compliance with all applicable regulatory,
statutory, financial, health and safety and social responsibilities
of the Manager. The Board also plays an important role of
overseeing risks and opportunities associated with environmental
(including climate), social and governance (ESG) factors, the
preparation of climate statements and compliance with any other
applicable ESG reporting or broader regulatory requirements.
Board composition
The Manager is committed to having an effective Board providing
a balance of independent skills, knowledge, experience and
perspectives.
All Directors bring a significant breadth and depth of expertise and
have the composite skills to optimise the financial and portfolio
performance of Vital and returns to Unit Holders.
Attendance at
Board meetings
Attended /
Eligible to attend
Date of appointment
Graham Stuart8/812 November 2018
(Appointed Chair
17 November 2020)
Michael Stanford8/819 November 2019
Craig Mitchell8/829 June 2021
Angela Bull8/826 April 2022
Mike Brady**7/89 August 2023
The Board does not impose any specific restriction on the tenure
of any Director as it considers such a restriction may lead to the
loss of experience and expertise. However, as noted below, the
Board does have regard for best practice around tenure when
assessing the independence of directors. In addition, there has been
on-going renewal of the Board and the longest serving director
has served for less than 7 years (as at the date of this report).
The table below shows all relevant interests of Directors
and Officers in units, which include legal and beneficial
interests in Vital units as at 30 June 2025.
DirectorsHoldings (number of
units) non-beneficial
Holdings (number
of units) beneficial
Graham Stuart-87,561
Angela Bull5,571
Officers
Aaron Hockly
1
-87,561
1
Aaron Hockly, former Fund Manager, has previously made a voluntary disclosure
that, in addition to his personal holdings, members of his immediate family own an
additional 114,461 units in Vital although he does not control or impact any investment
decisions in relation to such holdings.
Independent Directors
Further information about the Board’s assessment of the
independence of Directors is contained in Recommendation 2.4 of
the NZX Corporate Governance Code on page 64 of this report.
Audit Committee
The Audit Committee is responsible for overseeing
the financial and reporting practices of Vital.
At financial year end and at the date of this report,
the Audit Committee assists the Board in fulfilling its
corporate governance and disclosure responsibilities with
particular reference to financial matters, and internal and
external audit, and is specifically responsible for:
• Reviewing proposed climate, sustainability and ESG
disclosures and advising the Board whether in the Committee’s
view that disclosure complies with applicable standards
and legislative requirements and ensuring that appropriate
controls and assurance processes are undertaken for the
preparation, review, verification and approval of climate,
sustainability and ESG related disclosure reporting;
• Recommending to the Board the appointment /
removal of Vital’s external auditor; and
• Reviewing the performance of the external auditor.
Attendance at Audit
Committee meetings
Attended /
Eligible to attend
Date of
appointment
Graham Stuart4/412 November 2018
Michael Stanford4/419 November 2019
Craig Mitchell4/429 June 2021
Angela Bull4/426 April 2022
**Mike Brady does not sit on the Audit Committee
58
|
VITAL HEALTHCARE PROPERTY TRUST
Australian Subsidiary of Vital
Northwest Healthcare Australian Property Limited (NWHAPL) is
an Australian company which acts as trustee of the two Australian
wholly owned subsidiaries of Vital Healthcare Property Trust, namely
Vital Healthcare Investment Trust and Vital Healthcare Australian
Property Trust. The directors of NWHAPL as at 30 June 2025 are
Mike Brady, Chris Adams, Richard Roos and Miles Wentworth.
Chris Adams replaced Craig Mitchell on and from 30 June 2025.
Management contract
Northwest manages Vital in accordance with Vital’s Trust Deed
in return for which Northwest receives management fees. From
these management fees, Northwest pays salaries and other
related costs (including taxes, rent, IT, travel and training) to
or for its employees, approximately 30 of whom are solely or
majority engaged with managing Vital, as well as the Directors
not appointed by all Unit Holders (two at the date of this report).
As a result, the details in this section relate to Northwest’s
employees rather than Vital’s employees (as there are none).
Remuneration
As noted above, Vital does not have any direct employees.
Instead, Northwest receives management fees to manage
Vital from which it provides remuneration to employees. As
a result, there is no reporting on individual employee salaries.
Notwithstanding the above, the following is
provided to enhance transparency:
1. Details of the holdings in Vital by Directors and officers as
at 30 June 2025 is provided on the previous page.
2. As at the date of this report, the Independent Chair of
the Manager and
Angela Bull (a New Zealand resident
Independent Director) own units. Currently the tax
regime for Vital makes it uneconomic for the offshore
based Directors and officers to hold units in Vital.
3. Details of the costs of Independent Directors appointed
by Unit Holders and, as a result, paid by Vital are
included in note 22 to the accounts in this report.
4. All Northwest’s executive bonuses globally are linked to
Northwest’s unit price as the long-term component of these
bonuses is paid in Northwest units or calculated with reference
to the value of Northwest units. In addition to being Vital’s
Manager, Northwest is Vital’s largest investor, holding an
aggregate shareholding of >28% as at 30 June 2025.
5. The following clawback / malus provisions are
included in the bonus plans for all Northwest executives
globally (including key Vital personnel):
• Where the Participant (i) has been terminated for cause, or
(ii) voluntarily resigns from his or her position with the Trust then
any Deferred Units granted on a discretionary basis pursuant
to Section 7.04 of the Northwest Healthcare Properties Real
Estate Investment Trust Omnibus Equity Incentive Plan (2022)
which have not yet vested at the time of the termination for
cause or voluntary resignation, shall be immediately forfeited
by such Participant.
Directors’ remuneration
DirectorBase
Audit
Committee
Member
ChairTotal
Graham Stuart
Independent Director,
Board Chair and Audit
Committee member
$90K$10K$80K
(Board)
$180K
Angela Bull
1
Independent Director and
Audit Committee member
$90K$10K-$100K
Craig Mitchell
2
Director and Audit
Committee member
N/A---
Michael Stanford
Independent Director and
Audit Committee Chair
A$90K-A$20K
(Audit
Committee)
A$110K
Mike Brady
2
Non-Independent Director
N/A---
($280K paid by Unit Holders, and A$110K paid by the Manager)
1
Paid by the Manager from management fees.
2
Executive of Northwest and, in the case of Craig Mitchell, a Non-Executive Director from
30 June 2025. No separate director’s fees are payable. Mr Mitchell resigned as a Non-
Executive Director on 12 August 2025.
Manager's fees
For the fees paid to the Manager by Vital, please see note 22 to the
accounts in this report.
Joint Investment Policy
Under the terms of the Joint Investment Policy, which applies
to Northwest Healthcare Properties REIT (NWH REIT) and its
owned and controlled entities (including the Manager), an
Investment Committee has been established to avoid, manage
and resolve actual or perceived conflicts of interests between
members of the NWH REIT group in a manner which complies
with any relevant legal obligations and is equitable to each party.
The Joint Investment Policy can be found on Vital’s website.
Modern slavery
In 2024, the Australian manager of the Vital trusts, Northwest
Healthcare Australian Property Limited again published a
statement under the Australian Modern Slavery Act 2018,
which underpinned Vital’s philosophical approach and
commitment to ensuring our operations have sufficient risk
mitigation strategies to address supply-chain risks. Vital
committed to training employees to identify these risks.
Our entire organisation has engaged with tenants and suppliers
to conduct further and ongoing due diligence to identify possible
modern slavery supply chain risks. Vital will continue to assess
the potential modern slavery risks in our operations and develop
and review company policies on these possible impacts.
As part of our ongoing commitment to ethical business practices
and sustainability, we continue to implement a Supplier Code of
Conduct for all new suppliers. The purpose of this code is to
ANNUAL REPORT 2025
|
59
ensure that our suppliers align with our values and principles
and to promote responsible business conduct throughout our
supply chain. By implementing this code we aim to mitigate
risks, uphold our reputation and contribute to positive social
and environmental impacts.
We have also committed to reviewing supplier contracts to ensure
they contain terms consistent with the principles underlying the Act.
Skills and ExperienceGraham
Stuart
Angela
Bull
Craig
Mitchell
Michael
Stanford
Mike
Brady
Accounting/Finance/Economics••
Commercial Real Estate/Asset
Management/Valuation
•••
Corporate Governance•••••
Legal/Regulatory
••
Healthcare Operator•
Sustainability/ESG including
Climate Related Matters
Highly skilled / experienced Moderate skills / experience
Board diversity and relevant skills
At a Board level, diversity of experience is critical to ensure a
healthy exchange of ideas and opinions to deliver higher quality
decision making and outcomes. All Board appointments are always
based on merit and diversity (including gender and ethnicity).
A majority of the Directors are members of professional
organisations such as the Institute of Directors (or equivalent) or
other industry specific and relevant organisations which support
the ongoing education and training of professional directors.
Healthcare real estate is a specialised sector and the Board
believes it is important to have members with a diverse range
of backgrounds, skills and experience to ensure robust
discussion. It is also important to balance skills and knowledge
gained through length of tenure and the value of fresh ideas
in decision making. The table below summarises the skills,
experience and length of service of the current Board.
60
|
VITAL HEALTHCARE PROPERTY TRUST
ReferenceRecommendationApproach
Principle 1 – Code of ethical standards
1.1The board should document minimum
standards of ethical behaviour to which
the issuer’s directors and employees are
expected to adhere (a code of ethics).
The code of ethics and where to find it should
be communicated to the issuer’s employees.
Training should be provided regularly. The
standards may be contained in a single
policy document or more than one policy.
The code of ethics should outline internal
reporting procedures for any breach of ethics,
and describe the issuer’s expectations about
behaviour, namely that every director and
employee:
a. acts honestly and with personal integrity
in all actions;
b. declares conflicts of interest and
proactively advises of any potential
conflicts;
c. undertakes proper receipt and use
of corporate information, assets and
property;
d. in the case of directors, gives proper
attention to the matters before them;
e. acts honestly and in the best interests of
the issuer, shareholders and stakeholders
and as required by law;
f. adheres to any procedures around
giving and receiving gifts (for example,
where gifts are given that are of value
in order to influence employees and
directors, such gifts should not be
accepted);
g. adheres to any procedures about whistle
blowing (for example, where actions
of a whistle blower have complied with
the issuer’s procedures, an issuer should
protect and support them, whether or not
action is taken); and
h. manages breaches of the code
In recognition of Vital’s role in the communities in which we operate, and where our investors live, we
continue to implement and refine policies and practices which encourage responsible investment
practices and compliance with all legal and regulatory requirements.
All of Vital’s Directors and employees must abide by Vital’s Code of Conduct and Business Ethics
(refreshed in May 2024), which documents policies on conflicts of interest, fair dealing, compliance with
applicable laws and regulations, maintaining confidentiality of information, dealing with Vital’s assets and
use of Vital’s information.
The Code recognises the importance of a work environment which actively promotes best practice and
does not compromise business ethics or principles and the Code’s purpose is to uphold the highest ethical
standards, acting in good faith and in the best interests of Unit Holders at all times.
Following the review of the Code, employees will be provided with training in relation to the Code and
Vital has committed to refreshing that training at least once every 3 years.
The Code is on Vital’s website https://www.vitalhealthcareproperty.co.nz/ governance/ and a copy
was provided to staff following the review in May 2024. All new starters are provided with a link to the
Code and are required to confirm their acceptance of its terms.
The Code is supplemented by a number of other policies including the Joint Investment Policy and
Whistleblower Policy which are available on the website at https://www.vitalhealthcareproperty.co.nz/
governance/.
1.2An issuer should have a financial product
dealing policy which applies to employees
and directors
Vital’s Directors, officers and employees, their families and related parties must comply with the Security
Trading Policy. A copy of the Security Trading Policy is on Vital’s website
https://www.vitalhealthcareproperty.co.nz/governance/
The Manager is committed to ensuring compliance with legal and regulatory requirements with respect
to insider trading and restricted persons trading. To assist with such compliance, the Manager’s Security
Trading Policy identifies circumstances where Directors, officers and other restricted persons are permitted
to trade or are prohibited from trading units in Vital. Compliance with these policies is monitored by
the Board. In addition, all trading by Directors and senior managers of the Manager is required to be
reported to NZX in accordance with the Financial Markets Conduct Act 2013. The holdings of Directors
of the Manager are disclosed on page 60.
Before trading in Vital units, a restricted person must get consent in writing from the Chief Financial Officer
of the Manager. Vital has set black-out periods for Directors and staff throughout the year. Also, blackout
periods can be invoked when specific events occur.
Emails are periodically sent to Directors and employees providing information as to the status of the
trading window in relation to the black-out periods.
NZX Corporate Governance Code
The NZX Corporate Governance Code (NZX Code) applies to all issuers of Equity Securities listed on the NZX Main Board.
The NZX Code does not apply to Vital Healthcare Properties Trust (Vital), as it is an issuer of Fund Securities under the NZX Listing Rules.
Notwithstanding the foregoing, the Board of Northwest Healthcare Properties Management Limited (Manager) considers it important from
a governance perspective to identify how, as at 30 June 2025, Vital and the Manager comply with the NZX Code dated January 2025.
The NZX Code is structured around eight principles. The table sets out each principle and an explanation as to if, and how, Vital and the
Manager comply with the recommendations in the NZX Code.
ANNUAL REPORT 2025
|
61
ReferenceRecommendationApproach
Principle 2 – Board composition and performance
2 .1The board of an issuer should operate under
a written charter which sets out the roles
and responsibilities of the board. The board
charter should clearly distinguish and disclose
the respective roles and responsibilities of the
board and management.
The Board has adopted a formal Board Charter which is available on Vital’s website at
https://www.vitalhealthcareproperty.co.nz/governance/.
The Charter sets out the roles and responsibilities of the Board, including in relation to distinguishing
between the respective roles and responsibilities of the Board and management.
The terms of a Director’s appointment are contained in the Board Charter. The Charter reaffirms that
Directors must comply with their duties as set out in the Manager’s Constitution (which is also available on
Vital’s website https://www.vitalhealthcareproperty.co.nz/governance/) and the Companies Act 1993,
including to act in good faith, together with other duties which include (but are not limited to) conducting
themselves in an honest, ethical and responsible manner.
The Board’s specific responsibilities include approving the Manager’s strategic objectives, including those
applicable to Vital and ensuring that effective risk management procedures for the Manager and Vital
are in place and are being observed.
2.2Every issuer should have a procedure for the
nomination and appointment of directors to
the board.
Vital partially complies with this recommendation as the process for appointment of directors is different
for a listed managed investment scheme. Vital is a trust and does not have directors. Its supervisor is
Trustees Executors Limited, which is also the trustee of the Vital Healthcare Property Trust.
The Manager has a Board of Directors, which, subject to the below, is appointed by its sole shareholder,
NWI Healthcare Properties LP.
Two Independent Directors are appointed to the Manager’s Board by Unit Holders in the manner
described in the Trust Deed. A copy of the Trust Deed is available on Vital’s website
(https://www.vitalhealthcareproperty.co.nz/governance/) and also on the Disclose Register through
the Companies Office https://companies-register.companiesoffice.govt.nz/.
Unit Holders have the opportunity to appoint two of the Independent Directors of the Manager. Unit
Holders may nominate and vote on one Independent Director of the Manager each year. The nominee
receiving the most votes will be approved as a Director of the Manager by the Manager’s shareholders.
2.3An issuer should enter into written agreements
with each newly appointed director
establishing the terms of their appointment.
The Manager enters into a written agreement with each newly appointed director setting out the terms of
their appointment, including expectations of the director in his or her role, remuneration entitlements and
indemnity and insurance arrangements.
2.4Every issuer should disclose information about
each director in its annual report or on its
website, including:
a. a profile of experience, length of service
and ownership interests;
b. the director’s attendance at board
meetings; and
c. the board’s assessment of the director’s
independence, including a description
as to why the board has determined
the director to be independent if one of
the factors listed in table 2.4 applies to
the director, along with a description of
the interest, relationship or position that
triggers the application of the relevant
factor
Vital’s Annual Report includes a profile of experience, length of service, and ownership interest of each
Director. The Annual Report also sets out the attendance of each Director at Board meetings and Audit
Committee meetings.
A profile of each director is also included on Vital’s website
https:// www.vitalhealthcareproperty.co.nz/board-management/
The Board considers that at the date of this Annual Report, the Independent Directors are independent,
including by virtue of the following factors listed in table 2.4:
None of the Independent Directors:
• is currently, or was within the last three years, employed in an executive role by the Manager;
• is currently deriving, or within the last 12 months, derived a substantial portion of his or her revenue
from the Manager or the Trust;
• is currently, or was within the last 12 months, in a senior role in a provider of material professional
services to the Manager or the Trust or any of their subsidiaries;
• is currently, or was within the last three years, employed by the external auditor to the Manager or the
Trust or any of their subsidiaries;
• currently has, or did have within the last three years, a material business relationship (e.g. as a supplier
or customer) with the Manager or the Trust or any of their subsidiaries;
• is a substantial product holder of the Trust, or a senior manager of, or person otherwise associated
with, a substantial product holder of the Trust;
• is currently, or was within the last three years, in a material contractual relationship with the Manager
or the Trust or their subsidiaries, other than as a director;
• has close family ties or personal relationships (including close social or business connections) with
anyone in the categories listed above; and
• has been a director of the Manager for a period of 12 years or more.
2.5An issuer should have a written diversity
policy which includes requirements for the
board or a relevant committee of the board
to set measurable objectives for achieving
diversity (which, at a minimum, should address
gender diversity) and to assess annually
both the objectives and the entity’s progress
in achieving them. An issuer within the S&P/
NZX20 Index at the commencement of its
reporting period should have a measurable
objective for achieving gender diversity in
relation to the composition of its board, that
is to have not less than 30% of its directors
being male, and not less than 30% of its
directors being female, within a specified
period. An issuer should disclose its diversity
policy or a summary of it.
This recommendation has not been adopted due to our structure.
We continue to improve diversity on the Board and in Management, in line with the REIT’s diversity policy
introduced in April 2022. The number of women in the organisation is almost 50% of the total number
employed and our focus on gender diversity at a Board level continues.
62
|
VITAL HEALTHCARE PROPERTY TRUST
ReferenceRecommendationApproach
2.6Directors should undertake appropriate
training to remain current on how to best
perform their duties as directors of an issuer.
The Manager provides formal training to Directors during the year and Directors undertake additional
training through professional bodies.
2.7The board should have a procedure
to regularly assess director, board and
committee performance.
Assessment of the Board and each director’s performance is determined by the Chair and takes into
account overall attendance, contribution, training and experience of each member concerned.
2.8A majority of the board should be
independent directors.
The Board of the Manager is comprised of a majority of Independent Directors.
2.9An issuer should have an independent chair
of the board.
The Board of the Manager is chaired by an Independent Director.
2 .10The chair and the CEO should be different
people.
The functions of chair of the Board of the Manager and CEO are fulfilled by different people.
Principle 3 – Board committees
3 .1An issuer’s audit committee should operate
under a written charter. An audit committee
should only comprise non-executive
directors of the issuer. One member of the
committee should be both independent and
have an adequate accounting or financial
background. The chair of the audit committee
should be an independent director and not
the chair of the board.
The Board has adopted a formal written Audit Committee Charter which is available on Vital’s website at
https://www.vitalhealthcareproperty.co.nz/governance/.
The minimum number of members on the Audit Committee is three Directors with a majority being
Independent Directors and at least one member with an adequate accounting or financial background.
The audit committee of the Manager is comprised of four members of which three are independent.
The fourth member is an executive director and, as a result, the composition does not comply with the
recommendation that the audit committee is only comprised of non-executive directors. The Chair of the
audit committee is an independent Director and is not the same person as the Chair of the Board.
3.2Employees should only attend audit
committee meetings at the invitation of the
audit committee.
Directors and officers have a standing invitation to attend audit committee meetings. Other employees
may attend on invitation only.
3.3An issuer should have a remuneration
committee which operates under a written
charter (unless this is carried out by the whole
board). At least a majority of the remuneration
committee should be independent
directors. Management should only attend
remuneration committee meetings at the
invitation of the remuneration committee.
This recommendation has not been adopted due to Vital’s structure.
A key feature of the external management structure under which Vital operates is that remuneration of
management is the responsibility of the Manager, not Vital. As Vital Unit Holders are not economically
exposed to employment remuneration costs, a remuneration committee is not considered necessary by
the Board at this time.
3.4An issuer should establish a nomination
committee to recommend director
appointments to the board (unless this is
carried out by the whole board), which
should operate under a written charter. At
least a majority of the nomination committee
should be independent directors.
This recommendation has not been adopted due to Vital’s structure.
Given its structure and the terms of the Trust Deed, the process for nomination of directors to the Board of
the Manager is not the same as for a listed company.
3.5An issuer should consider whether it is
appropriate to have any other board
committees as standing board committees.
All committees should operate under written
charters. An issuer should identify the members
of each of its committees, and periodically
report member attendance.
From time to time the Board establishes Due Diligence Committees (DDC) under a formal process
memorandum to report on the due diligence process in relation to any potential transaction for Vital of
material size or complexity. An example would be the capital raisings undertaken by
Vital in recent years. A DDC would normally be comprised of an Independent Director, executive
director, relevant management staff and external consultants appropriate for the transaction.
3.6The board should establish appropriate
protocols that set out the procedure to be
followed if there is a “control transaction”
for the issuer including the procedure for
any communication between the issuer’s
board and management and the bidder.
The board should disclose the scope of
independent advisory reports to shareholders.
These protocols should include the option
of establishing an independent control
transaction committee, and the likely
composition and implementation of an
independent control transaction committee.
This recommendation has not been fully adopted due to Vital’s structure and the composition of its unit
register.
The Takeovers Code does not apply to Vital, as a listed managed investment scheme. Vital’s Trust Deed
does include some provisions which would regulate takeover-like transactions relating to units in Vital.
Given the REIT’s ownership of the Manager and cornerstone holding of Vital units, a “control transaction”
is considered unlikely.
As a result of the above, the Board of the Manager has not established protocols that set out the
procedure to be followed if there is a “control transaction” for Vital units.
Principle 4 – Reporting and disclosure
4 .1An issuer’s board should have a written
continuous disclosure policy.
It is important that the market and investors feel confident in the timing or manner of any buying or selling
of Vital units. As a NZX issuer, the Manager is acutely aware of the need to ensure the market, investors
and regulators remain fully informed of any material or price sensitive information relevant to Vital. The
Board, management and employees are aware of the NZX Continuous Disclosure requirements and
Vital has internal procedures in place to ensure compliance.
The Continuous Disclosure Policy can be found on Vital’s website at
https://www.vitalhealthcareproperty.co.nz/governance/.
ANNUAL REPORT 2025
|
63
ReferenceRecommendationApproach
4.2An issuer should make its code of ethics,
board and committee charters and the
policies recommended in the NZX Code,
together with any other key governance
documents, available on its website.
A copy of all relevant policies noted in this document can be viewed on Vital’s website
https://www.vitalhealthcareproperty.co.nz/governance/.
In addition, the website includes the Privacy Policy, the Whistleblower Policy and the Modern Slavery
Statement, all of which are endorsed by the Board.
4.3Financial reporting should be balanced, clear
and objective.
We provide disclosures of financial matters in our Annual Report. In addition, disclosures are provided quarterly
to keep the market updated as to the financial matters impacting Vital.
The Manager maintains and regularly reviews a risk management framework as part of its compliance
assurance programme. Reports are provided to both the Audit Committee and Board along with an annual risk
assessment.
4.4An issuer should provide non-financial
disclosure at least annually, including
considering environmental, social
sustainability factors and practices. It should
explain how operational or non-financial
targets are measured. Non- financial
reporting should be informative, include
forward looking assessments, and align with
key strategies and metrics monitored by the
board.
Vital’s Annual Report includes non-financial disclosures, including environmental, economic and social
sustainability factors and practices. In this regard see page 38 onwards in the sustainability section
for an outlay of ESG related achievements and forward-looking targets, and page 52 onwards in
the sustainability section for references to regulatory non-financial ESG disclosures to which Vital is
committed.
Principle 5 – Remuneration
5 .1An issuer should have a remuneration policy
for the remuneration of directors. An issuer
should recommend director remuneration to
shareholders for approval in a transparent
manner. Actual director remuneration should
be clearly disclosed in the issuer’s annual
report.
This recommendation has not been adopted due to Vital’s structure.
Vital is a trust and does not have directors. Subject to the below, the remuneration costs of the Manager’s
directors are borne by the Manager. As a result, Vital Unit Holders are not economically exposed to
those costs.
Vital’s Trust Deed provides that the costs associated with the two Independent Directors appointed to the
Board of the Manager by Unit Holders are reimbursed out of the trust fund.
Directors are paid a flat fee for each service provided (currently a base director fee and additional
fees for being the Chair, Audit Committee Chair and / or Audit Committee Member). Such fees are
market based by reference to other NZX listed entities; this is assessed annually. Accordingly, the Board
considers that it is unnecessary for Vital to maintain a remuneration policy.
Refer to page 61 of this Annual Report for details of Director remuneration.
5.2An issuer should have a remuneration policy
for remuneration of executives which outlines
the relative weightings of remuneration
components and relevant performance
criteria.
This recommendation has not been adopted due to Vital’s structure.
As noted above, all officers’ remuneration is paid by the Manager not Vital. Accordingly, the Board
considers that it is unnecessary for Vital to maintain a remuneration policy.
5.3An issuer should disclose the remuneration
arrangements in place for the CEO in its
annual report. This should include disclosure
of the base salary, short term incentives and
long term incentives and the performance
criteria used to determine performance based
payments.
This recommendation has not been adopted due to Vital’s structure.
Vital does not have any employees as it is externally managed by the Manager. The remuneration of
executives is not paid by Vital but by the Manager or its related parties.
Principle 6 – Risk management
6 .1An issuer should have a risk management
framework for its business and the issuer’s
board should receive and review regular
reports. An issuer should report the material
risks facing the business and how these are
being managed
The Board of Directors maintains a sound understanding of key risks faced by Vital. Effective management
of all financial and non-financial risks is fundamental to the delivery of the Board’s strategy. In addition, the
Manager will engage other external advisers as appropriate to deal with specific risks.
The Manager has a risk management framework that is integrated into day-to-day operations. As part of
this framework, the Board and Audit Committee work closely with management and external auditors to
support the identification, management and reporting of risks.
This risk management framework is part of Vital’s compliance assurance requirements under the FMCA.
Higher risk groups are reviewed yearly with lower risk groups reviewed biennially. The risk management
framework/Compliance Assurance Programme is reviewed on an annual basis and approved by the
Board.
The Manager has currently identified the following key risk categories:
• Fund manager risk
• Development risk;
• Acquisition of Investment risk
• Asset and facilities management risk
• Information, data security/cybersecurity risk
• Energy/carbon efficiency of assets and operations risk;
• Talent recruitment, retention and succession planning;
• Reputation (social responsibility, brand and stakeholder relationships)
• Access to capital risk
• Compliance risk
• Governance risk
• Fraud/Misconduct risk
• Climate-related risk
64
|
VITAL HEALTHCARE PROPERTY TRUST
ReferenceRecommendationApproach
6.2An issuer should disclose how it manages
its health and safety risks and should
report on their health and safety risks,
performance and management
The Directors and Manager are committed to ensuring that as far as practical, a safe and healthy working
environment is provided for all employees, tenants, contractors and others who may visit our properties.
The Trust’s Health and Safety Policy aims to reflect this commitment.
We have a Risk Management Framework meaning we employ a systematic approach to identifying,
evaluating and managing safety risks.
We have regular training to ensure employees are knowledgeable about our safety practices. A register
is maintained to track participation and ensure compliance.
The Operational Risk Committee oversees our safety protocols and implements strategies to address
operational risks.
Safety expectations are integrated into our supplier contracts and tender/ RFI procedures to ensure
consistency across all external arrangements.
Principle 7 – Auditors
7.1The board should establish a framework
for the issuer’s relationship with its external
auditors. This should include procedures:
a. for sustaining communication with the
issuer’s external auditors;
b. to ensure that the ability of the external
auditors to carry out their statutory audit
role is not impaired, or could reasonably
be perceived to be impaired;
c. to address what, if any, services (whether
by type or level) other than their statutory
audit roles may be provided by the
auditors to the issuer; and
d. to provide for the monitoring and
approval by the issuer’s audit committee
of any service provided by the external
auditors to the issuer other than in their
statutory audit role.
The Board has established an Audit Committee with a majority of Independent Directors.
A copy of the Audit Committee Charter can be found on Vital’s website
https://www.vitalhealthcareproperty.co.nz/governance/.
The Audit Committee Charter sets out the procedures to be followed to ensure the independence of the
Trust’s external auditor. The Audit Committee is responsible for recommending the appointment of the
external auditor and maintaining procedures for the rotation of the external audit engagement partner.
Under the Audit Committee Charter, the external audit engagement partner must be rotated at least every
five years.
The Committee will only recommend to the Board the approval of an external auditor if that external
auditor would be regarded, by a reasonable investor, with full knowledge of all the relevant facts and
circumstances, as capable of exercising objective and impartial judgement on all issues encompassed
within the auditor’s engagement. The continued appointment of Vital’s external auditors is confirmed
annually by the Committee following its review of the external auditor’s performance. One of the duties
of the Committee is ensuring that the external auditor or lead audit partner is changed at least every five
years in accordance with relevant audit independence guidelines and the Audit Committee Charter.
Vital’s auditors annually confirm their compliance with professional standards and ethical guidelines of
Chartered Accountants Australia and New Zealand to evidence their competencies, as well as attend
Vital’s annual meeting to answer question from investors in relation to the audit. Deloitte, Vital’s current
auditor, was first appointed in 2008 and the current engagement partner, Andrew Boivin was appointed
in 2023.
The Audit Committee Charter covers provision of non-audit services with the general principle being
that the external auditor should not have any involvement in the production of financial information or
preparation of financial statements such that they might be perceived to be auditing their own work.
The Board facilitates regular and full interface between its Audit Committee, the external auditors and
management as reflected in the Audit Committee charter.
7. 2The external auditor should attend the
issuer’s Annual Meeting to answer
questions from shareholders in relation to
the audit.
To maximise the effectiveness of communication at the Annual Meeting, the Manager also requires its
external auditors to attend the meeting and be prepared to answer Unit Holders’ questions about the
conduct of the audit, as well as the preparation and content of the independent auditor’s report.
Vital undertakes an annual audit engagement with its external auditor. As part of the process the Audit
Committee identifies any key areas of focus and reporting required of the auditors. Management
is required to attend the meeting to discuss the findings of the report and respond to queries. Any
recommendations for improvement are discussed and management is required to agree a timetable for
the implementation of the changes.
7. 3Internal audit functions should be
disclosed.
The Manager’s ultimate parent has an internal audit programme that includes an annual global internal
control review. The scope of this programme encompasses both the Manager and Vital.
In addition, Vital has a Supervisor who undertakes oversight functions on behalf of Unit Holders, including
in relation to conduct and the payment of management fees / expenses.
Principle 8 – Shareholder rights and relations
8 .1An issuer should have a website where
investors and interested stakeholders
can access financial and operational
information and key corporate governance
information about the issuer.
Vital’s website www.vitalhealthcareproperty.co.nz enables Unit Holders to access financial and
operational information and key corporate governance information about Vital. The website allows key
stakeholders to access and navigate important information with ease.
ANNUAL REPORT 2025
|
65
ReferenceRecommendationApproach
8.2An issuer should allow investors the ability
to easily communicate with the issuer,
including by designing its shareholder
meeting arrangements to encourage
shareholder participation and by
providing shareholders the option to
receive communications from the issuer
electronically.
A key focus of investor relations is to ensure the market and investors are informed of all details necessary
to assess their investment and Vital’s performance as specified by NZX Listing Rules. The Board aims to
foster constructive communications and encourages all stakeholders to engage with Vital.
A key element of corporate communication is the Trust’s website at
www.vitalhealthcareproperty.co.nz. Vital’s website is designed to make it easier for Unit Holders to
locate and understand key information. The website enables all existing and potential Unit Holder to
view information including: an overview of the business and corporate structure, a history of financial
and investment performance, key calendar dates and the ability to access and download all NZX
announcements, presentations and investor forms.
The website also includes key corporate governance documents including the Board Charter, Statement
of Investment Policies and Objectives (SIPO) and other key policy documentation.
The Manager also actively encourages engagement through a communication strategy which includes:
• The Annual Meeting for the Unit Holders to meet with and ask questions of the Board, the Supervisor,
management and external auditors;
• Any other meetings called to obtain approval for the Manager’s action as appropriate;
• Results webcasting providing all investors with the ability to listen and ask questions of Management;
and
• Various investor communications including Annual Reports and Interim Reports.
Through Vital’s external registrar investors have the ability to easily communicate with the issuer, including
providing the option to receive communications from the issuer electronically.
There is a NZ toll free number 0800 225 264 and email address enquiry@vhpt.co.nz to which general
enquiries can be directed.
To further enhance Unit Holder engagement, the format of Vital’s annual meetings is a ‘hybrid’ meeting,
allowing investors to attend in-person or virtually by attending the meeting online. Where one format of
meeting may be more appropriate in the circumstances, the Directors will take into account the competing
interests, cognisant of the importance of Unit Holder participation. The Directors have at the forefront, when
making this decision, the importance of ensuring that all Unit Holders are adequately informed about the
format of these meetings as well as the rules applicable to voting and participation generally.
8.3Quoted equity security holders should
have the right to vote on any major
decisions which may change the nature of
the issuer in which they are invested.
The Manager respects the views of Unit Holders and seeks to foster constructive relationships that
encourages engagement.
Our Unit Holders are entitled to vote to replace the supervisor or the Manager, which would be the two
key decisions which would change the nature of Vital, given its structure as a listed managed investment
scheme. In addition, Unit Holders have the right to appoint two independent directors to the board of the
Manager at each annual meeting.
As a managed investment scheme regulated by the FMCA, investment objectives, investment philosophy,
investment strategy and categories of authorised investments are required to be set out in the SIPO. A
copy of Vital’s SIPO is available here:
https://www.vitalhealthcareproperty.co.nz/app/ uploads/2021/02/SIPO_Vital_New.pdf
Changes to the SIPO may only be made in accordance with section 165 of the FMCA after having given
written notice to Vital’s supervisor, Trustees Executors Limited. Depending on the nature of the changes,
prior notice to Unit Holders or Unit Holder approval may be required.
8.4If seeking additional equity capital,
issuers of quoted equity securities should
offer further equity securities to existing
equity security holder of the same class
on a pro rata basis, and on no less
favourable terms, before further equity
securities are offered to other investors.
Vital’s most recent equity capital raising was implemented in April and May 2022 as an accelerated
entitlement offer. Eligible Unit Holders were entitled to subscribe for 1 new unit for every 8.54 units held at
the record date. This structure allowed existing Unit Holders to participate on a pro rata basis, on no less
favourable terms (subject to certain exceptions, like for Unit Holders outside New Zealand).
Vital has an active dividend reinvestment plan (DRP) under which all eligible Unit Holders are able to
participate. The terms of the DRP remained unchanged during the current accounting period save that a
2% discount applied from the third quarter.
8.5The board should ensure that the notices
of annual or special meetings of quoted
equity security holders is posted on the
issuer’s website as soon as possible and
at least 20 days prior to the meeting.
Under Vital’s Trust Deed at least 14 days’ notice is required for notices of meeting to be sent by post. Vital
will continue to follow the Trust Deed when determining the period of notice to be given. Having said
that, the Notices of Meeting for Vital’s annual meeting since 2020 were provided at least 20 days prior
to the meeting, as was the Notice of Meeting for the special meeting of Unit Holders held in 2021.
The notice of meeting is released on the NZX and included on Vital’s website.
66
|
VITAL HEALTHCARE PROPERTY TRUST
Maitland Private Hospital, Maitland
ANNUAL REPORT 2025
|
67
Financial Statements
Avive Clinic, Melbourne
68
|
VITAL HEALTHCARE PROPERTY TRUST
ANNUAL REPORT 2025|69
Contents
Consolidated Statement of Comprehensive Income70
Consolidated Statement of Financial Position71
Consolidated Statement of Changes in Equity72
Consolidated Statement of Cash Flows73
Notes to the Consolidated Financial Statements74
ABOUT THIS REPORT74
1. Reporting Entity 74
2. Basis of Preparation74
3. Material Accounting Policies76
PERFORMANCE77
4. Segment Information 77
5. Taxation79
6. Investment Properties 82
7. Other Expenses90
CAPITAL STRUCTURE, FINANCING AND RISK MANAGEMENT91
8. Units on Issue91
9. Earnings per Unit92
10. Distributable Income 93
11. Borrowings94
12. Lease Liabilities 96
13. Derivative Financial Instruments96
14. Financial and Risk Management 98
15. Commitments and Contingencies 103
EFFICIENCY OF OPERATIONS104
16. Statement of Cash Flows Reconciliation from Operating Activities104
17. Trade and Other Receivables105
18. Other Assets106
19. Trade and Other Payables106
OTHER NOTES107
20. Investment in Subsidiaries 107
21. Subsequent Events 107
22. Related Party Transactions107
70|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of
Comprehensive Income
For the year ended 30 June 2025
Note
2025
$000s
2024
$000s
Gross property income from rentals154,908150,978
Gross property income from expense recoveries22,19317,810
Property expenses(28,267)(24,255)
Net property income4148,834144,533
Other expenses7(23,355)(30,003)
Strategic transaction expenses(2,872)-
Finance income1,7382,645
Finance expense11.b(46,907)(43,251)
Operating profit77,43873,924
Other gains/(losses)
Valuation (loss)/gain on investment property6.a(96,722)(165,244)
Net (loss)/gain on disposal of investment property(2,376)(5,702)
Fair value (loss)/gain on foreign exchange derivatives487(284)
Fair value (loss)/gain on interest rate derivatives(28,681)(10,540)
Realised (loss)/gain on foreign exchange(11)(87)
Unrealised (loss)/gain on foreign exchange2,072(270)
(125,231)(182,127)
(Loss)/Profit before income tax(47,793)(108,203)
Taxation benefit/(expense)5(3,427)592
(Loss)/Profit for the year attributable to Unit Holders of the Trust(51,220)(107,611)
Other comprehensive income
Items that may be reclassified subsequently to profit and loss:
Movement in foreign currency translation reserve(14,391)6,076
Total other comprehensive (loss)/income after tax(14,391)6,076
Total comprehensive (loss)/income after tax(65,611)(101,535)
Earnings per unit
Basic and diluted earnings per unit (cents)9(7.58)(16.09)
The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.
ANNUAL REPORT 2025|71
Consolidated Statement of
Financial Position
As at 30 June 2025
Note
2025
$000s
2024
$000s
Non-current assets
Investment properties63,170,5663,213,689
Derivative financial instruments1329417,720
Other non-current assets188,09713,980
Total non-current assets3,178,9573,245,389
Current assets
Investment properties held for sale641,29426,284
Cash and cash equivalents1615,64218,934
Trade and other receivables173,31810,081
Other current assets187,4223,888
Derivative financial instruments131,459183
Total current assets69,13559,370
Total assets3,248,0923,304,759
Unit Holders' funds
Units on issue81,217,6841,204,977
Reserves(25)20,966
Retained earnings461,856579,183
Total Unit Holders' funds1,679,5151,805,126
Non-current liabilities
Borrowings111,363,6391,287,477
Lease liability - ground lease9,2689,982
Derivative financial instruments139,0661,856
Deferred tax5144,591158,762
Total non-current liabilities1,526,5641,458,077
Current liabilities
Trade and other payables1929,55332,171
Income in advance1,7881,653
Derivative financial instruments134,87094
Lease liability - ground lease620123
Taxation payable5,1827,515
Total current liabilities42,01341,556
Total liabilities1,568,5771,499,633
Total Unit Holders' funds and liabilities3,248,0923,304,759
For and on behalf of the Manager, Northwest Healthcare Properties Management Limited
G Stuart, Independent Chair
13 August 2025
M Stanford,
Independent Director
The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.
72|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of
Changes in Equity
For the year ended 30 June 2025
Units on
issue
$000s
Retained
earnings
$000s
Translation
of foreign
operations
$000s
Foreign
exchange
hedges
$000s
Share
based
payments
$000s
Total
Unit
Holders'
funds
$000s
For the year ended 30 June 2024
Balance at the start of the period1,180,922753,220(55,121)63,41114,9511,957,383
Changes in Unit Holders' funds24,055---(14,951)9,104
Manager's incentive fee----6,6006,600
Profit/(loss) for the period-(107,611)---(107,611)
Distributions to Unit Holders-(66,426)---(66,426)
Other comprehensive income for the period
Movement in foreign currency translation reserve--6,076--6,076
Balance at the end of the year1,204,977579,183(49,045)63,4116,6001,805,126
For the year ended 30 June 2025
Balance at the start of the period1,204,977579,183(49,045)63,4116,6001,805,126
Changes in Unit Holders' funds12,707---(6,600)6,107
Profit/(loss) for the period-(51,220)---(51,220)
Distributions to Unit Holders-(66,107)---(66,107)
Other comprehensive income for the period
Movement in foreign currency translation reserve--(14,391)--(14,391)
Balance at the end of the year1,217,684461,856(63,436)63,411-1,679,515
The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.
ANNUAL REPORT 2025|73
Consolidated Statement of
Cash Flows
For the year ended 30 June 2025
Note
2025
$000s
2024
$000s
Cash flows from operating activities
Property income155,291151,043
Recovery of property expenses21,97917,711
Interest received9111,289
Property expenses(23,874)(23,637)
Management and trustee fees(19,500)(19,994)
Interest paid(44,759)(41,080)
Tax paid(17,793)(20,006)
Other trust expenses(3,847)(3,881)
Net cash provided by/(used in) operating activities68,40861,445
Cash flows from investing activities
Receipts from foreign exchange derivatives20212,255
Payments for foreign exchange derivatives(260)(12,479)
Capital additions on investment properties(155,685)(250,760)
Purchase of properties(1,436)(10,679)
Proceeds from disposal of properties51,034239,403
Fitout loans to tenants4,028(11,374)
Strategic transaction expenses(1,977)(455)
Net cash provided by/(used in) investing activities(104,094)(34,089)
Cash flows from financing activities
Debt drawdown358,056316,327
Repayment of debt(264,022)(277,227)
Issue of units(57)-
Loan issue costs(1,640)(1,084)
Costs associated with new equity raised(83)(100)
Distributions paid to Unit Holders(59,860)(57,223)
Net cash from/(used in) financing activities32,394(19,307)
Net increase/(decrease) in cash and cash equivalents(3,292)8,049
Cash and cash equivalents at the beginning of the period18,93410,885
Cash and cash equivalents at the end of the year15,64218,934
The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.
74|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
About this Report
1. Reporting Entity
Vital Healthcare Property Trust (“VHP” or the “Trust”) is a unit trust established under the Unit Trusts Act 1960 by a Trust Deed dated
11 February 1994 (as subsequently amended and replaced), domiciled in New Zealand. The Trust is managed by Northwest Healthcare
Properties Management Limited (the “Manager”), with its registered office at Level 17, HSBC Tower, 188 Quay Street, Auckland
Central 1010.
The consolidated financial statements of VHP for the year ended 30 June 2025 comprise VHP and its subsidiaries (together referred to as
the “Group”). VHP is listed on the New Zealand Stock Exchange (NZX) and is a FMC reporting entity for the purpose of the Financial
Markets Conduct Act 2013. The Group's principal activity is the direct and/or indirect investment in, and management of, high quality real
estate in good locations primarily used by healthcare operators or used for healthcare, life sciences and related purposes.
These consolidated financial statements were approved by the Board of Directors of the Manager on 13 August 2025.
2.
Basis of Preparation
(a) Statement of compliance
These financial statements have been prepared in accordance with New Zealand Generally Accepted Accounting Practice ("NZ GAAP")
and comply with New Zealand equivalents to IFRS Accounting Standards ("NZ IFRS") and other applicable Financial Reporting Standards,
as appropriate toprofit-oriented entities. These financial statements comply with NZ IFRS and IFRS Accounting Standards ("IFRS").
(b)
Basis of consolidation
The Group’s financial statements incorporate the financial statements of the Trust and entities controlled by the Trust (its subsidiaries) as
set out in Note 20. Control is achieved where the Trust has power over the investees; is exposed, or has rights to variable returns from
its involvement with the investees; and has the ability to use its power to affect its returns. The results of subsidiaries are included in the
consolidated financial statements from the date of acquisition to the date of disposal. All intra-group transactions, balances, cashflows,
income and expenses are eliminated on consolidation.
(c)
Basis of measurement
The Group uses the historical cost basis except for derivative financial instruments and investment properties which are measured at fair
value. Historical cost is based on the fair value of the consideration given or received in exchange for assets or liabilities. Fair value is
the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date, regardless of whether that price is directly observable or estimated using another valuation technique.
(d)
Functional and presentation currency
These financial statements are presented in New Zealand Dollars ($), which is the Trust's functional and presentation currency. All
information has been rounded to the nearest thousand dollars ($000), unless stated otherwise.
In preparing the financial statements, transactions in currencies other than the Trust’s functional currency (i.e. a foreign currency transaction)
are recorded at the rates of exchange prevailing at the dates of the transactions. At the end of each reporting period, foreign currency
denominated monetary items are retranslated at the rate of exchange prevailing at that time. Exchange differences are recognised in profit
or loss in the period in which they arise, except for exchange differences on transactions entered into to hedge foreign currency exposure.
The assets and liabilities of the Group’s foreign operations are translated to New Zealand Dollars using exchange rates prevailing at the
end of the reporting period. Income and expense items are translated at the average exchange rates for the period. Exchange differences
arising on translation are recognised in other comprehensive income and the foreign currency translation reserve.
ANNUAL REPORT 2025|75
(e) Changes in accounting policy and presentation
All accounting policies have been applied on a basis consistent with the prior year's financial statements.
(f) Standards and Interpretations in issue not yet effective
At the date of authorisation of these financial statements, the Group has not applied new and revised NZ IFRS standards and amendments
that have been issued but are not yet effective. It is not expected that the adoption of these standards and amendments will have a material
impact on the financial statements of the Group except as outlined below.
In May 2024, NZ IFRS 18 Presentation and Disclosure in Financial Statements (effective for reporting periods beginning on or after
1 January 2027) was issued. This standard replaces NZ IAS 1 Presentation of Financial Statements. Management are still assessing the
impact and note this may change the presentation of primary statements.
(g) Climate-related disclosures
Vital is a Climate Reporting Entity (CRE) and is required to comply with the Financial Sector Amendment Act 2021 to provide climate-related
disclosures. In accordance with the External Reporting Board (XRB) Aotearoa New Zealand Climate Standards, Vital expects to release its
second report in October 2025.
(h)
Material accounting policy information
Material accounting policies that summarise the measurement basis used and are relevant to an understanding of the consolidated financial
statements are provided throughout the notes to the consolidated financial statements. Where necessary, comparative information has been
reclassified to achieve consistency in disclosure with the current period.
(i)
Fair value hierarchy
The valuation technique inputs used to determine the value of an asset or liability are classified into Levels 1 to 3 based on the degree to
which the fair value inputs are observable. A description of the levels of fair value hierarchy are as follows:
Level 1 fair value measurements are those derived from quoted prices in active markets for identical assets or liabilities.
Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the
asset or liability, either directly (as prices) or indirectly (derived from prices).
Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on
observable market data (unobservable inputs).
(j)
The notes to the consolidated financial statements
The following notes include information required to understand these financial statements that is relevant and material to the operations,
financial position and performance of the Group. The notes have been collated into sections to help users find and understand inter-related
information. Information is considered material and relevant if, for example:
•the amount is significant by virtue of its size or nature;
•it is important to understand the results of the Group;
•it helps explain the impact of significant changes in the Group's business; or
•it relates to an aspect of the Group's operations that is important to its future performance.
76|VITAL HEALTHCARE PROPERTY TRUST
3. Material Accounting Policies
Critical accounting estimates and judgements
In the application of NZ IFRS, the Board and management are required to make judgements, estimates and assumptions about carrying
values of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on
experience and other factors that are believed to be reasonable under the circumstances, however actual results may differ from these
estimates and assumptions.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in
which the estimate is revised and in any future periods affected.
The critical judgements, estimates and assumptions made in the current period are contained in the following notes:
NoteDescription
Note 5Current and deferred taxation
Note 6Valuation of investment properties
Note 22Related party transactions
ANNUAL REPORT 2025|77
Performance
This section shows the results and performance of the Group and its reporting segments and includes detailed information in respect to its
revenues, expenses and profitability. It also provides information on the investment properties that underpin the Group's performance.
4. Segment Information
The Group's principal activity is the investment in, and management of, high quality real estate in good locations primarily used by
healthcare operators or used for healthcare, life sciences and related purposes. Segment profit represents the profit earned by each
segment including an allocation of
identifiable administration costs, finance costs and gains/(losses) on disposal of investment properties.
This is the measure reported to the Board, who are the chief operating decision makers for the purposes of resource allocation and
assessment of segment performance. The Group operates in both Australia and New Zealand.
The following is an analysis of the Group’s results by reportable segment.
Australia
$000s
New Zealand
$000s
Total
$000s
Segment profit/(loss) for the year ended 30 June 2025:
Gross property income from rentals101,68853,220154,908
Gross property income from expense recoveries8,43813,75522,193
Property expenses(12,893)(15,374)(28,267)
Net property income97,23351,601148,834
Other expenses(14,789)(8,566)(23,355)
Strategic transaction expenses-(2,872)(2,872)
Net finance expense(38,309)(6,860)(45,169)
Operating profit44,13533,30377,438
Fair value (losses) on interest rate derivatives(25,002)(3,679)(28,681)
Valuation gains/(losses) on investment properties(106,338)9,616(96,722)
Net losses on disposal of investment property(2,244)(132)(2,376)
Other foreign exchange gains/(losses)2112,3372,548
Total segment profit/(loss) before income tax(89,238)41,445(47,793)
Taxation expense / (benefit)(3,427)
Profit/(loss) for the year(51,220)
Segment profit/(loss) for the year ended 30 June 2024:
Gross property income from rentals101,46349,515150,978
Gross property income from expense recoveries7,28010,53017,810
Property expenses(11,966)(12,289)(24,255)
Net property income96,77747,756144,533
Other expenses(15,636)(14,367)(30,003)
Net finance expense(38,341)(2,265)(40,606)
Operating profit42,80031,12473,924
Fair value (losses) on interest rate derivatives(7,643)(2,897)(10,540)
Revaluation (losses) on investment properties(133,505)(31,739)(165,244)
Net losses on disposal of investment property(4,523)(1,179)(5,702)
Other foreign exchange gains/(losses)(210)(431)(641)
Total segment profit/(loss) before income tax(103,081)(5,122)(108,203)
Taxation expense / (benefit)592
Profit/(loss) for the year(107,611)
78|VITAL HEALTHCARE PROPERTY TRUST
Net property income comprises rental income and expense recoveries from tenants less property expenses. The Group has three Australian
tenants and one New Zealand tenant that in aggregate contributed $100.2m of gross property income (2024: three Australian tenants and
one New Zealand tenant that contributed $100.5m).
There were no inter-segment sales during the year (2024: nil).
Australia
$000s
New Zealand
$000s
Total
$000s
Segment assets at 30 June 2025:
Investment properties2,106,3601,064,2063,170,566
Other non-current assets3,1985,1938,391
Current assets59,2879,84869,135
Consolidated assets2,168,8451,079,2473,248,092
Segment assets at 30 June 2024:
Investment properties2,213,762999,9273,213,689
Other non-current assets25,0306,67031,700
Current assets47,26112,10959,370
Consolidated assets2,286,0531,018,7063,304,759
Segment liabilities at 30 June 2025:
Borrowings1,095,540268,0991,363,639
Other liabilities172,28832,650204,938
Consolidated liabilities1,267,828300,7491,568,577
Segment liabilities at 30 June 2024:
Borrowings1,107,629179,8481,287,477
Other liabilities178,63233,524212,156
Consolidated liabilities1,286,261213,3721,499,633
All assets and liabilities have been allocated to reportable segments.
Net finance expense and borrowings are allocated against the borrowers segment. In accordance with the Group’s finance facilities,
comprising a common terms deed and bi-lateral facility agreements (refer note 11.a), financing arrangements are cross collateralised across
the Group’s investment properties and other assets and are managed on an aggregate basis.
ANNUAL REPORT 2025|79
5. Taxation
Income tax recognised in the consolidated statement of comprehensive income
2025
$000s
2024
$000s
Profit/(loss) before tax for the period(47,793)(108,203)
Taxation (charge)/credit - 28% on profit before income tax13,38230,297
Effect of different tax rates in foreign jurisdictions(11,601)(13,431)
Tax exempt income / (Non-deductible expense)4,054(1,339)
Foreign tax credits3,0241,559
Tax charges on overseas investments(12,559)(13,058)
Over/(under) provided in prior periods(1,403)1,228
Other adjustments1,676(4,664)
Taxation benefit/(expense)(3,427)592
The taxation (charge)/credit is made up as follows:
Current taxation(15,546)(19,046)
Deferred taxation12,11919,638
Taxation benefit/(expense)(3,427)592
The key assumptions used in the preparation of the Group’s tax calculation are as follows:
Tax rate:
The Group is subject to New Zealand tax on assessable income, including assessable Foreign Investment Fund ("FIF") income attributed
from its Australian subsidiaries (applying either the Fair Dividend Rate ("FDR") method or the attributable FIF method), at a rate of 28%. Its
Australian subsidiaries are subject to Australian withholding tax on assessable income at a rate of 10% for interest income or 15% for 'fund
payment' amounts as they are Australian Managed Investment Trusts (MIT). A New Zealand tax credit is generally available for Australian
withholding tax.
80|VITAL HEALTHCARE PROPERTY TRUST
Deferred Tax balances
Interest rate
swaps
$000s
Revaluation
of investment
properties
$000s
Borrowings
$000s
Other
$000s
Total
$000s
At 1 July 2024(292)(158,383)(223)136(158,762)
Charge to profit and loss for the year3,2277,70485533312,119
Change in exchange rate(53)2,139(27)(7)2,052
At 30 June 20252,882(148,540)605462(144,591)
At 1 July 2023(7,359)(170,190)(174)197(177,527)
Charge to profit and loss for the year7,07112,718(49)(102)19,638
Change in exchange rate(4)(911)-41(874)
At 30 June 2024(292)(158,383)(223)136(158,762)
Imputation credits
2025
$000s
2024
$000s
Imputation (deficit)/credits at end of year(4,295)(4,306)
Recognition and measurement
Income tax comprises current and deferred tax. It is recognised in the consolidated profit or loss unless it relates to items recognised in other
comprehensive income, in which case the current or deferred tax is recognised in other comprehensive income.
Current tax
Current tax is the expected tax payable on the taxable income for the financial year, determined using tax rates enacted or substantively
enacted at the reporting date in the countries where the Group operates, and any adjustments to tax payable in respect of previous
financial years. Management periodically evaluates positions taken in tax returns where the applicable tax regulation is subject to
interpretation and establishes appropriate provisions on the basis of amounts expected to be paid to the tax authorities.
Deferred tax
Deferred tax is provided using the balance sheet liability method, recognising temporary differences between the carrying amounts of assets
and liabilities for financial reporting purposes and their amounts for taxation purposes.
Deferred tax liabilities are recognised for all taxable temporary differences. Deferred tax assets are recognised for all deductible temporary
differences and carried forward tax losses, to the extent that it is probable that taxable profit will be available to utilise them.
The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profits will be available to utilise them.
Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to the forecast circumstances and the
period(s) when the asset or liability giving rise to them are realised or settled, based on the tax rates and laws enacted or substantively
enacted at balance date.
Deferred tax assets and liabilities are offset where there is a legally enforceable right to set off, they relate to the same taxation authority,
and the Group intends to settle its obligations on a net basis.
ANNUAL REPORT 2025|81
Unrecognised deferred tax assets
Deferred tax assets totalling $10.3m (2024: $0.7m) relating to debt deductions in Australia that have not been recognised. These tax losses
can be carried forward 15 years and utilised in future periods subject to specific conditions.
Uncertain tax positions
The Group is in the process of revising tax depreciation claims in relation to the financial years ended 30 June 2021 to 2024 in relation to
Australian and New Zealand investment properties (currently estimated at $1.9m). This tax depreciation and therefore current tax benefit
has not been recorded as the required tax return amendments / positions are subject to the Commissioner of Inland Revenue’s discretion or
determination, which has currently been assessed as not probable.
Significant estimates and judgements
Significant estimates and judgements made in the determination of deferred tax include:
•Deferred tax on fixtures and fittings: It is assumed that all fixtures and fittings will be sold at their tax book value.
•Deferred tax on depreciation: Deferred tax is provided for in respect of New Zealand properties for the depreciation expected to be
recovered on the sale of investment property, using an estimated split between land and buildings as determined by registered valuers.
•Deferred tax on changes in fair value of investment properties: Deferred tax for Australian properties is provided on the capital gain that
is expected from the sale of investment properties based on their fair value. The tax rate used when measuring the deferrred tax position
is either15% (FDR method which applies the Australian 'fund payment' withholding tax rate) or 28% (Attributed FIF method which applies
the New Zealand tax rate) based on the Group's actual FIF income attribution method election and/or its intention to 'opt-in' to the
FDR method.
82|VITAL HEALTHCARE PROPERTY TRUST
6. Investment Properties
Investment properties comprise real estate predominately leased, or targeted to be leased, to health, life sciences and related sector
tenants that is held for either deriving rental income, for capital appreciation or both. The following information excludes Investment Property
reclassified to Investment Properties held for sale.
(6.a) Reconciliation of Carrying Amounts
2025
$000s
2024
$000s
Carrying value of investment property at the beginning of the year3,213,6893,288,356
Acquisition of properties1,18713,183
Capitalised costs127,060212,949
Capitalised interest costs24,87026,480
Net capitalised incentives(2,130)7,159
Disposal of properties(23,275)(161,317)
Classified as held for sale(41,294)(26,284)
Foreign exchange translation difference(32,819)12,174
Revaluation gain/(loss) on investment property(76,602)(165,244)
Carrying value gain/(loss) on investment property under construction(20,120)-
Right of use asset recognised-6,233
Carrying value of investment property at the end of the year3,170,5663,213,689
The Group owns the freehold title to all properties except the car parks at the rear of Ascot Hospital and Ascot Central ("Ascot") and the
GenesisCare Integrated Cancer and Health Centre ("GenesisCare") which are the subject of ground leases ("right-of-use" asset). These
ground leases have a weighted average term remaining of 13.8 and 53.7 years respectively (2024: 14.8 and 54.7 years). As at reporting
date the fair value of the right-of-use assets are $3.5m and $6.3m respectively (2024: 3.7 and $6.4). The ground lease at the Ascot
carpark has a 20 year option to extend the term commencing 8 April 2039. The ground lease at the GenesisCare property has two 15
year options to extend the term commencing 28 February 2079 and 28 February 2094.
(6.b)
Acquisition of Property
During the period the Group:
•acquired Beck Court Road, Noble Park, VIC for A$1.0m. The road is located adjacent to South Eastern Hospital and other strategic land
holdings, and improves the overall development of the proposed brownfield expansion of the South Eastern Hospital.
(6.c)
Disposal of Property
During the year the Group:
•divested Hirondelle Private Hospital in Chatswood, NSW Australia for A$24.0m (excluding transaction costs) on 23 October 2024.
•divested Epworth Rehabilitation and the land at 10-14 Alverna Grove in Brighton, VIC Australia for A$19.3m (excluding transaction
costs) on 3 December 2024.
•divested 6a Millet Street, Hurstville, NSW Australia for A$1.7m (excluding transaction costs) on 2 May 2025.
ANNUAL REPORT 2025|83
(6.d) Leasing Arrangements
Investment properties are leased to tenants predominately under long term operating leases. Rent is receivable from tenants monthly.
Minimum lease payments to be received under non-cancellable operating leases not recognised in the consolidated financial statements as
receivable are as follows:
2025
$000s
2024
$000s
Not later than one year163,106148,990
Later than one year and not later than five years608,496568,910
Later than five years1,535,1731,474,202
2,306,7752,192,102
(6.e) Contractual arrangements
The Group is a party to contracts to purchase and construct property, provide incentives and amortising fitout loans to tenants which are not
recognised in the financial statements, unless otherwise noted, for the following amounts:
2025
$000s
2024
$000s
Capital expenditure commitments39,030140,422
The Group has committed to:
•providing up to A$2.0m for air conditioning replacement works at Sportsmed Hospital, Clinic and Consulting suites (incorporated into
the valuation of this property).
•capital expenditure and property acquisition committments relating to development projects' cost to complete.
•reimbursing 50% of a tenants costs (up to A$0.6m) should the agreement for lease be terminated by the Group at any time before
commencement of the developments construction.
•acquire and rentalise additional development works previosuly undertaken by Avive at the Mt Eliza Clinic, totalling A$1.74 million,
contingent on the tenant achieving a defined performance hurdle before the sunset date of 31 December 2027.
(6.f)
Individual Valuations and Carrying Amounts
The details of the New Zealand and Australian investment property portfolio, including its location, sub sector, fair value, market
capitalisation rate, occupancy and weighted average lease expiry term are as follows:
84|VITAL HEALTHCARE PROPERTY TRUST
Latest independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-25
$M
Jun-24
%
Jun-25
%
Jun-24
%
Jun-25
%
Jun-24
Years
Jun-25
Years
Jun-24
Australia
New South Wales
Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-25191.9205.45.34.9100.0100.025.721.7
Maitland Private HospitalEast Maitland, New South Wales
Hospital (Acute/Mental
Health/Rehab)Healthe CareJun-25149.9146.55.65.5100.0100.022.018.1
Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2491.191.46.06.0100.0100.021.817.8
Kellyville Private HospitalKellyville, New South WalesHosptial (Mental Health)AuroraDec-2450.455.35.65.0100.0100.022.023.0
GenesisCare Integrated Cancer & Health CentreCampbelltown, New South WalesHosptial (Ambulatory Care)GenesisCareJun-2547.650.75.44.9100.0100.013.714.7
Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2540.244.95.34.9100.0100.025.718.1
Toronto Private Hospital
1
Toronto, New South WalesHospital (Mental Health/Rehab)AuroraJun-24-42.9-6.5-100.0-21.7
Victoria
Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationJun-25414.0428.25.04.698.697.222.723.5
South Eastern Private HospitalNoble Park, VictoriaHospital (Mental Health/Rehab)AuroraDec-2489.586.75.55.5100.0100.015.716.7
Epworth CamberwellCamberwell, VictoriaHospital (Mental Health/Rehab)Epworth FoundationJun-2577.883.25.45.0100.0100.019.020.0
Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesJun-2536.037.26.35.897.897.84.14.1
Avive Clinic - Mornington PeninsulaMount Eliza, VictoriaHospital (Mental Health)AviveDec-2430.731.25.55.3100.0100.023.324.3
120 Thames StreetBox Hill, VictoriaAmbulatory CareNewlife IVFJun-2512.012.66.86.375.775.73.94.6
Epworth Rehabilitation
2
Brighton, VictoriaHospital (Rehab)Epworth Foundationn.a-16.4-n.a.-100.0-0.1
Queensland
Belmont Private HospitalCarina Heights, QueenslandHospital (Mental Health)AuroraDec-24145.6164.35.44.8100.0100.020.221.2
Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Mental Health)AuroraJun-2562.574.55.65.0100.0100.010.211.2
Western Australia
Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Mental Health)AuroraDec-2459.061.95.35.0100.0100.016.617.6
Marian CentreWembley, Western AustraliaHospital (Mental Health)AuroraDec-2458.862.45.45.0100.0100.019.110.1
South Australia
Playford Health Hub – MOB, Retail and CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2590.988.25.45.392.273.69.36.8
Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-2588.994.85.65.3100.0100.06.06.0
Burnside Hospital Stepney, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Burnside Hospital FoundatonJun-2577.189.07.16.1100.0100.021.322.3
Total Australia1,813.91,967.85.55.299.099.119.018.1
1Classified as investment property held for sale at 30th June 2025
2This property was divested in Dec24
ANNUAL REPORT 2025|85
Latest independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-25
$M
Jun-24
%
Jun-25
%
Jun-24
%
Jun-25
%
Jun-24
Years
Jun-25
Years
Jun-24
Australia
New South Wales
Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-25191.9205.45.34.9100.0100.025.721.7
Maitland Private HospitalEast Maitland, New South Wales
Hospital (Acute/Mental
Health/Rehab)Healthe CareJun-25149.9146.55.65.5100.0100.022.018.1
Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2491.191.46.06.0100.0100.021.817.8
Kellyville Private HospitalKellyville, New South WalesHosptial (Mental Health)AuroraDec-2450.455.35.65.0100.0100.022.023.0
GenesisCare Integrated Cancer & Health CentreCampbelltown, New South WalesHosptial (Ambulatory Care)GenesisCareJun-2547.650.75.44.9100.0100.013.714.7
Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2540.244.95.34.9100.0100.025.718.1
Toronto Private Hospital
1
Toronto, New South WalesHospital (Mental Health/Rehab)AuroraJun-24-42.9-6.5-100.0-21.7
Victoria
Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationJun-25414.0428.25.04.698.697.222.723.5
South Eastern Private HospitalNoble Park, VictoriaHospital (Mental Health/Rehab)AuroraDec-2489.586.75.55.5100.0100.015.716.7
Epworth CamberwellCamberwell, VictoriaHospital (Mental Health/Rehab)Epworth FoundationJun-2577.883.25.45.0100.0100.019.020.0
Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesJun-2536.037.26.35.897.897.84.14.1
Avive Clinic - Mornington PeninsulaMount Eliza, VictoriaHospital (Mental Health)AviveDec-2430.731.25.55.3100.0100.023.324.3
120 Thames StreetBox Hill, VictoriaAmbulatory CareNewlife IVFJun-2512.012.66.86.375.775.73.94.6
Epworth Rehabilitation
2
Brighton, VictoriaHospital (Rehab)Epworth Foundationn.a-16.4-n.a.-100.0-0.1
Queensland
Belmont Private HospitalCarina Heights, QueenslandHospital (Mental Health)AuroraDec-24145.6164.35.44.8100.0100.020.221.2
Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Mental Health)AuroraJun-2562.574.55.65.0100.0100.010.211.2
Western Australia
Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Mental Health)AuroraDec-2459.061.95.35.0100.0100.016.617.6
Marian CentreWembley, Western AustraliaHospital (Mental Health)AuroraDec-2458.862.45.45.0100.0100.019.110.1
South Australia
Playford Health Hub – MOB, Retail and CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2590.988.25.45.392.273.69.36.8
Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-2588.994.85.65.3100.0100.06.06.0
Burnside Hospital Stepney, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Burnside Hospital FoundatonJun-2577.189.07.16.1100.0100.021.322.3
Total Australia1,813.91,967.85.55.299.099.119.018.1
1Classified as investment property held for sale at 30th June 2025
2This property was divested in Dec24
86|VITAL HEALTHCARE PROPERTY TRUST
Latest independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-25
$M
Jun-24
%
Jun-25
%
Jun-24
%
Jun-25
%
Jun-24
Years
Jun-25
Years
Jun-24
New Zealand
Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareJun-25188.7183.35.55.5100.0100.022.423.4
AscotGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-24125.0125.05.45.4100.098.414.414.2
Grace HospitalTauranga, Bay of PlentyHospital (Acute)Evolution Southern Cross LimitedDec-24122.2109.45.55.4100.0100.025.526.5
Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2495.086.35.85.5100.0100.024.425.4
Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedJun-2586.183.45.45.492.3100.015.614.9
Kawarau ParkLake Hayes, QueenstownHospital (Acute)Southern Cross CLT LimitedJun-2572.069.55.85.6100.094.16.27.1
Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2467.959.45.95.9100.0100.013.014.0
Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareJun-2567.766.05.55.5100.0100.024.425.4
Endoscopy AucklandEpsom, AucklandHospital (Acute)Evolution HealthcareJun-2548.631.75.55.5100.0100.016.917.9
Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedJun-2539.838.55.96.096.996.94.65.5
68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareHealth New Zealand - CanterburyJun-2539.539.45.85.882.271.18.38.8
Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedDec-2434.034.05.55.5100.0100.011.011.8
Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2424.723.66.16.3100.0100.021.022.0
Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-248.48.411.411.797.391.511.511.9
Total New Zealand1,019.6957.75.65.697.997.017.818.6
Properties held for development337.1288.2
Investment properties - non current3,170.63,213.7
Investment properties held for sale41.326.3
TOTAL FAIR VALUE OF
INVESTMENT PROPERTIES3,211.93,240.05.55.398.698.018.518.3
ANNUAL REPORT 2025|87
Latest independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-25
$M
Jun-24
%
Jun-25
%
Jun-24
%
Jun-25
%
Jun-24
Years
Jun-25
Years
Jun-24
New Zealand
Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareJun-25188.7183.35.55.5100.0100.022.423.4
AscotGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-24125.0125.05.45.4100.098.414.414.2
Grace HospitalTauranga, Bay of PlentyHospital (Acute)Evolution Southern Cross LimitedDec-24122.2109.45.55.4100.0100.025.526.5
Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2495.086.35.85.5100.0100.024.425.4
Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedJun-2586.183.45.45.492.3100.015.614.9
Kawarau ParkLake Hayes, QueenstownHospital (Acute)Southern Cross CLT LimitedJun-2572.069.55.85.6100.094.16.27.1
Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2467.959.45.95.9100.0100.013.014.0
Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareJun-2567.766.05.55.5100.0100.024.425.4
Endoscopy AucklandEpsom, AucklandHospital (Acute)Evolution HealthcareJun-2548.631.75.55.5100.0100.016.917.9
Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedJun-2539.838.55.96.096.996.94.65.5
68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareHealth New Zealand - CanterburyJun-2539.539.45.85.882.271.18.38.8
Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedDec-2434.034.05.55.5100.0100.011.011.8
Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2424.723.66.16.3100.0100.021.022.0
Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-248.48.411.411.797.391.511.511.9
Total New Zealand1,019.6957.75.65.697.997.017.818.6
Properties held for development337.1288.2
Investment properties - non current3,170.63,213.7
Investment properties held for sale41.326.3
TOTAL FAIR VALUE OF
INVESTMENT PROPERTIES3,211.93,240.05.55.398.698.018.518.3
88|VITAL HEALTHCARE PROPERTY TRUST
(6.g) Recognition and Measurement
Recognition and measurement
Investment Property
Investment properties are initially measured at cost, including any related transaction costs. Expenditure is capitalised to a property's
carrying value only when its cost can be measured reliably and it is probable that future economic benefits will flow to the Group. All other
repairs and maintenance expenditure is charged to the statement of comprehensive income.
Subsequent to initial recognition, investment properties, including investment properties held for sale, are measured at fair value (inclusive
of adjustments for straight line rental revenue recognition, unamortised lease incentives and costs, and capital expenditure obligations) with
any gains or losses arising on re-measurement recognised in
profit or loss.
Lessee arrangements and Right-of-Use assets
On inception of a lease arrangement (where the Group is a lessee), the lease liability is initially measured as the aggregate of fixed lease
payments due (net of incentives receivable), expected residual value guarantees and the exercise price of purchase options (if reasonably
certain to be exercised) and expected lease termination payments, discounted using the interest rate implicit in the lease, or if this cannot be
determined, the Group's incremental cost of borrowing.
Subsequent to initial recognition, lease payments are allocated between finance costs (which is expensed to the consolidated statement
of comprehensive income over the term of the lease using the effective interest rate method) and a reduction of the initial lease liability
recognised. Refer to Note
12 for the lease liabilities recognised by the Group.
Right-of-Use assets are initially measured at cost, comprising the aggregate of the initial measurement of the lease liability (net of
incentives received), lease payments made before commencement date, initial direct costs and restoration costs and are classified as
Investment Property.
Subsequent to initial recognition right-of-use assets are measured at fair value.
Development of investment property
Investment property that is being developed is measured at cost until either its fair value becomes reliably measurable or the development
reaches practical completion. Borrowing costs are capitalised from when activities to prepare the property for development commence, until
the property is ready for use.
As at 30 June 2025, the carrying value of RDX, QLD (a property currently under construction and expected to achieve practical completion
in early 2026 - therefore held at cost) was reassessed, resulting in a reduction of $20.1m. This primarily reflects required carrying value
adjustments due to actual and forecast costs to complete, updated market observations and broader trends affecting healthcare properties
(and commercial real estate more generally) since construction commenced in late 2022. The adjustment relied on assumptions and
estimates as at 30 June 2025, informed by independent advice, forecast costs to complete estimates, and leasing considerations. The actual
fair value of RDX on completion may differ from the current carrying amount.
Rental income
Rental income from investment properties is comprised of lease components (including base rent, recovery of property taxes and insurance)
and non-lease components (including property outgoing recoveries). Rental income is recognised at the fair value of consideration
receivable (excluding GST).
Rental income relating to lease components is recognised on a straight-line basis over the term of the lease for the period where the rental
income is fixed and determinable. For leases where the rental income is determined based on unknown future variables such as inflation,
market reviews or other factors, rental income is recognised on an accruals basis in accordance with the terms of the lease.
Rental income from property outgoing recoveries is recognised as the costs are incurred, which is typically when the services are provided.
ANNUAL REPORT 2025|89
Rental income not received at reporting date is reflected in the consolidated statement of financial position as a receivable or, if paid in
advance, as income in advance.
Lease incentives, commissions and other costs
Lease incentives provided to tenants, such as fit-outs or rent free periods, and leasing commissions and other costs incurred when entering
into a lease are recognised as a reduction of net property income on a straight-line basis over the non-cancellable term of the lease.
Derecognition
An investment property is derecognised upon disposal or when no future economic benefits are expected from use. The gain or loss arising
on derecognition of the property is measured as the difference between the net proceeds from disposal and the carrying amount at disposal
date and is recognised in the consolidated statement of comprehensive income in the period in which the property is derecognised.
Valuation process
The purpose of the valuation process is to ensure that investment properties are held at fair value. In accordance with the Group's valuation
policy, external valuations are performed by independent professionally qualified valuers who hold a recognised and relevant professional
qualification and have specialised expertise in the type of investment property being valued. The valuation policy requires that a valuer
may not value the same property for more than two consecutive valuations. All valuations are reviewed by the Manager and approved by
the Board.
The fair value of investment property as at 30 June 2025 was determined through independent professional valuers for approximately 64%
of the portfolio with the balance of the investment property portfolio subject to independent valuation at 31 December 2024. Manager's
valuations are used to determine the balance of the porfolio at each reporting date and are informed by market data and valuation advice
provided by independent valuers, comparable transactional evidence and current period leasing activities. The valuers of properties which
have been independently valued at
30 June 2025 included: Ernst & Young, Colliers International, Cushman & Wakefield, Jones Lang
LaSalle Australia, Savills, CBRE, Urbis, Valued Care, and Absolute Value. The properties which have been independently valued at 30 June
2025 are disclosed above in Note 6.f.
The methods used for assessing the fair value of investment property are the Direct Comparison, Discounted Cash Flow (using a risk adjusted
discount rate), Capitalisation of Contract and Market Income approaches and are unchanged from the prior year. The principal factors
that influence a valuation include the market capitalisation / discount rates, occupancy, market rent assessments and the weighted average
lease term to expiry (WALE).
Climate change
The Group continues to assess the impact of climate change on its business and its real estate assets. While valuers have made no explicit
adjustments to the fair value of investment property in respect of climate change matters, it is anticipated that climate change may have a
greater influence on valuations in the future as investment markets place a greater emphasis on climate change and a property's / tenants
environmental resilience and credentials.
Fair Value Hierarchy
Investment properties are classified as Level 3 under the fair value valuation hierarchy.
Estimates and judgements
The key inputs used in the valuation of investment property are tenant quality, occupancy, rental growth rates, weighted average lease
duration, capitalisation rates, discount rates and terminal yields.
Generally, as:
•tenant quality, occupancy, rental growth rates and/or weighted average lease durations increase, yields firm, resulting in increased fair
values for investment properties, and vice versa;
•capitalisation, discount rates and/or terminal yields used in the valuation approaches decrease (firm), the fair values for investment
properties increase, and vice versa.
90|VITAL HEALTHCARE PROPERTY TRUST
7. Other Expenses
(7.a) Other Expenses
2025
$000s
2024
$000s
Other Expenses
Manager's fees17,65218,084
Manager's incentive fee-6,600
Trustee fees564569
Other operating expenses4,9224,533
Total other expenses23,13829,786
(7.b) Fees Paid To Auditor
2025
$000s
2024
$000s
Fees Paid To Auditor
Auditor's remuneration:
Audit and review of financial statements
Statutory audit of the consolidation financial statements168168
Review of the condensed consolidated interim financial statements4646
Other services
AGM scrutineering33
Total fees paid to auditor217217
ANNUAL REPORT 2025|91
Capital Structure, Financing and Risk Management
This section outlines how the Group manages its capital structure and related financing activities and presents the resultant returns delivered
to Unit Holders via distributions and earnings per unit.
8. Units on Issue
2025
$000s
2024
$000s
Balance at the beginning of the year1,204,9771,180,922
Issue of units under Distribution Reinvestment Plan6,2479,203
Issue of units to satisfy Manager's incentive fee6,60014,951
Issue costs of units(140)(99)
Balance at the end of the year1,217,6841,204,977
2025
000s
2024
000s
Reconciliation of number of units
Balance at the beginning of the year671,923661,014
Issue of units under the Distribution Reinvestment Plan3,3274,492
Units issued to satisfy Manager's incentive fee3,6466,417
Balance at the end of the year678,896671,923
Distributions for the financial year were 9.75 cents per unit (2024: 9.75 cents per unit) including the final quarter distribution of 2.4375 cents
per unit (2024: 2.4375 cents per unit) declared subsequent to the reporting date. Refer Note 21.
There have been no equity raise activities outside of the units issued under the distribution reinvestment plan, and the payment of the
manager's incentive fee in units.
Recognition and measurement
Issued capital
Issued and paid up units are recognised at the fair value of the consideration received by the Group, net of directly incurred transaction
costs. Fully paid ordinary units carry one vote per unit and the right to distributions.
Distributions are recognised as a liability in the Group’s financial statements in the period in which the distribution is declared.
92|VITAL HEALTHCARE PROPERTY TRUST
Share based payments (Managers incentive fee)
Subject to the Trust Deed, the Manager is entitled to an incentive fee that is settled in newly issued units (i.e. a share based payment). As
such, the incentive fee expense is recognised in the share based payment reserve as the services are provided until such a time as it is settled
via the issuance of new units, at which point the amount is reclassified to units on issue.
On 21 August 2024, 3,645,936 units were issued against the 2024 Manager’s incentive fee of $6.6 million (2024: 6,417,684 units were
issued against the 2023 Manager’s incentive fee of $14.9 million).
Capital risk management
The Manager's objective when managing the capital of the Group is to ensure compliance with the capital requirements under the Trust
Deed (i.e. total borrowings do not exceed 50% of the gross value of the Trust Fund), borrowings arrangements (refer note
11.a)and that
the Group will be able to continue as a going concern while maximising the return to investors through the optimisation of the Group's
cost of capital. The Manager maintains or adjusts the capital of the Group through various methods including by adjusting the quantum of
distributions paid, raising or repaying debt, issuing or buying back units, or buying or selling assets.
As at reporting date, the Group's total borrowings to the Gross Value of the Group (as defined in the Trust Deed) was 42.1% (2024: 39.1%).
The Group’s policies in respect of capital management and allocation are reviewed regularly by the Board of the Manager. There have
been no material changes in the Group’s overall capital risk management strategy during the year.
9.
Earnings per Unit
20252024
Profit/(loss) attributable to Unit Holders of the Trust ($000s)(51,220)(107,611)
Weighted average number of units on issue (000's of units)675,899668,753
Basic and diluted earnings per unit (cents)(7.58)(16.09)
Recognition and measurement
Basic and diluted earnings per unit is calculated by dividing the profit attributable to Unit Holders of the Trust by the weighted average
number of ordinary units on issue during the year.
ANNUAL REPORT 2025|93
10. Distributable Income
Statutory profit attributable to Unit Holders is determined in accordance with NZ GAAP and includes a number of non-cash items including
fair value movements, straight line lease accounting adjustments and amortisation of borrowing and leasing costs and incentives.
The Manager uses Adjusted Funds from Operations ("AFFO") and AFFO per unit as the Group's key performance metric, representative of
the Group's underlying performance, and as a guide to informing the Group's distribution policy. AFFO adjusts statutory operating profit for
certain items that are non-cash, unrealised, capital in nature or are one-off or non-recurring (i.e. outside the Group's ordinary operations or
not reflective of its underlying performance). As AFFO is a non GAAP measure it may not be directly comparable with AFFO presented by
the Group's peers.
A reconciliation of statutory operating profit to AFFO and AFFO per unit is as follows:
2025
$000s
2024
$000s
Adjusted funds from operations
Operating profit before tax and other gains and losses77,43873,924
Add/(deduct):
Current tax expense(15,546)(19,046)
Incentive fee-6,600
Strategic transaction expenses2,848-
Current tax on translation of foreign currency funding transactions(59)(48)
Current tax on interest rate swap restructure and property disposals1,2146,536
Amortisation of borrowing costs2,0942,009
Amortisation of leasing costs & tenant inducements3,6043,423
IFRS 16 Operating lease accounting(117)(157)
Funds from operations ("FFO")71,47673,241
Add/(deduct):
Actual maintenance capex from continuing operations(1,108)(342)
Adjusted funds from operations (AFFO)70,36872,899
AFFO (cpu)10.4110.90
Distribution per unit (cpu)9.7509.750
AFFO payout ratio94%89%
Units on issue (weighted average, 000s)675,899668,753
94|VITAL HEALTHCARE PROPERTY TRUST
11. Borrowings
2025
$000s
2024
$000s
AUD denominated loans1,156,5321,145,753
NZD denominated loans211,917146,900
Borrowing costs(4,810)(5,176)
Total borrowings1,363,6391,287,477
Current liability--
Non current liability1,363,6391,287,477
Total borrowings1,363,6391,287,477
2025
$000s
2024
$000s
Total borrowings at the beginning of the year1,287,4771,239,156
Drawdowns during the year358,056316,327
Repayments during the year(264,022)(277,227)
Additional facility refinancing fee(1,640)(1,084)
Facility refinancing fee amortised during the year2,0942,009
Foreign exchange movement(18,326)8,296
Total borrowings at the end of the year1,363,6391,287,477
Recognition and measurement
Borrowings are initially measured at fair value, net of transaction costs. Subsequent to initial recognition, borrowings are measured at
amortised cost using the effective interest rate method. Gains and losses on derecognition are recognised in the consolidated statement of
comprehensive income in the period in which they arise. The carrying values of these balances are approximately equivalent to their fair
values because the loans have floating rates of interest that generally reset every 90 days.
Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the facility for at least 12
months as at year-end.
(11.a)
Summary of Borrowing Arrangements
The Group has a club financing arrangement governed by a common terms deed and bi-lateral facility agreements. Currently there are
eight financiers (2024: 8 financiers) that provide facilities to the Group. The facilities' expiry profile and undrawn limits are as follows:
ANNUAL REPORT 2025|95
Jun-25Jun-24
A$m LimitA$m UndrawnExpiryA$m LimitA$m UndrawnExpiry
Common Terms Deed - AUD
Facility A150.015.5May-30100.042.2Oct-28
Facility A225.0-May-2850.0-Mar-27
Facility A475.030.0May-3275.075.0Mar-29
Facility D275.0-Mar-2775.0-Mar-27
Facility D350.0-Apr-2825.0-Mar-26
Facility K170.1-Mar-2870.1-Mar-28
Facility K221.0-Mar-2921.0-Mar-29
Facility K313.0-Mar-2813.0-Mar-28
Facility L75.0-Sep-2875.0-Sep-28
Facility M119.0-Mar-2919.0-Mar-29
Facility M212.0-Mar-2812.0-Mar-28
Facility O50.0-May-3050.0-Mar-28
Total AUD Facility535.145.5960.1117.2
Common Terms Deed - NZD
NZ$m LimitNZ$m UndrawnExpiryNZ$m LimitNZ$m UndrawnExpiry
Facility A50.0-May-2850.0-Mar-27
Facility B75.05.0Mar-2875.019.6Mar-28
Total NZD Facility125.05.0125.019.6
Common Terms Deed -
Multicurrency (A$/NZ$)
A$m LimitA$m UndrawnExpiryA$m LimitA$m UndrawnExpiry
Facility A5150.00.2May-2975.05.0Mar-27
Facility B150.0-May-2850.02.1Mar-27
Facility C162.5-May-2862.5-Mar-27
Facility C262.5-May-2962.5-Mar-27
Facility C3125.0-May-30125.0-Mar-29
Facility D1100.0-Apr-29125.0-Mar-27
Facility N125.06.7Mar-28125.01.7Mar-28
Total Multicurrency Facility675.06.9250.08.8
In addition to the above, the Group has available a A$5.0m (2024: A$5.0m) bank guarantee facility of which A$0.4m (2024: A$0.7m)
has been utilised at the reporting date.
The facilities provided are secured and cross collateralised over the Group's mortgaged investment properties (by first ranking real property
mortgages) and other assets (via a first ranking general 'all assets' security agreement).
The common terms deed contains both financial and non-financial covenants and undertakings that are customary for secured facilities of
this nature. The key financial covenants (being defined terms in the common terms deed) are as follows:
Covenant
2025
Actual
2024
Actual
Banking Covenants
Loan to value ratio< 55%43.6%40.4%
Interest cover> 2.00x3.023.07
Total EBITDA of Obligors v total EBITDA of GroupNot < 95%100%100%
Total assets of Obligors v total assets of GroupNot < 95%100%100%
Total value of unmortgaged properties v total assets of GroupNot > 10%0.9%0.9%
96|VITAL HEALTHCARE PROPERTY TRUST
(11.b) Finance Expense
2025
$000s
2024
$000s
Expenses
Interest expense71,77769,731
Borrowing costs capitalised(24,870)(26,480)
Total finance expenses46,90743,251
The effective interest rate on borrowings, incorporating interest rate swaps, as at the reporting date was 4.90% per annum (2024: 5.06%).
Recognition and measurement
Interest expense is recognised in the consolidated statement of comprehensive income using the effective interest rate method except where
it is incurred in relation to a qualifying asset, where it is capitalised during the period of time that is required to hold, complete and/or
prepare the asset for its intended use.
The effective interest rate method calculates the amount to be recognised over the relevant period at the rate that exactly discounts estimated
future cash payments through the expected life of the financial instrument or a shorter period where appropriate, to the net carrying amount
on initial recognition.
12.
Lease Liabilities
The Group holds a ground lease over the car parks at the rear of Ascot Hospital and Ascot Central and the GenesisCare Integrated Cancer
Centre. The weighted average terms remaining are 13.8 and 53.7 years respectively (2024: 14.8 and 54.7 years) noting that Vital has
options to extend the ground leases (refer Note6.a).
13.
Derivative Financial Instruments
(13.a) Interest Rate Swaps
The Group has exposure to debt facilities that are subject to floating interest rates. The Group uses derivative financial instruments, on a
portfolio basis, to manage its exposure to interest rates such as interest rate swaps (to lock-in fixed interest rates), interest rate swaptions
(interest rate swaps for a fixed period of time, which are extendable at the counterparties election for a fixed period of time at the same
interest rate) and/or interest rate caps (to limit exposure to rising interest rates). At the reporting date, 82.3% of borrowings were fixed using
derivate financial instruments (2024: 77.0%). Refer Note14.c for further information on the Group's exposure to interest rate risk.
All interest rate derivative providers receive the benefit of pari-passu security and cross collateralisation rights over the Group’s
mortgaged investment properties (via first registered real property mortgages) and other assets (via a first ranking general 'all assets'
security agreement).
Generally, interest rate contracts settle on a quarterly basis coinciding with the dates on which the interest is payable on the underlying
debt. The floating rate incurred on the debt is based on New Zealand BKBM - Bid or Australian BBSY. The difference between the
fixed and floating interest rate is generally settled on a net basis by the relevant counterparty. The interest rate contracts have not been
identified as hedging instruments and any movements in their fair value are recognised immediately in the consolidated statement of
comprehensive income.
ANNUAL REPORT 2025|97
2025
$000s
2024
$000s
Current assets
Interest rate derivative assets1,085149
Non-current assets
Interest rate derivative assets23117,704
Current liabilities
Interest rate derivative liabilities(4,870)-
Non-current liabilities
Interest rate derivative liabilities(9,066)(1,850)
Total(12,620)16,003
During the period the Group recognised a fair value loss of $28.7m (2024: $10.5m loss) on interest rate contracts. The Group's interest rate
swaps outstanding and the corresponding floating interest rates at the reporting date are as follows:
2025
$000s
2024
$000s
Notional value of interest rate swaps - AUD905,630863,630
Notional value of interest rate swaps - NZD150,00045,655
Average fixed interest rate A$3.26%3.52%
Average fixed interest rate NZ$3.73%4.63%
Floating rates based on AUD BBSY3.75%4.39%
Floating rates based on NZD BKBM3.36%5.68%
Interest rate derivatives mature over the next four years and have fixed interest rates ranging from 2.50% to 4.37% (2024: from 2.50%
to 4.63%).
At balance date the Grouphad six A$ forward start swaps with a total notional value of A$300m with fixed rates ranging from 2.89% to
3.60% (2024: one swap, A$50m notional value at 3.54%), and one $50m forward start swap with a fixed rate of 3.15% (2024: one
swap, $50m notional value at 4.63%). The start dates for these swaps range from September 2025 to March 2026 with tenors ranging
between one and three and a half years (2024: December 2024 start date and a three year tenor).
The Group also had five A$ callable swaptions (at the counterparty's option) with a notional value of A$348.5m with fixed rates ranging
from 2.89% to 3.92% (2024: three swaptions, A$200m notional value, with rates ranging from 3.54% to 3.92%), and one $50m callable
swaption with a fixed rate of 2.99% (2024: nil). The exercise dates on the callable swaptions range from March 2026 to March 2028 with
tenors ranging between one and three years (2024: exercise dates ranging from March 2026 to June 2027 with tenors between two and
three years).
During the year, the Group entered into a NZ$50m cross-currency basis swap for a 1-year term, maturing in March 2026. This transaction
settles quarterly with VHP paying BKBM and receiving BBSY which in June 2025 were 3.36% and 3.76% respectively. At 30 June 2024,
the Group had no cross-currency basis swaps.
Recognition and measurement
Interest rate derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised and
subsequently measured at fair value derived from independent 3rd party valuations, discounting the estimated future cashflows and using
market interest rates for a substitute instrument at the measurement date. The resulting gain or loss is recognised immediately in profit or loss in
the consolidated statement of comprehensive income as hedge accounting has not been applied.
98|VITAL HEALTHCARE PROPERTY TRUST
(13.b) Forward Exchange Contracts
The Group has exposure to foreign currency risk arising from owning investment property in Australia. Derivative financial instruments, such
as forward exchange contracts, may be used to reduce the exposure to foreign exchange risk by locking in the conversion of Australian
dollar denominated income (transaction hedging) or net assets (translation hedging) to New Zealand dollars. Refer Note14.c for further
details on the Group's exposure to foreign exchange risk.
Transaction hedging arrangements generally settle on a quarterly basis while translation hedging arrangements settle on a periodic basis
depending on the term of the contract. At reporting date forward exchange contracts have not been designated as hedging instruments and
any movements in the fair value are recognised immediately in profit or loss in the consolidated statement of comprehensive income.
2025
$000s
2024
$000s
Current assets
Foreign exchange derivative assets37434
Non-current assets
Foreign exchange derivative assets6316
Current liabilities
Foreign exchange derivative liabilities-(94)
Non-current liabilities
Foreign exchange derivative liabilities-(6)
Total437(50)
During the period the Group recognised a fair value gain of $0.49m (2024: $0.28m loss) on forward exchange contracts. The Group's
forward exchange contracts outstanding at the reporting date are as follows:
2025
$000s
2024
$000s
Nominal value of foreign exchange contracts - AUD20,00122,750
Average foreign exchange rate0.91210.9110
Recognition and measurement
Foreign exchange derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised
and subsequently measured at fair value derived from counterparty bank valuations. Counterparty bank valuations are tested for
reasonableness by using a valuation model based on the applicable forward price curves derived from observable forward prices.
As hedge accounting has not been applied any resulting gain or loss is recognised immediately in profit or loss in the consolidated
statement of comprehensive income.
(13.c)
Fair value hierarchy
The Group has determined that interest rate swaps and foreign exchange contract derivatives are valued using Level 2 inputs (observable
prices of similar instruments). There have been no reclassifications between levels in the current year (2024: nil).
14.
Financial and Risk Management
The Group’s activities expose it primarily to credit risk, market risk (interest rate risk and foreign exchange risk) and liquidity risk. The Group’s
overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on
the Group’s financial performance. The Group uses financial derivatives to manage market risks. The use of financial derivatives is governed
ANNUAL REPORT 2025|99
by the Group’s policies approved by the Board of the Manager, which provide written principles that are consistent with the Group’s risk
management strategy and appetite. The Group does not use derivative financial instruments for speculative purposes.
(14.a) Financial Instruments
The Group has the following financial instruments:
•cash and cash equivalents;
•receivables (including loans);
•payables;
•borrowings; and
•derivative financial instruments.
Transactions in these instruments expose the Group to a variety of financial risks including market risk (which includes interest rate risk, foreign
exchange risk and other price risks), credit risk and liquidity risks.
Categories of
financial instruments
The Group’s financial instruments are classified as:
Financial assets
at amortised
cost
$000s
Financial
liabilities at
amortised cost
$000s
Financial
assets at fair
value through
profit or loss
$000s
Financial
liabilities at fair
value through
profit or loss
$000s
30 June 202533,198(1,403,080)1,753(13,936)
30 June 202442,995(1,329,752)17,903(1,950)
Cash, cash equivalents, trade and other receivables (including loans), trade and other payables and borrowings
The carrying values of these financial instruments approximate their fair values because of their short terms to maturity, frequency of interest
rate reset dates and/or pricing based on counterparty credit ratings.
(14.b)
Credit Risk
The Group is subject to credit risk (the risk that a counterparty will default on its contractual obligations resulting in financial loss to the
Group) predominately through its trade and other receivables (including loans), derivatives and cash exposures. The maximum exposure to
credit risk at a reporting date is the carrying value of each financial asset as disclosed in the applicable note to the financial statements.
Credit risk is managed by:
•ensuring that at the time of entering into a contractual arrangement or acquiring a property, counterparties or tenants are of appropriate
credit worthiness, provide appropriate security or other collateral and/or do not show a history of default;
•seeking to optimise tenant diversity by actively managing the property portfolio composition and leasing arrangements; and
•only entering into derivative financial instruments and placing cash and deposits with high credit quality financial institutions.
The Group applies an expected credit losses (ECL's) model (simplified approach) that uses historical experience, external indicators and
forward looking information to calculate the expected lifetime credit loss for financial assets carried at amortised cost.
The expected lifetime credit loss of trade receivables is assessed on a collective basis (grouped based on days past due), reflecting shared
credit characteristics, and is determined based on the forecast shortfalls in contractual cash flows considering the potential for default at any
point during the life of the financial instrument. Details of the expected credit loss recognised in relation to trade receivables is disclosed
in Note17.a.
100|VITAL HEALTHCARE PROPERTY TRUST
(14.c) Market Risk
The Group is subject to market risk (the risk that borrowings or derivatives are repriced to different interest rate margins on refinance or
renewal arising from changes in the debt markets), interest rate risk (the risk of a change in interest rates may impact the Group’s profitability,
cashflows and/or financial position) and foreign exchange risk (the risk of a change in foreign exchange rates on translation of foreign
currency denominated assets, liabilities, revenue and expenses) predominantly through its investment property, borrowings, derivatives and
cash exposures.
The interest rates applicable to each category of financial instrument are disclosed in the relevant note to the financial statements.
Interest rate risk
Loans have floating rates of interest that are generally reset every 90 days. The risk is managed by the Group by maintaining an appropriate
mix between fixed and floating rates by the use of interest rate swaps. The following table indicates the effective interest rates and the
earliest period in which financial instruments reprice.
Weighted
effective
interest rate
%
Less than
1 year
$000s
1-2 years
$000s
2-3 years
$000s
3+ years
$000s
Total
$000s
30 June 2025
Cash and cash equivalents
(floating rates)
3.70%15,642---15,642
Borrowings (floating rates)5.18%(242,029)---(242,029)
Borrowings (fixed rates)
1
4.80%(508,361)(357,951)(160,108)(100,000)(1,126,420)
(734,748)(357,951)(160,108)(100,000)(1,352,807)
30 June 2024
Cash and cash equivalents
(floating rates)
4.54%18,934---18,934
Borrowings (floating rates)5.47%(296,831)---(296,831)
Borrowings (fixed rates)
1
4.22%(10,952)(573,464)(306,648)(104,759)(995,823)
(288,849)(573,464)(306,648)(104,759)(1,273,720)
1Fixed rate balances are presented with the effect of hedging derivatives.
Interest rate sensitivity
The Group’s sensitivity to interest rate risk can be expressed in two ways:
Fair value sensitivity
A change in interest rates impacts the fair value of the Group’s fixed rate financial instruments. Fair value changes impact profit or loss or
equity only where the instruments are carried at fair value. Accordingly, the fair value sensitivity to a 100 bps movement in interest rates
(based on the financial instruments held at reporting date) is:
Impact on
profit/(loss)
2025
$000s
Impact on
Unit Holders'
funds
2025
$000s
Impact on
profit/(loss)
2024
$000s
Impact on
Unit Holders'
funds
2024
$000s
If interest rates had been 100 bps higher:23,50423,50418,01318,013
If interest rates had been 100 bps lower:(27,375)(27,375)(19,807)(19,807)
ANNUAL REPORT 2025|101
Instruments included in the fair value sensitivity are the Group's interest rate swaps.
Cash flow sensitivity analysis
A change in interest rates impacts interest income and expense on the Group’s interest bearing floating rate financial instruments.
Accordingly, the one-year cash flow sensitivity to a 100 bps movement in interest rates (based on the financial instruments held at reporting
date) is:
Impact on
profit/(loss)
2025
$000s
Impact on
unit holders'
funds
2025
$000s
Impact on
profit/(loss)
2024
$000s
Impact on
unit holders'
funds
2024
$000s
If interest rates had been 100 bps higher:(2,420)(2,420)(2,968)(2,968)
If interest rates had been 100 bps lower:2,4202,4202,9682,968
Instruments included in the cash flow sensitivity are the Group's interest rate swaps and its borrowings.
Foreign exchange risk
The following table presents the foreign currency risk that the Group is exposed to arising from Australian dollar (AUD) denominated assets
and liabilities:
2025
$000s
2024
$000s
Non-financial instrument assets and liabilities denominated in Australian dollars
Investment properties2,106,3592,213,762
Other assets50,40128,848
Deferred tax(139,858)(148,160)
Total non-financial instrument assets and liabilities2,016,9022,094,450
Non-derivative financial instruments
Cash and cash equivalents7,78012,764
Trade and other receivables2,97012,805
Trade and other payables(19,238)(22,430)
Borrowings(1,156,532)(1,107,630)
Lease liabilities(6,349)(6,381)
Total exposure from non-derivative financial instruments(1,171,369)(1,110,872)
Derivative financial instruments
Foreign exchange derivatives437(50)
Interest rate swaps(12,620)16,003
Total exposure from derivative instruments(12,183)15,953
Net exposure to currency risk833,350999,531
Foreign currency sensitivity
A change in the New Zealand dollar (NZD) / AUD exchange rate impacts profit after tax and equity on the conversion of AUD
denominated assets, liabilities, revenue and expenses. A 10% change in the exchange rate (2024:10%), based on year end exposures, has
the following effect:
102|VITAL HEALTHCARE PROPERTY TRUST
2025
$000s
2024
$000s
If the New Zealand Dollar versus the Australian Dollar was 10% higher for the year:
Profit and loss5,9572,742
Other comprehensive income(80,161)(91,783)
Unit Holders' funds(74,204)(89,041)
If the New Zealand Dollar versus the Australian Dollar was 10% lower for the year:
Profit and loss(7,280)(3,352)
Other comprehensive income97,974112,179
Unit Holders' funds90,694108,827
(14.d) Liquidity Risk
The Group is subject to liquidity risk (the risk that the Group will not be able to meet its contractual or other operating obligations).
Liquidity risk is managed by continuously monitoring forecast and actual cash flows, maintaining appropriate head room under debt
facilities and matching the maturity profiles of financial assets and liabilities. To help reduce liquidity risks the Group:
•has readily accessible unutilised credit facilities and other funding arrangements;
•seeks a debt maturity profile that limits the total debt maturing in any one 12-month period; and
•seeks to maintain sufficient loan covenant headroom to ensure that the Group can withstand downward movements in investment
property valuations, a reduction in revenue and/or an increase in interest rates without breaching loan facility covenants.
Liquidity risk exposure
The following table details the Group’s exposure to liquidity risk based on the contractual undiscounted cash flows relating to financial
liabilities, foreign exchange contracts and interest rate derivatives:
Carrying
value
$000s
Contractual
cash flows
$000s
Less than 1
year
$000s
1-2 years
$000s
2-3 years
$000s
3+ years
$000s
30 June 2025
Non-derivative financial instruments
Borrowings (excluding borrowing costs)(1,368,449)(1,624,773)(66,438)(142,592)(485,168)(930,575)
Trade and other payables(29,553)(29,553)(29,553)---
Lease liability - ground lease(9,888)(28,254)(620)(626)(631)(26,377)
(1,407,890)(1,682,580)(96,611)(143,218)(485,799)(956,952)
Derivative financial instruments
Interest rate swaps(12,620)(8,628)(3,598)(3,675)(1,058)(297)
Foreign exchange derivatives437437437---
(12,183)(8,191)(3,161)(3,675)(1,058)(297)
30 June 2024
Non-derivative financial instruments
Borrowings (excluding borrowing costs)(1,292,653)(1,295,831)(259,487)(226,706)(372,821)(436,817)
Trade and other payables(32,171)(32,171)(32,171)---
Lease liability - ground lease(10,105)(9,389)(123)29(143)(9,151)
(1,334,929)(1,337,390)(291,780)(226,677)(372,964)(445,969)
Derivative financial instruments
Interest rate swaps16,00319,15112,5205,0351,406190
Foreign exchange derivatives(50)(50)(50)---
15,95319,10112,4705,0351,406190
ANNUAL REPORT 2025|103
(14.e) Hedge Accounting
The Group is exposed to foreign exchange risk on its net investment in its AUD functional currency subsidiaries and seeks to hedge this risk
using AUD-denominated borrowings and foreign exchange derivatives (net investment hedges).
Recognition and measurement
For a financial instrument to be classified and accounted for as an effective hedge there must be:
•an economic relationship between the hedged item and the financial instrument;
•the effect of credit risk does not dominate the value changes that result from that economic relationship; and
•the hedge ratio of the hedging relationship is the same as that resulting from the quantity of the hedged item that the Group actually
hedges and the quantity of the
financial instrument that the Group actually uses to hedge that quantity of hedged item.
The Group documents its hedging relationships at their inception in accordance with the requirements of NZ IFRS 9 and the Board
approved risk management strategy.
Hedge effectiveness is determined by the Group at the inception of the hedge relationship, and through semi-annual prospective
effectiveness assessments, to ensure that an economic relationship exists between the hedged item and the financial instrument. That portion
of the foreign exchange differences arising on the financial instruments determined to be an effective hedge is recognised directly in other
comprehensive income. Any ineffective portion is recognised in profit or loss.
On disposal of the foreign operation, the cumulative value of such gains or losses recognised in other comprehensive income is reclassified
to the profit and loss in the statement of comprehensive income.
No foreign exchange derivatives currently held are designated as hedging instruments (2024: Nil).
15.
Commitments and Contingencies
Other than the contractual obligations disclosed in Note 6.e and Note15.a, there are no other commitments and contingencies in effect at
the reporting date (2024: nil).
(15.a)
NZX Bank Bond
As a condition of listing on the New Zealand Stock Exchange (NZX), NZX requires all issuers to provide a bank bond to NZX under
NZX/DX Listing Rule 1.23.2. The bank bond required by the Group for listing on the NZX is $75,000.
104|VITAL HEALTHCARE PROPERTY TRUST
Efficiency of Operations
This section presents the Group's working capital position and the efficiency in which it converts operating profits into cash available for Unit
Holders or reinvestment back into the operations of the Group.
16. Statement of Cash Flows Reconciliation from Operating Activities
2025
$000s
2024
$000s
Cash and cash equivalents
Australian financial institutions7,78012,764
New Zealand financial institutions7,8626,170
Cash at bank15,64218,934
Reconciliation of profit after income tax to net cash flows from operating activities
Profit after tax for the year(51,220)(107,611)
Adjustments for non-cash items
Change in fair value of investment properties96,722165,244
Fair value (gain)/loss on derivative financial instruments28,19410,824
Unrealised foreign exchange (gain)/loss(2,072)270
Deferred taxation(12,119)(19,638)
Income in advance135127
Strategic transaction costs2,872-
Manager's incentive fee-6,600
Other2,1792,224
Operating cash flow before changes in working capital64,69158,040
Change in trade and other payables3,557(1,136)
Change in taxation payable(2,333)(1,174)
Change in trade and other receivables11713
Items classified as investing activities2,3765,702
Net cash from operating activities68,40861,445
Excluded from investing and financing activities are distributions paid during the year of $6.2m (2024: $9.2m) that have been reinvested
under the Distribution Reinvestment Plan (DRP).
Recognition and measurement
Cash and cash equivalents comprise cash at bank and call deposits, net of outstanding bank overdrafts.
The statement of cash flows is prepared on a GST exclusive basis. The GST component of cash flows arising from investing and financing,
which is recoverable from/payable to, the taxation authority, is classified as part of operating cash flows.
ANNUAL REPORT 2025|105
17. Trade and Other Receivables
2025
$000s
2024
$000s
Trade receivables1,2325,615
Loss allowance(473)(552)
7595,063
Other receivables2,5594,075
Tenant fitout loans-943
Total trade and other receivables3,31810,081
(17.a) Ageing of receivables Past Due
2025
$000s
2024
$000s
0-30 days past due4654,735
31-60 days past due67307
61-90 days past due40177
beyond 90 days past due660396
1,2325,615
2025
$000s
2024
$000s
Movement in the loss allowance
Balance at the beginning of the year552388
(Decrease)/increase in allowance recognised in profit or loss(79)164
Balance at the end of the year473552
During the year the Group recognised bad debt write offs of $9,000 (2024: $18,000) in the statement of comprehensive income.
The Group holds $0.8m security or other collateral (2024: $0.2m) in respect of rent receivables past due. The Group does not have
significant credit risk exposure to any single counterparty or counterparties having similar characteristics in respect of rent receivables
past due (2024: nil). There are no significant financial assets that have had renegotiated terms that would otherwise have been past due
(2024: nil).
Recognition and measurement
Rent receivables
Rent receivables are recorded initially at fair value (including GST) and subsequently at amortised cost.
Loan receivables
Loan receivables are initially measured at fair value and subsequent at amortised cost using the effective interest rate method.
Impairment of financial assets
Loss allowances for financial assets (other than those measured at fair value through profit and loss) are measured using the simplified
approach based on a lifetime expected loss allowance. Refer Note14.b for further details.
106|VITAL HEALTHCARE PROPERTY TRUST
18. Other Assets
2025
$000s
2024
$000s
Current
GST refundable178197
Tenant fitout loans6,141-
Other1,1033,691
Total Current7,4223,888
Non-Current
Tenant fitout loans and other receivables8,09713,980
Total Non-current8,09713,980
The Group has provided unsecured amortising fitout loans to two tenants totaling $8.4m and $5.9m. These loans amortise over 10 and 15
years from inception and are currently subject to interest at 8.00% and 6.45% respectively.
Recognition and measurement
Rent receivables
Other assets are recorded initially at fair value (including GST) and subsequently at amortised cost.
Loan receivables
Loan receivables are initially measured at fair value and subsequent at amortised cost using the effective interest rate method.
Impairment of financial assets
Loss allowances for financial assets (other than those measured at fair value through profit and loss) are measured using the simplified
approach based on a lifetime expected loss allowance. Refer Note14.b for further details.
19.
Trade and Other Payables
2025
$000s
2024
$000s
Current liabilities
Interest accrued on borrowings5,0073,952
Other creditors and accruals24,54628,219
Total trade and other payables29,55332,171
Recognition and measurement
Trade and other payables are recognised initially at fair value (inclusive of GST) and subsequently measured at amortised cost using the
effective interest method. The average credit term on purchases is generally 30 days and they are non-interest bearing. The Group has
management policies in place to ensure that all amounts are paid within the applicable credit terms.
ANNUAL REPORT 2025|107
Other Notes
20. Investment in Subsidiaries
The Trust has control over the following subsidiaries.
Holding
Name of subsidiaryPrincipal activity
Place
of incorporation
and operation20252024
Vital Healthcare Australian Property TrustProperty investmentAustralia100%100%
Vital Healthcare Investment TrustProperty investmentAustralia100%100%
Vital Healthcare Property LimitedProperty investmentNew Zealand100%100%
Colma Services LimitedHolding companyNew Zealand100%100%
All subsidiaries have the same reporting date as the Trust.
21.
Subsequent Events
On 13 August 2025 a final cash distribution of 2.4375 cents per unit was announced. The Record Date for the final distribution is
4 September 2025 and is payable to Unit Holders on 18 September 2025. Imputation credits of 0.6327 cents per unit will be attached to
the distribution.
22.
Related Party Transactions
The Manager
Vital is managed by Northwest Healthcare Properties Management Limited (the "Manager"), a wholly owned subsidiary of NWI
Healthcare Properties LP (NWI LP).
The ultimate parent of NWI LP is Toronto listed Northwest Healthcare Properties Real Estate Investment Trust (NWH REIT) that, as at
reporting date, holds a 28.2% (2024: 28.4%) interest in Vital. NWH REIT and its controlled entities (including the Manager) are considered
related parties to Vital and its controlled entities by virtue of common ownership and/or directorships.
Other related parties by virtue of common ownership and/or directorship to the Manager of Vital include Australian Properties Limited and
Northwest Healthcare Australian Properties Limited.
Remuneration of the Manager
Vital pays fees to the Manager in accordance with the Trust Deed. The aggregate of Base Fees, Incentive Fees and Activity Fees is capped
at 1.75% per annum of Vital's Gross Asset Value (GAV) as at the end of a financial year.
Current fee arrangements
Base Fee
The Base Fee structure is as follows:
•65 bps per annum up to $1bn of GAV:
•55 bps per annum from $1bn to $2bn of GAV;
•45 bps per annum from $2bn to $3bn of GAV; and
•40 bps per annum over $3bn of GAV.
108|VITAL HEALTHCARE PROPERTY TRUST
Incentive Fee
The Incentive Fee is determined as 10% of the average annual increase in Vital’s Net Tangible Assets ("NTA") (being a defined term in the
Trust Deed) over the respective financial year and the two preceding financial years, with payment being made by way of subscribing
for new units. The incentive fee calculations are also subject to a "three year High Watermark Net Tangible Asset” requirement (being a
defined term in the Trust Deed), such that for the purpose of determining the increase in NTA for a Financial Year, the annual NTA increase
for that Financial Year will reduce to zero if the actual NTA does not exceed the High Watermark Net Tangible Asset requirement.
Activity Fees
a. Leases or licences
Vital pays the Manager leasing or licence fees where the Manager has negotiated leases or licences. The fees are charged at 11% of the
aggregate annual rental for terms less than 3 years, 12% of the aggregate annual rental for terms of 3 years, and 12% plus an additional 1%
for each full year (pro rata for part years) for terms greater than three years (to a maximum of 20%), subject to a minimum fee of $2,500.
Lease or licence renewals are charged at 50% of a new lease or licence fee.
Leasing or licence fees are capitalised to the respective investment or property in the consolidated statement of financial position and
amortised over the term of the lease.
b. Property management
Vital pays the Manager property management fees where the Manager acts as the property manager. These fees are charged at 1%
- 2% of gross income depending on the number of tenants at the property and may be recovered from tenants if permitted under
lease agreements.
Property management fees, net of recoveries from tenants, are expensed through the consolidated statement of comprehensive income in the
year in which they arise.
c. Facilities management
Vital pays the Manager a facilities management fee where the Manager acts as a property facilities manager based on the market rate
(referenced to a reputable and high-quality third party service provider) for similar services at similar properties. This fee may be recovered
from tenants if permitted under lease agreements.
Facilities management fees are expensed, net of recoveries from tenants, through the consolidated statement of comprehensive income in the
year in which they arise.
d. Project management
Vital pays project management fees to the Manager for managing capital expenditure projects where the purpose of the project is to
upgrade, repair or otherwise extend the life of the property, including via the replacement or repair of major plant and equipment, structural
items and building envelope.
Project management fees for projects with a budget of between $0.2m and $2.5m are 2% of the committed spend where the Manager is
the project lead and 1% of committed spend where the Manager has an oversight role, increasing to 4% and 2% respectively for projects
with a budget greater than $2.5m.
Project management fees are capitalised to the respective property in the consolidated statement of financial position.
Additional Costs
a. Acquisitions
Vital pays fees to the Manager for managing the due diligence, financing, legal aspects and settlement of the purchase of an investment or
property instead of, or alongside, a third party agent. These fees are charged at 1.5% of the capitalised cost of the relevant investment or
property, being the contracted price payable, excluding any deductions netted off the settlement price (such as rates), together with other
related capitalised acquisition costs.
ANNUAL REPORT 2025|109
Acquisition fees are capitalised to the respective investment or property in the consolidated statement of financial position.
b. Disposals
Vital pays fees to the Manager for managing the due diligence, legal aspects and settlement of the sale of an investment or property
instead of, or alongside, a third party agent. These fees are charged at 1% of the contracted sale price of the relevant investment or property
actually received, provided that, if a third party agent has been engaged to provide services for the disposal, then the fee payable to the
Manager will be net of the third party agent’s costs and commissions.
Disposal fees are expensed through the consolidated statement of comprehensive income in the year in which they arise.
c. Development Management
Vital pays fees where the Manager acts as a development manager on Vital developments. These fees are charged at 4% of the committed
spend (excluding land) approved by the Board of the Manager provided that, if a third party agent has been engaged to provide
development management services, then the fee payable to the Manager will be reduced by the non-rentalisable third party costs paid.
Development management fees are capitalised to the respective property in the consolidated statement of financial position.
Other Services
Vital has entered into an agreement with Northwest Healthcare Australian Properties Limited to receive Level 2 energy audit and climate risk
assessment services for its Australian and New Zealand properties under clause 24.4 of the Trust Deed. The fees for these services do not
exceed prevailing market rates.
Other Related Parties
On 30 December 2022 the Group entered into an agreement with Northwest Healthcare Australia RE Limited as trustee for Northwest
Healthcare Australia Lumina Trust ("Lumina") under which Vital purchased the land at 15 Nexus Way, Southport, Queensland Australia
(Land) to facilitate the development of a new state of the art, 6-Star Green Star health, research and innovation building to be known as
“RDX”. Consideration paid, based on an independent valuation by Jones Lang LaSalle of the Land, totalled A$6.9m, including A$4.3m
payable to Lumina.
In conjunction with the purchase of the Land:
•Lumina has agreed to guarantee the net operating income of RDX will not be less than A$3.712m for the 12 months from practical
completion of RDX; and
•the Group has agreed to pay Lumina 50% of the actual net operating income in excess of A$3.712m plus 50% of any outperformance
against the leasing assumptions, capped at A$2.0m.
Other than the above there have been no transactions that occurred during the reporting period or remain outstanding at the reporting date
with other related parties.
110|VITAL HEALTHCARE PROPERTY TRUST
Transactions with related parties
Amounts charged by the Manager and related parties and owing are as follows:
30 June 2025
$000s
30 June 2024
$000s
Statement of
Comprehensive
Income
Statement of
Financial
PositionTotal
Amounts
Owing/
(Receivable)
Statement of
Comprehensive
Income
Statement of
Financial
PositionTotal
Amounts
Owing/
(Receivable)
Base fee17,652-17,652-18,084-18,084-
Incentive Fee
1
----6,600-6,6006,600
Activity Fees:----
Leasing/licensing
2
1462,6052,7512462472,5442,791238
Property management
3
2,444-2,4443492,299-2,299320
Facilities management
3
--------
Project management
4
-----5555-
Other services
5
-126126125----
AFSL fee1,284-1,284-1,341-1,341-
21,5262,73124,25772028,5712,59931,1707,158
Additional Costs:
Acquisitions
6
-1515--(180)(180)274
Disposals
7
86-86-789-789485
Development management
8
-1,4001,4001,213-3,7453,7451,543
861,4151,5011,2137893,5654,3542,302
Other Amounts:
Reimbursement of third
party expenses:
Other expenses104-104-120-120-
Amounts paid to directors:
9
Graham Stuart117-117-65-65-
Angela Bull44-44-100-100-
Michael Stanford121-121-76-76-
386-386-361-361-
21,9984,14626,1441,93329,7216,16435,8859,460
1Manager's incentive fee outstanding at 30 June 2025 of nil (Jun 24: $6.6m) is payable to Northwest Healthcare Properties Management Limited
2Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24:$0.2m); Northwest Healthcare Australian Property Limited $0.2m (Jun
24: $0.1m)
3Property Management and Facilities Management fees, exclusive of recoveries from tenants, incurred by the Trust totalled $2.4m and nil respectively for the 30 June 2025 year (Jun 24:
$2.3m and nil respectively).
Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited $0.1m (Jun 24: $0.1m); Northwest Healthcare Australian Property Limited $0.2m
(Jun 24:$0.2m)
4Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24: $0.1m) Northwest Healthcare Australian Property Limited Nil (Jun 24: Nil)
5Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Pty Ltd $0.1m (2024: Nil)
6Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24: Nil); Northwest Healthcare Australian Property Limited Nil (Jun 24: $0.3m)
7Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24: $0.2m); Northwest Healthcare Australian Property Limited Nil (Jun
24: $0.3m)
8Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited $0.5m (Jun 24: $0.9m); Northwest Healthcare Australian Property Limited $0.7m (Jun
24: $0.7m)
9Directors' fees for Graham Stuart are currently paid by the Manager
Independent Auditor’s Report
To the Unitholders of Vital Healthcare Property Trust
Opinion
We have audited the consolidated financial statements of Vital Healthcare Property Trust and its
subsidiaries (the ‘Group’), which comprise the consolidated statement of financial position as at 30
June 2025, and the consolidated statement of comprehensive income, statement of changes in
equity and statement of cash flows for the year then ended, and notes to the consolidated financial
statements, including material accounting policy information.
In our opinion, the accompanying consolidated financial statements, on pages 70 to 110, present
fairly, in all material respects, the consolidated financial position of the Group as at 30 June 2025,
and its consolidated financial performance and cash flows for the year then ended in accordance
with New Zealand Equivalents to IFRS Accounting Standards (‘NZ IFRS’) as issued by the External
Reporting Board and IFRS Accounting Standards (‘IFRS’) as issued by the International Accounting
Standards Board.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (‘ISAs’) and
International Standards on Auditing (New Zealand) (‘ISAs (NZ)’). Our responsibilities under those
standards are further described in the Auditor’s Responsibilities for the Audit of the Consolidated
Financial Statements section of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis
for our opinion.
We are independent of the Group in accordance with Professional and Ethical Standard 1
International Code of Ethics for Assurance Practitioners (including International Independence
Standards) (New Zealand) issued by the New Zealand Auditing and Assurance Standards Board and
the International Ethics Standards Board for Accountants’ International Code of Ethics for
Professional Accountants (including International Independence Standards), and we have fulfilled
our other ethical responsibilities in accordance with these requirements.
Other than our capacity as auditor, we perform other assurance services in relation to the Group’s
quarterly reporting pack to the Group’s Parent. We also carry out other assignments for the Group
as independent AGM vote scutineer. These services have not impaired our independence as auditor
of the Group. The firm has no other relationships with, or interests in, the Group.
Audit materiality
We consider materiality primarily in terms of the magnitude of misstatement in the financial
statements of the Group that in our judgement would make it probable that the economic decisions
of a reasonably knowledgeable person would be changed or influenced (the ‘quantitative’
materiality). In addition, we also assess whether other matters that come to our attention during
the audit would in our judgement change or influence the decisions of such a person (the
‘qualitative’ materiality). We use materiality both in planning the scope of our audit work and in
evaluating the results of our work.
We determined materiality for the Group financial statements as a whole to be $3.87 million.
Key audit matters Key audit matters are those matters that, in our professional judgement, were of most significance
in our audit of the consolidated financial statements of the current period. These matters were
addressed in the context of our audit of the consolidated financial statements as a whole, and in
forming our opinion thereon, and we do not provide a separate opinion on these matters.
Key audit matter How our audit addressed the key audit matter
Valuation of Investment Properties
The Group’s investment properties (including those held for sale)
consist of health sector properties totalling $3,212 million as at 30
June 2025. Valuation losses on the Group’s investment properties
for the year ended 30 June 2025 totalled $97 million, which
includes a $20 million carrying value adjustment relating to
investment property under development. Further details on the
Group’s property portfolio and valuation are provided in Note 6.
Investment properties are carried at fair value. Where
development is in progress at a property, this is carried at cost,
until either its fair value becomes reliably measurable or the
development reaches practical completion.
The valuation of investment property is highly dependent on
forecasts and estimates including a number of unobservable inputs
to take into account property-specific attributes.
Independent registered valuers determined the fair value of
approximately 64 percent of the investment properties at 30 June
2025, and the Manager determined the fair value of the remaining
properties.
The valuation methods used for assessing the fair value include a
combination of direct comparison, discounted cash flow,
capitalisation of contract and market income approaches.
The external valuers and the Manager, amongst other matters,
take into consideration occupancy rates, weighted average lease
term to expiry (‘WALE’) and capitalisation rates.
The valuation of investment properties is a key audit matter due to
the subjective judgements and assumptions in the valuation
models.
We have evaluated the appropriateness of the valuation of
investment property by performing the following:
• Reviewing the external valuers’ valuation reports and the
valuation reports prepared by the Manager.
• We evaluated the key metrics, including
capitalisation rate, market rent and contract rent on
a property and portfolio basis for year on year
movements and assessed whether, in our
judgement, the movements represented outliers to
investigate.
• We held discussions, on a sample basis, with the
valuers and separately, with representatives of the
Manager and challenged assumptions, including the
possible outliers identified.
• We agreed property specific information supplied
to the external valuer and used in the Manager’s
valuations, including occupancy data, current
rentals, and lease terms, to the underlying records
held by the Group, on a sample basis.
• We involved our valuation specialists to consider
and challenge, on a sample basis, the
reasonableness of the assumptions and valuation
methodology applied, including comparing
assumptions to market data where available.
• Evaluating the objectivity, independence and expertise of
the external valuers.
• Evaluating the expertise of the Manager.
• With respect to significant property developments:
• Where the Group has determined the development
has reached practical completion, obtaining
evidence supporting the Group’s estimates of the
expected future rental cash flows that will apply
upon completion and the costs to complete the
development.
• Where property developments are carried at cost,
testing the cost incurred to date on a sample basis.
• Where the Group has recorded a carrying value
adjustment to property under development, we
reviewed management’s assessment of the carrying
value of the property by evaluating the assumptions
and estimates made as at 30 June 2025 (including
forecast costs to complete estimates, and leasing
considerations), as well as the independent advice
received by management.
Other information
The Board of Directors of the Manager is responsible on behalf of the Group for the other
information. The other information comprises the information in the Annual Report that
accompanies the consolidated financial statements and the audit report, and the Climate Statement.
The Climate Statement is expected to be made available to us after the date of the audit report.
Our opinion on the consolidated financial statements does not cover the other information and we
do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and consider whether it is materially inconsistent
with the consolidated financial statements or our knowledge obtained in the audit or otherwise
appears to be materially misstated. If so, we are required to report that fact. We have nothing to
report in this regard.
When we read the Climate Statement, if we conclude that there is a material misstatement therein,
we are required to communicate the matter to the Board of Directors of the Manager and consider
further appropriate actions.
Board of Directors’ responsibilities
for the consolidated financial
statements
The Board of Directors of the Manager is responsible on behalf of the Group for the preparation and
fair presentation of the consolidated financial statements in accordance with NZ IFRS and IFRS, and
for such internal control as the directors determine is necessary to enable the preparation of
consolidated financial statements that are free from material misstatement, whether due to fraud
or error.
In preparing the consolidated financial statements, the Board of Directors of the Manager is
responsible on behalf of the Group for assessing the Group’s ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the Group or to cease operations, or have
no realistic alternative but to do so.
Auditor’s responsibilities for the
audit of the consolidated financial
statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial
statements as a whole are free from material misstatement, whether due to fraud or error, and to
issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of
assurance, but is not a guarantee that an audit conducted in accordance with ISAs and ISAs (NZ) will
always detect a material misstatement when it exists. Misstatements can arise from fraud or error
and are considered material if, individually or in the aggregate, they could reasonably be expected
to influence the economic decisions of users taken on the basis of these consolidated financial
statements.
A further description of our responsibilities for the audit of the consolidated financial statements is
located on the External Reporting Board’s website at:
https://www.xrb.govt.nz/standards/assurance-standards/auditors-responsibilities/audit-report-1-1/
This description forms part of our auditor’s report.
Restriction on use
This report is made solely to the Group’s unitholders, as a body. Our audit has been undertaken so
that we might state to the Group’s unitholders those matters we are required to state to them in an
auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept
or assume responsibility to anyone other than the Group’s unitholders as a body, for our audit work,
for this report, or for the opinions we have formed.
Andrew Boivin, Partner
for Deloitte Limited
Auckland, New Zealand
13 August 2025
114|VITAL HEALTHCARE PROPERTY TRUST
Unit Holder statistics
Analysis of unit holders as at 30 June 2025
Holding Range
Number of
Unit HoldersTotal units% of total units issued
1 - 49923943,5460.01
500 - 9999062,6340.01
1,000 - 1,999202284,9420.04
2,000 - 4,9997402,535,4070.37
5,000 - 9,9999156,469,0510.95
10,000 - 49,9991,82640,361,2595.95
50,000 - 99,99927218,200,5772.68
100,000 - 499,99914325,712,7173.79
500,000 - 999,999118,202,8711.21
1,000,000 Over28577,023,03984.99
Total4,466678,896,043100
Substantial unit holders as at 30 June 2025
Unit HoldersDate of noticeNumber of units
% of total units
issued
1
FORSYTH BARR INVESTMENT MANAGEMENT LIMITED13-May-2579,641,34711.76
ACCIDENT COMPENSATION CORPORATION30-Apr-2546,778,3096.91
NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST6-Sep-24191,708,03628.38
ANZ NEW ZEALAND INVESTMENTS LTD21-Mar-2226,304,8415.06
1On date notice filed
ANNUAL REPORT 2025|115
Twenty largest unit holders as at 30 June 2025
Unit holdersTotal% of units
NZGT SECURITY TRUSTEE LIMITED191,481,80428.20
FORSYTH BARR CUSTODIANS LIMITED <1-CUSTODY>94,542,01013.93
CUSTODIAL SERVICES LIMITED <A/C 4>50,930,7917.50
ACCIDENT COMPENSATION CORPORATION - NZCSD <ACCI40>44,127,4106.50
BNP PARIBAS NOMINEES (NZ) LIMITED - NZCSD <BPSS40>30,194,9744.45
HSBC NOMINEES (NEW ZEALAND) LIMITED - NZCSD <HKBN90>25,436,6093.75
TEA CUSTODIANS LIMITED CLIENT PROPERTY TRUST ACCOUNT - NZCSD <TEAC40>19,680,0622.90
NEW ZEALAND DEPOSITORY NOMINEE LIMITED <A/C 1 CASH ACCOUNT>16,473,0352.43
ANZ WHOLESALE TRANS-TASMAN PROPERTY SECURITIES FUND - NZCSD <PNTT90>15,807,1712.33
FNZ CUSTODIANS LIMITED11,050,8811.63
JBWERE (NZ) NOMINEES LIMITED <NZ RESIDENT A/C>9,872,0661.45
ADMINIS CUSTODIAL NOMINEES LIMITED9,626,5841.42
FORSYTH BARR CUSTODIANS LIMITED <ACCOUNT 1 E>8,060,1231.19
INVESTMENT CUSTODIAL SERVICES LIMITED <A/C C>7,502,2391.11
CITIBANK NOMINEES (NEW ZEALAND) LIMITED - NZCSD <CNOM90>7,302,7531.08
SIMPLICITY NOMINEES LIMITED - NZCSD6,045,4370.89
MFL MUTUAL FUND LIMITED - NZCSD <MFLA90>4,519,0010.67
HSBC NOMINEES (NEW ZEALAND) LIMITED A/C STATE STREET -NZCSD <HKBN45>4,073,3000.60
NZX WT NOMINEES LIMITED <CASH ACCOUNT>3,263,2450.48
PT (BOOSTER INVESTMENTS) NOMINEES LIMITED3,250,0000.48
Top 20 holders of Units563,239,49582.96
Total Remaining Holders Balance115,656,54817.04
Vital’s structure
About Vital
Vital Healthcare Property Trust (Vital, the Trust) is an NZX-
listed investment fund (NZX:VHP) that invests in high-
quality healthcare properties in New Zealand and
Australia. The Trust is externally managed by Northwest
Healthcare Properties Management Limited.
Vital's portfolio of 34 properties is valued at
~$3.2b with 67.0% (by value) located in Australia
and the balance in New Zealand. The portfolio
has over 143 tenants and over 2,100 beds.
Vital’s tenants include hospital operators and healthcare
providers who deliver a wide range of services
across the full spectrum of health services.
Further information is available at vhpt.co.nz
About the Manager
Northwest Healthcare Properties Management Limited
(NWHPM, the Manager) is an external manager that
provides management services to Vital and its Unit Holders.
The Manager’s primary responsibilities include the day-to-
day administration of Vital, portfolio management, sourcing
new opportunities and conducting due diligence on potential
acquisitions. The Manager is also responsible for providing
specialist property management, project management,
development management and leasing services to the Trust.
The Manager’s Board of five comprises three independent
directors and two Northwest appointees. Refer to page 54
for more details.
Vital’s leadership team is led by Chris Adams (Co-Head,
A/NZ Region), and draws on the skills and experience
of over 50 real estate professionals across New Zealand
and Australia with offices in Auckland, Melbourne
and Sydney. Refer to page 56 for more details.
OUR STRUCTURE – A UNIT TRUST
Vital Unit Holders
New Zealand’s largest specialist and
only listed owner of healthcare real estate
~$10.3b7
assets under
management
number of countries
Northwest
operates in
Vital’s Manager and largest Unit Holder
Management of Vital in accordance with the Trust Deed
Majority NZ based institutions and retail investors
~$3.2b portfolio healthcare
real estate in Australia and New Zealand
~28.0%
~72.0%
>240
healthcare
real estate
professionals
Vital benefits from being managed by a global
healthcare property owner and manger.
11 6
|
VITAL HEALTHCARE PROPERTY TRUST
Vital is the only
NZX listed specialist
landlord of healthcare
property and the fourth
largest NZX listed
property vehicle.
Ormiston Hospital Stage 1 Expansion, Auckland
In Australia and New
Zealand, Northwest has
a 50+ team of healthcare
property professionals.
Northwest
The Manager is a subsidiary of Toronto Stock
Exchange-listed Northwest Healthcare Properties
REIT (Northwest REIT). Northwest REIT operates
across seven countries in four continents.
Northwest REIT has ~$10.3b of assets
under management globally and over
240 real estate professionals.
ANNUAL REPORT 2025
|
11 7
GenesisCare Integrated Cancer and Health Centre, Sydney
Driving operational
performance
MANAGER
Northwest Healthcare Properties Management Limited
Level 17, HSBC Tower
188 Quay Street
Auckland 1010
Telephone: 0800 225 264 (NZ freephone);
+64 9 973 7300
Email: enquiry@vhpt.co.nz
Northwest Healthcare Properties Management – Australia
Level 45, Rialto South Tower
525 Collins Street
Melbourne 3000
Sydney Office
Northwest Healthcare Properties REIT
Level 2, 285 George Street
Sydney, NSW 2000, Australia
BOARD AND OFFICERS OF THE MANAGER
Graham Stuart – Independent Chair
Mike Brady - Non-Independent Director
Angela Bull – Independent Director
Craig Mitchell – Non-Executive Director (resigned 12 August 2025)
Dr Michael Stanford – Independent Director
Zachary Vaughan - Non-Independent Director (appointed 12 August 2025)
Chris Adams - Co-Head, A/NZ Region
Michael Groth – Chief Financial Officer
Vanessa Flax – Regional General Counsel and Company Secretary
Directory
11 8
|
VITAL HEALTHCARE PROPERTY TRUST
AUDITOR
Deloitte Limited
Deloitte Centre
1 Queen Street
Auckland 1010
Private Bag 115-033
Auckland 1140
Telephone: +64 9 303 0700
Facsimile: +64 9 303 0701
LEGAL ADVISERS TO THE
TRUST AND THE MANAGER
Bell Gully
Deloitte Centre
Level 14, 1 Queen Street
PO Box 4199
Auckland 1140
Telephone: +64 9 916 8800
Facsimile: +64 9 916 8801
Ashurst Australia
Level 16, 80 Collins Street
South Tower,
GPO Box 4958
Melbourne, Victoria 3001
Telephone: +61 3 9679 3000
SUPERVISOR
Trustees Executors Limited
Level 9, Spark Central
42-52 Willis Street
Wellington 6011
PO Box 4197
Auckland 1140
Telephone: +64 9 308 7100
BANKERS TO THE TRUST
ANZ Bank New Zealand Limited
ANZ Centre
23–29 Albert Street
Auckland 1010
Australia and New Zealand
Banking Group Limited
ANZ Centre Melbourne, Level 9
833 Collins Street, Docklands
Victoria 3008, Australia
Bank of New Zealand
80 Queen Street
Auckland 1010
Westpac Banking Corporation
Westpac Place
275 Kent St
Sydney NSW 2000
Australia
The Hongkong and Shanghai
Banking Corporation Limited
International Towers
100 Barangaroo Avenue
Sydney NSW 2000
Australia
The Hongkong and Shanghai
Banking Corporation, incorporated
in the Hong Kong SAR, acting
through its New Zealand Branch
HSBC Tower
188 Quay Street
Auckland 1010
New Zealand
Industrial and Commercial Bank
of China Limited – Australia
International Towers
100 Barangaroo Avenue
Sydney NSW 2000
Australia
Industrial and Commercial Bank of
China Limited – New Zealand
2 Queen Street
Auckland CBD
Auckland 1010
New Zealand
Credit Agricole CIB Australia Limited
Aurora Place
88 Phillip Street
Sydney NSW 2000
Australia
Bank of China Limited
140 Sussex Street
Sydney NSW 2000
Australia
Commonwealth Bank of Australia Limited
Tower One, Collins Square
727 Collins Street
Docklands VIC 3008
Australia
UNIT REGISTRAR
Computershare Investor Services Limited
159 Hustmere Road
Takapuna, Auckland 0622
Private Bag 92119
Auckland 1142
New Zealand
vital@computershare.co.nz
Telephone: +64 9 488 8777
Facsimile: +64 9 488 8787
This document is printed on an environmentally responsible
paper, produced using Elemental Chlorine Free (ECF),
FSC(R) certified, Mixed Source pulp from Responsible
Sources, and manufactured under the strict ISO14001
Environmental Management System.
ANNUAL REPORT 2025
|
11 9
DISCLAIMER:
This document has been prepared by Northwest Healthcare Properties Management
Limited (the Manager) as manager of the Vital Healthcare Property Trust (the Trust).
This document provides general information only and is not intended as investment,
legal, tax, financial product or financial advice or recommendation to any per-
son and must not be relied on as such. You should obtain independent professional
advice prior to making any decision relating to your investment or financial needs.
All references to $ are to New Zealand dollars unless otherwise indicated.
This document may contain forward-looking statements. Forward-looking statements
can include words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar
words in connection with discussions of future operating or financial performance or
conditions. Any indications of, or guidance or outlook on, future earnings or financial
position or performance and future distributions are also forward-looking statements. The
forward-looking statements are based on management’s and directors’ current expectations
and assumptions regarding the Trust’s business, assets and performance and other future
conditions, circumstances and results. As with any projection or forecast, forward-looking
statements are inherently susceptible to uncertainty and to any changes in circumstanc-
es. The Trust’s actual results may vary materially from those expressed or implied in the
forward-looking statements. The Manager, the Trust, and its or their directors, employees
and/or shareholders have no liability whatsoever to any person for any loss arising from
this document or any information supplied in connection with it. The Manager and the
Trust are under no obligation to update this document or the information contained in it
after it has been released. Past performance is no indication of future performance.
The information in this document is of general background and does not purport to
be complete. It should be read in conjunction with Vital’s market announcements
lodged with NZX, which are available at www.nzx.com/companies/VHP.
---
FY25 Annual
Results
Presentation
Driving operational performance
13 AUGUST 2025
Contents
Presenters
Richard Roos
CO-HEAD,
ANZ REGION
Michael Groth
CHIEF FINANCIAL
OFFICER
Chris Adams
CO-HEAD,
ANZ REGION
Investing in Healthcare Property
across Australia and New Zealand 3
FY25 Highlights 6
Financial Results and Capital Management 11
Property and Sector Update 17
Development Activity 21
Outlook 26
Appendices 28
All amounts are in NZD unless otherwise shown
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
2
Investing in Healthcare Property across Australia and New Zealand
*Excludes strategic land held for development
1
Inclusive of landlord options
2
On a constant currency basis
VITAL IS THE ONLY SPECIALIST HEALTHCARE LANDLORD LISTED ON THE NZX
Active property management with both occupancy and
WALE enhanced
Two value enhancing developments delivered
$11.5m accretive capacity expansion at Wakefield initiated
$1.1b debt refinance secured on improved terms and flexibility
DELIVERING ON STRATEGY
~$2 .1b
20* PROPERTIES;
5.5% WACR
~$1.1b
14* PROPERTIES;
5.6% WACR
Further enhanced over the past two years through
non-core asset sales
Predominantly located in health precincts
Diversified by geography and tenants
HIGH-QUALITY PORTFOLIO
Strategic land holdings and brownfield expansions potential
over time
Unmatched healthcare property development team
EMBEDDED VALUE
Hospital operator profitability improvements emerging
Attractive tenant demand dynamic and sector fundamentals
MEDIUM-TERM OUTLOOK
~$3.2b
34* PROPERTIES;
5.5% WACR
3.7%
LIKE-FOR-LIKE, NET
PROPERTY INCOME
GROWTH
2
18. 5 years
WALE
1
AustraliaNew Zealand
NZ 9.75cpu
DISTRIBUTION PAID IN FY25 AND
GUIDANCE MAINTAINED FOR FY26
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
3
Why healthcare real estate?
Vital focuses on the cure parts of the healthcare
real estate spectrum; a defensive asset class that
provides attractive risk-adjusted returns, driven
by an ageing and growing population
Shift to
ambulatory care
Increasing number
of procedures being
performed outside
of hospitals
Sustained
population
migration
Shift of population creating
outsized need for medical
facilities in local markets
Growing need
for health and life
sciences space
Health and life science
growing rapidly, driven
by increased funding and
emerging technologies
Growing demand
for healthcare
Ageing population and
growth (including chronic
disease) supported by
recent and proposed
government policy /
funding
Transition towards
healthcare
precincts
Demand for precincts
that combine educational
and clinical facilities with
other amenities
Increased
M&A activity
Consolidation and
transaction activity
increasing number of
sophisticated players
at scale
Ormiston Hospital Stage 1 Expansion, Auckland
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
4
Sector tailwinds
underpinned by robust
consumer demand
Embedded value in
strategic land for shovel
ready developments
Defensive, diversified
and long duration
cash flows
7.3% gross yield
1
High-quality portfolio
Majority independent
board and experienced
management team
Unit Price trading at
a 19.8% discount to
NTA of $2.47 per unit
Why invest in Vital?
1
3
5
7
2
4
6
RDX, Gold Coast (Artist's Impression)
1
Based on 12 August closing price of $1.98 per unit assuming NZ domiciled investor with a 33% tax rate.
Cash yield before tax benefit is ~4.9%.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
5
FY25
Highlights
Wakefield Hospital Stage 2, Wellington (Development now completed)
Ormiston Hospital Stage 1 Expansion, Auckland
FY25 Highlights
1
On a constant currency basis
$49. 7m
realised from FY25 asset
sales at a 7.0% discount
to book value
18 . 5 years
WALE versus 18.1 years in
FY20 despite passage of time
3.7%
increase in like-for-like
net property income
1
1s t
place globally in GRESB
for listed healthcare in
developments
completed developments
for total cost of $108.8m
2
DPU maintained, 93.6%
AFFO payout ratio
9. 75c pu
3.8
years
weighted average debt
duration – no maturity
before March 2027
98.6%
Occupancy,
up 0.6% versus FY24
OPERATIONAL PERFORMANCE FOCUS DELIVERED STRONG LEASING OUTCOMES,
COMPLETION OF HIGH-QUALITY DEVELOPMENTS AND AN ENHANCED BALANCE SHEET
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
7
98.6%
OCCUPANCY
Portfolio further strengthened
Over 51,000sqm of space were leased, extended or renewed during FY25, including over 9,400sqm of
new leasing. Represents 22% of Vital’s total income and 20% of the portfolio's lettable area.
The strong leasing success and early extensions increased Vital's WALE to 18.5 years, up from 18.3 years
at 30 June 2024.
Leasing momentum continuing in FY26 across vacancies at 68 Saint Asaph Street, Ascot and Ascot Central,
Playford Health Hub and 120 Thames Street to further increase Vital's occupancy post balance date.
Vital's income security continues to be enhanced by early lease renewals with no material lease expiries
scheduled for the next 18 months.
BUILDING A RESILIENT PORTFOLIO
Leasing highlights
18.5 years
WALE
51,000 sqm
NEW LEASING & EXTENSIONS
Playford Health Hub, Adelaide
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
8
2025
Sustainability achievements
MBA NSW 2024 AWARDS - EXCELLENCE IN SUSTAINABILITY
– COMMERCIAL CATEGORY | MACARTHUR HEALTH PRECINCT
STAGE 1 (GENESISCARE, CAMPBELLTOWN)
DEVELOPMENT EXCELLENCE AWARDS 2025 – WINNER – HIGHLY
COMMENDED HEALTH SOCIAL INFRASTRUCTURE | MACARTHUR
HEALTH PRECINCT STAGE 1 (GENESISCARE, CAMPBELLTOWN)
CIVIC, HEALTH AND ARTS PROPERTY AWARD
ORMISTON HOSPITAL - STAGE 1 EXPANSION
2025 NEW ZEALAND COMMERCIAL PROJECT AWARDS –
GOLD | ORMISTON HOSPITAL – STAGE 1 EXPANSION
GOLD AWARD FOR VITAL’S ANNUAL REPORT
GRESB SECTOR LEADER IN DEVELOPMENTS
FOR LISTED HEALTHCARE GLOBALLY
Vital achieved sector leader status (first place) for listed
healthcare globally in developments by GRESB
1
. In
addition, Vital was ranked second place across healthcare
listed entities globally. These results and awards below
are a reflection of our commitment to sustainability and
responsible investment practices.
Sustainability performance is a key driver in:
seeking to advance the long-term resilience and value of our property
portfolio by future-proofing against regulatory and climate-related risks
seeking to enhance Unit Holder returns by lowering borrowing costs
and improving access to capital markets
Playford Health Hub, Adelaide
1
The Global Real Estate Sustainability Benchmark (GRESB) is an international and independent standards organisation which reviews over 2,200 entities in 80 markets representing over US$7.0 trillion in investments.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
9
GenesisCare Integrated Cancer
and Health Centre, Sydney
RDX, Queensland -
6 Star Green Star Design
certification achieved
Endoscopy Auckland -
Targeting 5 Star
Green Star
Playford Health Hub, Adelaide
Two 6 Star Green Star 'Design & As Built' developments completed
in FY24 achieved 6 Star Green Star certification in FY25
Sustainability
17 %
BETTER ENERGY
PERFORMANCE
13%
BETTER WATER
PERFORMANCE
45%
LOWER EMBODIED
EMISSIONS
10 0%
ENERGY FROM
RENE WABLE SOURCES
34%
BETTER ENERGY
PERFORMANCE
25%
BETTER WATER
PERFORMANCE
32%
LOWER EMBODIED
EMISSIONS
10 0%
ENERGY FROM
RENE WABLE SOURCES
Artist's impression
RDX, Gold Coast (Artist's Impression)
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
10
Financial Results
and Capital
Management
Ormiston Hospital Stage 1 Expansion, Auckland
Financial performance
INCREASED OPERATING PROFIT BEFORE TAX
ACTUAL
FY25
ACTUAL
FY24
(%)
CHANGE
Net property income148,83414 4 , 533 3.0%
Corporate expenses(5,854) (5,798)(1. 0 %)
Management fees( 1 7, 6 5 2 )(24,684)28.5%
Realised transaction gains / (losses)151 479 (68.4%)
Strategic transaction costs(2,872)--
Net finance expenses(45,169)(40,606)(11 . 2 % )
Operating profit before tax and other income77,43873,924 4.8%
Property revaluations and other losses(12 5 , 231)(182,127)31. 2 %
Profit (loss) before income tax( 4 7, 7 9 3 )(108, 203)55.8%
Adjusted funds from operations (AFFO)70,36972,899 (3.5%)
Adjusted funds from operations (cpu)10. 4110.90 (4.5%)
Distributions per unit (cpu)9. 75 9. 75 -
All values shown as $000
Average NZD/AUD exchange rate in the period0 .91210.9249
3.7%
LIKE-FOR-LIKE NET PROPERTY
INCOME GROWTH
10.41cpu
AFFO
9.75cpu
DPU
Net property income up 3.0%
Rent reviews and development rent
partially offset by impact of asset disposals
Higher interest expense as
developments complete
Management fees down substantially
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
12
144.5
9.6
4.9(11.0)
(0.5)
1.4148.8
100
105
110
115
120
125
130
135
140
145
150
155
160
FY24Development
income
Rent reviews and
leasing activity
Disposals
(1)
Amortisation
and other
(2)
Foreign
exchange
FY25
Net property income
RENT REVIEWS AND DEVELOPMENTS UNDERPIN 3.0% NET PROPERTY INCOME GROWTH
NET PROPERTY INCOME DRIVERS
($M)
1
Disposals of non-core assets; Epworth Brighton (VIC), Alverna Grove (VIC), Hurstville Houses (NSW) and Hirondelle Private (NSW)
2
Amortisation, non-recurring R&M and abatements
~82.5% of Vital's leases (by income)
are CPI linked
Positive leasing momentum and results achieved:
+$9.6m additional development income
+$4.9m income from rent reviews and increased occupancy
Partially offset by current and prior year property disposals
+3.0%
NET PROPERTY INCOME (NPI)
+3.7%
LIKE-FOR-LIKE NPI
+0.6%
OCCUPANCY IMPROVEMENT TO 98.6%
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
13
Balance sheet
1
Including property held for sale
2
Calculated in accordance with Vital's Trust Deed
STRONG BALANCE SHEET AND CAPITAL POSITION
30 J U N E
2025
30 J U N E
2024
(%)
CHANGE
Investment properties
1
3,211,8603,239,973 (0.9 %)
Other assets36,23264,786 (4 4 .1%)
Bank debt1,368, 4 491,292,653 5.5%
Other liabilities2 0 0 ,12820 6,979 (3.3%)
Debt to gross assets
2
42.1%3 9.1 %3.0%
Unit Holder funds1, 679, 5151,805,126 ( 7. 0 % )
Units on issue (000s)678,896671,923 1.0%
Net tangible assets ($/unit)2.472.69 (7.9%)
All values shown as $000s
Period end NZD/AUD exchange rate0.92750 .9131
5.54%
WEIGHTED AVERAGE
PORTFOLIO CAP RATE
$2.47
NET TANGIBLE ASSETS
PER UNIT
DOWN 22 CENTS TOSOFTENED BY 23BPS TO
$6.2m
NEW EQUITY RAISED
VIA DRP
Strong balance sheet:
Property values stabilising
$133m investment in developments
and value-adding capex
Proceeds from asset sales, debt liquidity
and DRP funded development spend
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
14
Capital management
MAJOR DEBT REFINANCE COMPLETED – IMPROVED TERMS AND DURATION
1
Trust Deed debt ratio is based on total borrowings to gross asset value of the Trust
2
Bank LVR is based on total indebtedness to secured property value as determined by external valuers
DEBT MATURITY PROFILE – 30 JUNE 2025 (A$M)
BANK FACILITIES30 JUNE 202530 JUNE 2024
Debt to gross assets (Trust Deed)
1
42.1%39.1%
Bank loan to value ratio – actual
2
43.6%40.4%
Bank loan to value ratio – covenant55.0%55.0%
Weighted average duration to maturity3.8 yrs3.5 yrs
Undrawn facility limit (A$)$56.8m$14 4 . 0 m
FY25 proactive capital management focus:
$1.1b debt facilities refinanced
Strong banking partner support and appetite
Improved terms, multi-currency flexibility and pricing
No debt maturing until March 2027
Headroom sufficient to cover committed development spend
42.1%
GEARING – TRUST DEED
3.0x
INTEREST COVER
3.8 years~$728m
WEIGHTED AVERAGE
DEBT MATURITY
TOTAL DEBT ABLE TO BE DRAWN
IN MULTI-CURRENCY
ANZBOCBNZCA CIBCBAHSBCICBCWBC
$0
$50
$100
$150
$200
$250
$300
$350
$400
$450
$500
FY32FY31FY26FY27FY28FY29FY30
Defensive, diversified and long-dated cash flows, together with
disciplined capital management support current gearing levels.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
15
FY25
3.32%
3.55%
3.57%
3.56%
3.68%
FY26FY27FY28FY29
Contracted hedging based on drawn debtAdditional potential hedging exercisable at counterparty election
82%
Hedged
72%
Hedged
42%
Hedged
19%
Hedged
4%
Hedged
Interest rate hedging
1
INTEREST RATE RISK EXPOSURE SUBSTANTIALLY MITIGATED
1
Excluding borrowing margins and costs
Interest rate risk management milestones:
$684m interest rate hedging completed
Interest rate risk protection increased
and duration extended
82% at 3.32%
HEDGED AT 30 JUNE 2025
72% at 3.55%
HEDGED AT 30 JUNE 2026
3.2 years
WEIGHTED AVERAGE INTEREST RATE HEDGE DURATION
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
16
Property and
Sector Update
Ormiston Hospital Stage 1 Expansion, Auckland
Market dynamics
MEDIUM-TERM PROSPECTS FOR PRIVATE HEALTHCARE IN THE INTEGRATED AUSTRALIAN AND NEW ZEALAND HEALTHCARE SECTORS
REMAIN STRONG
Maitland Private Hospital, Maitland
Focal areas for operators
Prioritising activities which support margin growth
and improve operating efficiency
Continued focus on efficiency, case mix
management and technology investment
Focus on maximising use of existing assets
and select brownfield capacity expansions to
drive operating performance
Increased focus on advocacy and engagement
with policy makers, prioritising actions which improve
the long-term sustainability of private healthcare
What this means for Vital
High-quality, well-located assets will
continue to perform
High barriers to entry; replacement costs
well in excess of Vital's portfolio value and
other barriers protect existing investments
Performance of Australian operators is
improving, following a period in which
cost inflation outpaced revenue growth
Performance of Vital’s operators continue to improve, demonstrated through improving Rent/EBITDAR (51% vs 57% pcp
1
)
NZ operators continue to trade strongly,
with potential to support Te Whatu Ora
health targets
1
Last twelve months performance to 31 March 2025
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
18
30%
3%
Portfolio overview
AUSTRALASIA'S HIGHEST QUALITY INVESTABLE HEALTHCARE PORTFOLIO
$3.2B PORTFOLIO DIVERSIFIED
ACROSS AUSTRALIA AND NZ
(BY VALUE)
DIVERSIFIED TENANT AND INCOME BASE
% OF RENT
FY26 income growth underpinned by CPI linked (~61%), market linked (~26%) and fixed (13%) rent reviews
with no exposure to Healthscope
occupancy
98.6%
NPI growth (like-for-like,
constant currency basis)
3.7%
WACR
(5.5% AUS; 5.6% NZ)
5.5%
of rental increases
linked to CPI
82.5%
hospitals
78%
ambulatory care
18%
life sciences
4%
Epworth HealthCare 13. 7%
Allevia 3.0%
Evolution Healthcare 13.9%
Healthe Care 16 . 4%
Southern Cross 4.2%
GenesisCare 2.3%
Burnside 3.0%
Boulcott Hospital 1.7%
Endoscopy Auckland
1
1. 5%
Other 21.9 %
Aurora Healthcare 18. 4%
WA
NT
SA
NSW
TAS
VIC
QLD
4%
8%
22%
12 %
21 %
NORTH
ISLAND
SOUTH
ISLAND
1
Joint venture between Evolution Healthcare and AlleviaVITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
19
FY35FY26FY27FY28FY29FY30FY31FY32FY33FY34
Total expiry
Largest single rent expiring10 Year average
0.0%
2.5%
5.0%
7.5%
Lease expiry profile
LOW-RISK EXPIRY PROFILE SUPPORTS SUSTAINABLE, PREDICTABLE AND DEFENSIVE CASH FLOWS
10-year average annual lease
expiry of only 1.7%
(as % of total portfolio income)
Vital's market-leading WALE increased to 18.5 years, up from 18.3
years in FY24 after a year passing, reflecting asset management
initiatives, the strength of Vital's portfolio and tenant demand
Lease expiries over the next three years are below the
10-year average, with no major single tenant exposure
Renewal confidence supported by historical renewal rates
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
20
Development
Activity
GenesisCare Integrated Cancer and Health Centre, Sydney
$108.8m of developments completed in FY25
Run-off of existing committed development
program with $36.9m left to be spent
$11.5m Wakefield Hospital Level 5 capacity
expansion initiated
~$530.0m of projects completed in the last
five years enhancing the quality and resilience of
Vital's portfolio
Development update
Maitland Private Hospital, Maitland
Development activity is focused on new high-
quality facilities, capacity expansion and portfolio
renewal to support operators and drive future Unit
Holder earnings and value growth
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
22
Wakefield Hospital - Stage 2
COMPLETED DEVELOPMENTS
Staged redevelopment of Wellington's largest private hospital
$49.9m Stage 1 completed in 2021, $91.5m Stage 2 acute
services building operational from January 2025
100% leased to Evolution Healthcare
Seismically resilient facility with base isolators and services
movement joints
State-of-the-art operating theatres and catheterisation
laboratories
Hospital operations, including surgery, continued throughout
this major transformation
Early activation of built space with commencement of
$11.5m capacity expansion project on Level 5
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
23
Maitland Private Hospital
COMPLETED DEVELOPMENTS
A$16.0m mental health and oncology expansion
completed in September 2024
100% leased to Healthe Care
Stage 1 included a new level constructed above
the existing mental health ward supporting an
increase in the mental health service capacity by
24 beds, including high-quality consulting suites,
communal areas, group rooms and gymnasium
Stage 2 relocated the day oncology unit,
providing an increase of 5 chairs to 12, added an
additional 67 car parks and improvements to the
hospital entry
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
24
COMMITTED DEVELOPMENTS
Boulcott Hospital - Refurbishment and Expansion
A$134 . 2m$36. 7m
$32.2m$11. 5 m~6.0%
~5.6%~5.5%
~5.4%~ 7. 0 %Mid-25
Early-26Mid-26
Mid-late-25Late-25
RDX
Endoscopy AucklandWakefield Hospital – Level 5 Expansion
Grace Hospital - Expansion
$24.8m
estimated
development cost
estimated
development cost
estimated
development cost
estimated
development cost
estimated
development cost
yield on cost
forecast yield on
cost (blended)
yield on cost
yield on costyield on cost
(blended)
forecast
completion
forecast completion
(delayed from Mid-25)
forecast
completion
forecast
completion
forecast
completion
Strategically focused on precincts and
growing ambulatory care exposure
All developments are 100% pre-leased
with the exception of RDX which is
subject to a 57% 12-month net property
income guarantee from practical
completion. Signed Agreements for
Lease and Heads of Terms are currently
below this level at 30 June 2025.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
25
Outlook
Kapa Haka Group from South Wellington Intermediate
School performing during the Wakefield Hospital
Stage 2 redevelopment official opening
Whāia te iti kahurangi ki te tūohu koe me
he maunga teitei.
Seek the treasure you value most dearly.
If you bow your head, let it be to a lofty
mountain.
Whakataukī
Māori proverb
Outlook and guidance
A FOCUS ON FUNDAMENTALS TO DRIVE OPERATIONAL PERFORMANCE AND UNIT HOLDER VALUE
Sector tailwinds
Development upside from
shovel ready projects and
brownfield expansions
AFFO and distribution
growth
Medium term
Core of everything we do
Positive long-term commercial
and community outcome focus
Sustainability
Vital is a 'best in class' investment platform.
9.75cpu distribution guidance
Continued enhancement and
optimisation of portfolio
Disciplined capital
deployment aligned with
long-term value creation
FY26 focus
Playford Health Hub, Adelaide
An attractive risk-adjusted
income return, opportunities to
leverage embedded portfolio
value and underlying demand
for health services offer long-
term Unit Holder value.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
27
Appendices
Board and Management
Maitland Private Hospital, Maitland
Experienced management team
Grace Hospital, Tauranga
Alex Belcastro
SENIOR VICE PRESIDENT
- DEVELOPMENTS AND
PRECINCTS
Kirsty Bowyer
VICE PRESIDENT -
DEVELOPMENT
Chris Adams jointly leads the Northwest business in Australia
and New Zealand, and manages Northwest’s NZX-listed
Vital Healthcare Property Trust, which he has been part of the
leadership team since 2017.
He has extensive experience in the property industry in
Australia, New Zealand and the United Kingdom, including
over 25 years’ direct experience in health property.
Chris was one of the founding Executives at ASX-listed
Generation Healthcare REIT which was acquired by Northwest
in 2017. Prior to that he established Vital Healthcare Property
Trust’s presence in Australia in 1999 following various roles
with the group in New Zealand.
Chris holds a Bachelor of Property from the University
of Auckland.
Alex Belcastro, formerly the Chief Business Development Officer
at Ramsay Health Care managing a multi-billion-dollar hospital
asset portfolio, joined our team in 2021.
Alex leads precinct transactions, leasing and developments.
She also provides strategic leadership to the development and
leasing divisions and heads our Strategy and Research function.
With over 18 years of specialised experience in social
infrastructure, she has facilitated large-scale transactions and
developments across public and private sectors.
Her diverse background spans advisory, operational, and
ownership roles, adding valuable real estate expertise to
our platform.
Holding a Master of Construction Management and a Bachelor
of Planning and Design from the University of Melbourne, Alex
has also honed her skills through executive education at Harvard
Business School.
Kirsty Bowyer joined the team in New Zealand in 2023 and is
responsible for overseeing the planning, design and construction of
Vital’s development projects across New Zealand. With more than 15
years of experience in the construction and property industry including
major healthcare infrastructure projects, Kirsty brings a deep and
practical understanding of the complexities of healthcare development,
combining technical expertise with strategic leadership.
Before joining Northwest, Kirsty spent 13 years at Johnstaff, one of
Australia’s leading property and construction consultancies. During her
time there, she held various senior roles, leading the end to end delivery
of capital works programmes across both Australia and New Zealand.
Over the course of her career, Kirsty has delivered more than
$2.5 billion worth of healthcare real estate. Her leadership is
characterised by a strong commitment to clinical user engagement,
operational efficiency and design excellence.
Kirsty is also a committee member of the New Zealand Health
Design Council, where she contributes to national discourse on health
infrastructure innovation.
Chris Adams
CO-HEAD, A/NZ REGION
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
29
Experienced management team
Michael Groth
CHIEF FINANCIAL OFFICER
Richard Roos
CO-HEAD, A/NZ REGION
Michael Groth has over 18 years’ experience as a senior
finance executive in the listed and unlisted property funds and
funds management industry. Prior to joining the team in 2019,
Michael’s most recent position was as Group Chief Financial
Officer of the Melbourne based and ASX-listed real estate
fund manager, APN Property Group Limited.
Michael has extensive experience in financial management
and reporting, taxation, treasury and capital management,
corporate structuring, acquisitions, disposals and equity
raisings in the listed and unlisted property and funds
management industry.
Michael holds a Bachelor of Commerce and Bachelor of
Science and has been a member of the Chartered Accountants
Australia and New Zealand since 2000.
Richard Roos jointly leads the Northwest business in Australia
and New Zealand. He has over 25 years’ experience in
commercial real estate financing, acquisitions and property
management, of which the last 17 years have been in healthcare
real estate in senior roles for Northwest in Canada and Australia.
Richard is responsible for asset management, transactions,
people and culture, and ESG. He is also focused on building
and expanding strong relationships with Northwest’s
operator partners.
Playford Health Hub, Adelaide
Vanessa Flax
VICE PRESIDENT, REGIONAL
GENERAL COUNSEL
AND COMPANY SECRETARY
Vanessa Flax joined the team in 2019, prior to which she was a
special counsel at Ashurst Australia.
Vanessa has 25 years of deep and broad ranging property
law experience in Australia and New Zealand, including acting
as primary legal adviser (for approximately 15 years) for Vital
and Northwest.
Vanessa’s legal experience covers all aspects of real estate
property transactions, including acquisitions, divestments and
sales, leasing and Crown leasing, development transactions and
due diligence.
Vanessa has a Bachelor of Arts and Bachelor of Laws from the
University of Witwatersrand, South Africa.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
30
Majority independent board
Graham Stuart
INDEPENDENT CHAIR AND
MEMBER OF THE AUDIT
COMMITTEE
Mike Brady
NON-INDEPENDENT
DIRECTOR
Angela Bull
INDEPENDENT DIRECTOR
AND MEMBER OF THE AUDIT
COMMITTEE
Graham Stuart is an experienced corporate director with
an established track record of performance in governance
and in prior executive roles. He is currently a Director of
Ravensdown Limited and Director of Dairy Goat Co-operative
(N.Z.) Limited.
He was previously the CEO of Sealord Group from 2007 to
2014 and Director, Strategy and Growth and CFO of Fonterra
Co-operative Group from 2001 to 2007, Independent Chair
of EROAD Limited and an Independent Director and Chair of
the Audit Committee at Tower Limited.
Graham is a Fellow of Chartered Accountants Australia &
New Zealand (CAANZ) and has a Master of Science degree
from Massachusetts Institute of Technology and a Bachelor of
Commerce with first class honours from the University of Otago.
Mike Brady was appointed global President of Northwest
Healthcare Properties REIT (TSX: NWH.UN) in 2023 after
serving as global Executive Vice President, General Counsel and
Board Secretary since joining the REIT in 2006. He has extensive
experience in real estate investments and finance, transaction
management, global leadership, governance and legal matters.
Mike has played a significant commercial and legal role in the
strategic direction and growth of the REIT, most recently leading
the team to complete a €2 billion pan-European joint venture
fund, a $435 million UK hospital portfolio, and a $2 billion joint
venture fund and acquisition of a $1.25 billion hospital portfolio
in Australia.
Prior to joining the corporate real estate world, Mike was a
corporate law partner at two Toronto-based law firms, where
he developed his real estate practice. He has a Bachelor of Arts
(Economics) and a joint LL.B./Masters of Business Administration
from Dalhousie University, Halifax.
Angela Bull is an independent director of Channel Infrastructure
Ltd (NZX: CHI), Property For Industry Limited (NZX:PFI),
Foodstuffs South Island Ltd and Foodstuffs NZ Ltd. She is also
on the Trust Board of St Cuthbert’s College and an independent
director of Bayleys Corporation Board (NZ) and recently joined
the Board of Fulton Hogan as an independent director.
Angela is a former Chief Executive of Tramco Group, a large
New Zealand owned property investment company which
specialises in large scale land holdings, notably the Viaduct
Harbour precinct in Auckland and Wairakei Estate in the
Waikato; a former Board member of the Property Council of
New Zealand; and a former independent director of the Real
Estate Institute of New Zealand and realestate.co.nz.
She holds a Bachelor of Laws and a Bachelor of Arts (Political
Science) and practised property and environmental law prior
to her executive career. Previously, Angela held a number of
senior positions over a 10-year period with Foodstuffs Auckland
and Foodstuffs North Island Ltd, most recently being General
Manager Property Development for Foodstuffs North Island.
RDX, Gold Coast (Artist's Impression)
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
31
Majority independent board
Craig Mitchell
NON-EXECUTIVE DIRECTOR AND
MEMBER OF THE AUDIT COMMITTEE
(ZACHARY VAUGHAN REPLACED CRAIG MITCHELL ON THE
BOARD EFFECTIVE 12 AUGUST 2025)
Zachary Vaughan
NON-INDEPENDENT DIRECTOR
(APPOINTED 12 AUGUST 2025)
Dr Michael Stanford AM
INDEPENDENT DIRECTOR AND CHAIR
OF THE AUDIT COMMITTEE
Craig Mitchell is a professional manager with an inclusive
leadership style, Craig has more than 20 years of experience
specialising in the property industry. His previous roles include
Northwest CEO (ceased 30 June 2025) and Executive Director
and Chief Operating Officer of Dexus, an ASX top 50 listed REIT.
Craig has a Master of Business Administration (Executive) from
the Australian Graduate School of Management, a Bachelor
of Commerce and a Fellow of CPA Australia. He has also
completed the Advanced Management Program at Harvard
University, Boston.
Zachary Vaughan was appointed Chief Executive Officer of
Northwest Healthcare Properties REIT in July 2025. He brings
over 20 years of experience in real estate investment and asset
management, with a strong track record of leadership across
global markets.
Prior to joining Northwest, Zachary served as Global Head
and Chief Investment Officer of Real Estate at Arrow Global,
where he led the firm’s real estate strategy. He remains a Non-
Executive Director at Arrow. Before Arrow, he held several senior
roles at Brookfield Asset Management, including Managing
Partner and Head of European Real Estate, Head of Multifamily
Investments, and CEO of Brookfield REIT.
Earlier in his career, Zachary was a Director in the Real Estate
Investment team at the Canada Pension Plan Investment Board
(CPPIB), and Director of Acquisitions at International Property
Corporation/Reichmann International.
Zachary holds an Honours Bachelor of Economics from
Western University. He is now based in Toronto, where he leads
Northwest’s global healthcare real estate platform spanning
North America, Brazil, Europe, and Australasia.
Zachary was appointed as a Non-Independent Director to the
board of the Manager on 12 August 2025.
RDX, Gold Coast (Artist's Impression)
Dr Michael Stanford has more than 30 years’ experience in the health sector in
either Group CEO or Board roles. Michael’s current Board roles include Chair
of Nexus Hospitals, a leading provider of specialist day and short stay private
hospital based care; and Board member of the Royal Australian College
of General Practitioners as well as Board member of Healius (ASX:HLS).
Other Board roles in the last three years have included Australian Clinical
Labs (ASX: ACL), Australia’s third largest private pathology provider; Nucleus
Networks, one of the world’s largest Phase one clinical research organisations;
Virtus Health (ASX: VRT), one of the world’s top five providers of Assisted
Reproductive Services; as Chair of disability, aged, employment and training
services provider GenU; and as President and Board Chair of Diabetes
Australia, a significant Not-for-Profit organisation.
Michael was the Group CEO of St John of God Healthcare, Australasia’s third
largest private hospital provider, for 16 years during which time the company
increased revenue fivefold through organic and M&A growth plus more
than A$1 billion greenfield and brownfield developments. Michael’s other
Managing Director roles included the ASX listed Australian Hospital Care
and two public hospital networks in Victoria. Michael holds an MBA from
Macquarie University and Bachelor of Medicine and Bachelor of Surgery
from UNSW. He is a Fellow of the Australian Institute of Company Directors.
In 2018 Michael was awarded a Member of the Order of Australia for
significant service to the health sector through executive roles, to tertiary
education and the WA community, in 2010 he received the WA Citizen of the
Year Award – Industry and Commerce category.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
32
Appendices
Additional financial information
Playford Health Hub, Adelaide
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
33
Adjusted funds from operations (AFFO)
DISTRIBUTIONS CASH COVERED
FY2025FY2024(%) CHANGE
Operating profit before tax and other income7 7, 4 3 8 73,924 4.8%
Add/(deduct):
Current tax expense(15, 5 4 6)(19,0 4 6) 18. 4%
Incentive fee- 6,600 (10 0 . 0 %)
Strategic transaction costs 2,848-10 0.0%
Realised and unrealised fx on borrowings (net of tax)(59)(48) (22.9%)
Amortisation of borrowing costs2,094 2,009 4.2%
Amortisation of leasing costs and tenant inducements3,604 3,423 5.3%
Current tax expense on interest rate swap restructure and asset disposals1, 214 6,536 (81. 4 %)
IFRS 16 operating lease accounting(117 )(157 ) 25.5%
Funds from operations (FFO)71,477 73,241 (2.4%)
Add/(deduct): -
Actual repairs and maintenance from continuing operations(1,10 8) (342) (224.0%)
Adjusted funds from operations (AFFO)70,369 72,899 (3.5%)
AFFO (cpu)10. 41c 10.90c(4.5%)
Distribution per unit (cpu)9. 75c9. 75c -
AFFO payout ratio93.6%89. 4%
All values shown in $000's
Units on issue (weighted average, 000s)675,89 96 68, 753
+4.8%
OPERATING PROFIT BEFORE TAX
93.6%
AFFO PAYOUT RATIO
10.41cpu
AFFO
Higher interest and tax expense, and
reduced income from asset disposals only
partially offset by income growth and from
completed developments:
1.1% increase in weighted average units
Repairs and maintenance spend up $0.8m
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
34
Net tangible assets (NTA)
NTA PER UNIT BRIDGE (FY25)
NTA PER UNIT IMPACTED PRIMARILY BY UNREALISED PROPERTY REVALUATION LOSSES
$2.69
($0.13)
($0.02)
$2.0
$2.2
$2.4
$2.6
$2.8
$2.1
$2.3
$2.5
$2.7
$2.9
$3.0
FY24Property
revaluations
Currency
translation
$2.47
($0.01)
($0.04)
($0.02)
New units
issued
Interest
rate swaps
OtherFY25
$2.47
NET TANGIBLE ASSETS
PER UNIT
DOWN 22 CENTS TO
NTA per unit impacted by:
$96.7m unrealised
property revaluation loss
$28.7m unrealised
mark-to-market loss
on interest rate swaps
Weaker exchange rate
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
35
Movement in investment property
STRONG CPI-LINKED HEALTHCARE PORTFOLIO OFFSETS CAP RATE SOFTENING
TOTAL PORTFOLIO VALUE BRIDGE (FY25)
($M)
1
$1.2m of acquisitions for strategic / development sites. All values shown in $, pre costs
2
Includes development expenditure and capitalised interest costs
3
Book value of properties disposed
4
Period end NZD/AUD exchange rate moved from 0.9131 at 30 June 2024 to 0.9275 at 30 June 2025
3,240
$2,240m
1
(97)
(46)
(36)
3,212
$0
$500
$1,000
$1,500
$2,000
$2,500
$3,000
$3,500
$4,000
FY24Acquisitions (1)Capital
additions (2)
Property
revaluations
Disposals (3)Foreign
exchange (4)
FY25
$1,000m
$2,148m
$1,064m
150
5.54%
5.49%
5.63%
WACR - PORTFOLIO
WACR - AUSTRALIA
WACR - NEW ZEALAND
SOFTENED 23BPS TO
SOFTENED 31BPS TO
SOFTENED 3BPS TO
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
36
Comparative returns
VITAL MAINTAINS LONG-TERM OUTPERFORMANCE VS BENCHMARK ON A TOTAL RETURN
1
BASIS
TOTAL RETURN
1
TO 30 JUNE 20251YR5YR (P.A.)10YR (P.A.)SINCE 2004 (P.A.)
2
Vital12. 6%(1. 2 %)5.8%9. 4%
S&P/NZX All Real Estate Index8.7%0.6%4.7%6.6%
Vital’s performance vs NZX REIT3.9%(1. 8%)1.0%2.8%
1
Total returns measured by change in unit price plus post-tax distributions to 30 June 2025Source: Forsyth Barr
VHP VS S&P NZX REAL ESTATE INDEX
2
S&P/NZX All Real Estate Index data from 31 December 2004, being the inception date of the NZX All Real Estate Index
0
100
200
300
400
500
600
700
800
900
1,000
Jun-05
Dec-05
Jun-06
Dec-06
Jun-07
Dec-07
Jun-08
Dec-08
Jun-09
Dec-09
Jun-10
Dec-10
Jun-11
Dec-11
Jun-12
Dec-12
Jun-13
Dec-13
Jun-14
Dec-14
Jun-15
Dec-15
Jun-16
Dec-16
Jun-17
Dec-17
Jun-18
Dec-18
Jun-19
Dec-19
Jun-20
Dec-20
Jun-21
Dec-21
Jun-22
Dec-22
Jun-23
Dec-23
Jun-24Dec-24Jun-25
VitalS&P/NZX All Real Estate Index
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
37
Appendices
Additional property information
Playford Health Hub, Adelaide
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
38
WESTERN
AUSTRALIA
NORTHERN
TERRITORY
SOUTH
AUSTRALIA
NEW SOUTH
WALES
TASMANIA
VICTORIA
QUEENSLAND
2
3
6
2
7
Investment properties
~$3.2B PORTFOLIO OF HEALTHCARE REAL ESTATE COMPRISING 34 INVESTMENT PROPERTIES
AS AT 30 JUNE 2025
South Australia (3)
Burnside Hospital - Stepney
Playford Health Hub – MOB, Retail and Carpark
Tennyson Centre
Victoria (6)
120 Thames Street
Avive Clinic, Mornington Peninsula
Ekera Medical Centre
Epworth Camberwell
Epworth Eastern Hospital
South Eastern Private Hospital
Wellington (4)
Boulcott Hospital
Bowen Hospital
Hutt Valley Health Hub
Wakefield Hospital
Northland (1)
Kensington Hospital
Bay of Plenty (1)
Grace Hospital
Christchurch (1)
68 Saint Asaph Street
Hawke's Bay (1)
Royston Hospital
Queenstown (1)
Kawarau Park
Health Hub
2
12
Click on one of the underlined properties
to see a fly-through of that property
Western Australia (2)
Abbotsford Private Hospital
Marian Centre
Auckland (5)
Ascot
Ascot Carpark (Right of Use)
Ascot Central
Endoscopy Auckland
Ormiston Hospital
Queensland (2)
Belmont Private Hospital
Currumbin Clinic
New South Wales (7)
GenesisCare Integrated Cancer
and Health Centre
Hurstville Private Hospital
Kellyville Private Hospital
Lingard Day Centre
Lingard Private Hospital
Maitland Private Hospital
Toronto Private Hospital
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
39
PRIVATE HOSPITALS
14 hospitals (acute and specialty
– mental health, rehabilitation)
Five hospital operators
83.0% of AUS portfolio value;
86.0% of AUS portfolio rent
WALE: 20.7 years
Six assets, multiple tenants
17.0% of AUS portfolio value;
14.0% of AUS portfolio rent
WALE: 9.5 years
AMBULATORY CARE
~$2.1b Australian portfolio overview
PRECINCT FOCUSED PORTFOLIO WITH A DIVERSE TENANT BASE
SUBSECTOR DIVERSITY (BY VALUE)
49. 8%
33.2%
17. 0 %
H
O
S
P
I
T
A
L
8
3
.
0
%
O
T
H
E
R
1
7
.
0
%
AMBULATORY
CARE
SPECIALTY
HOSPITAL
19.0 years
WALE
1
1
Inclusive of landlord options
ACUTE
HOSPITAL
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
40
H
O
S
P
I
T
A
L
8
4
.
1
%
O
T
H
E
R
1
5
.
9
%
~$1.1b New Zealand portfolio overview
STRONG GROWTH IN NZ PORTFOLIO OVER LAST FIVE YEARS
REFLECTING POSITIVE CONDITIONS FOR PRIVATE OPERATORS
PRIVATE HOSPITALS
Nine hospitals (all acute)
Six hospital operators
84.1% of NZ portfolio value;
84.3% of NZ portfolio rent
WALE: 19.2 years
Five assets, multiple tenants
15.9% of NZ portfolio value;
15.7% of NZ portfolio rent
WALE: 10.2 years
AMBULATORY CARE
17. 8 years
WALE
SUBSECTOR DIVERSITY (BY VALUE)
15.9 %
8 4 .1%
AMBULATORY
CARE
ACUTE
HOSPITAL
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
41
Rent reviews undertaken in FY25
HIGH PERCENTAGE OF TOTAL RENT IS REVIEWED ANNUALLY WITH STRUCTURED
1
REVIEW MECHANISMS
1
Includes fixed percentage and CPI reviews
Rent reviews have been
completed for 172 leases
in FY25
Structured reviews
represented 96.1%
1
of leases by income
Positive uplift via CPI and
fixed rent reviews
FY25
#
June 24 Rent p.a.
(NZD)
June 25 Rent p.a.
(NZD)
Increase
(NZD)
Annualised Growth
(Stable currency)
AustraliaAUS9499,212,005102,025,1082 , 813 ,10 22.8%
New ZealandNZ7850,537,85752,589,5632,051, 7074 .1%
Total172149,749,862154,614,6714,864,8093.2%
#
June 24 Rent p.a.
(NZD)
June 25 Rent p.a.
(NZD)
Increase
(NZD)
Annualised Growth
(Stable currency)
CPICPI108125,340,238129,368,3004,028,0623.2%
FixedFixed4618,542,5391 9 , 1 7 7, 8 9 2635,3523.4%
MarketMarket174,645,4714,772,4901 2 7, 0 1 92.7%
TurnoverTurnover11,221, 6141,295,98974 , 3 766 .1%
Total172149,749,862154,614,6714,864,8093.2%
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
42
No Review
(1.0%)
Turnover
(0.8%)
Fixed <3%
(1.7%)
Fixed 3%+
(10.2%)
Market Review
Rent Review Breakdown
(3.8%)
Other Reviews
CPI Linked Reviews
(82.5%)
(17.5%)
Rent review profile
BREAKDOWN OF PORTFOLIO CPI REVIEWS
FOR THE YEAR ENDED 30 JUNE 2025
TYPE%
CPI - Un-Capped 20.8%
CPI - 2.5% Cap1.3%
CPI - 3% Cap5.4%
CPI - 3.5% Cap1. 7%
CPI - 4% Cap42.3%
CPI - 5% Cap0.6%
CPI x 1.5 - 2.5% Cap4.8%
CPI x 1.5 - 3% Cap15. 7 %
CPI x 1.75 - 5% Cap2.2%
Lesser of CPI and 3%5.1%
FY26 rent review profile:
13% Fixed
26% market linked
61% CPI linked
RENT REVIEW BREAKDOWN
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
43
Core portfolio metrics
FIVE YEAR TRENDS HIGHLIGHT PORTFOLIO STRENGTH AND UNDERPIN LONG-TERM PERFORMANCE
OCCUPANCY
AVERAGE 10 YR LEASE EXPIRY
1
WALE
TOTAL INCOME SUBJECT TO
STRUCTURED RENT REVIEWS
>98.0%
Occupancy
Long-term track record of maintaining
High degree of confidence that
future expiries will be renewed
or replaced with new tenants in
advance of expiry
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
PERCENTAGE OF INCOME
1.6%1.7%
1.8%
1.8%
1.7%
2 0 212022202320242025
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
2 0 212022202320242025
PERCENTAGE OF INCOME
95.0%
92.3%
94.2%
96.0%96.4%
15
16
17
18
19
20
18.7
17.6
17.8
18.3
18.5
2 0 212022202320242025
95.0%
96.0%
97.0%
98.0%
99.0%
100.0%
2 0 212022202320242025
99.2%
98.7%98.8%
98.0%
98.6%
1
Reflects the average % of total portfolio income that expires over the next 10 years
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
44
Appendices
Additional development information
Playford Health Hub, Adelaide
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
45
Committed developments – Australia and New Zealand
DEVELOPMENTS ENHANCE EARNINGS GROWTH AND IMPROVE ASSET QUALITY
ALL VALUES SHOWN IN $MDESCRIPTION OF WORKSDEVELOPMENT
COST
1
LAND
VALUE
SPEND
TO DATE
COST TO
COMPLETE
FORECAST
NET RETURN
FORECAST
COMPLETION DATE
STATUS
Australia
RDX (QLD)9 level research and development centre of excellence
and 3 level, 181 bay basement car parking.
134.27. 2119 . 215 . 05.6%
2
Early-26Façade complete. Internal services fit off and finishes continue to all
levels. Completion delayed to early-26 due to inclement weather
(Cyclone Alfred) and to accommodate rework of atrium.
Total Australian Developments A$134.27. 211 9 . 215.05.6%
Total Australian Developments NZ$144.77. 7128.516.25.6%
New Zealand
Grace Hospital (NZ TRG)Fitout of 2 theatres, endoscopy and 10 beds.36.7 - 26.610 .15.5%Mid-26Same day admissions unit, OT8/9, on-grade car park and
Oropi Day Unit works are complete. Western Wing IPU construction
is on program.
Endoscopy Auckland (NZ AKL)New endoscopy clinic.32.2 - 29.92.35.4%Mid-late-25Main works construction currently on program.
Boulcott Hospital (NZ LH)2 theatres, post-anaesthesia care unit (PACU)
expansion and conversion.
24.8 - 23.31.56.0%Mid-25Construction works are forecast to be completed on program.
Wakefield Hospital Level 5
Expansion (NZ WGN)
34 bed ward expansion of Level 5 shell space.11 . 5 - 4.76.87.0%Late-25Fitout works are underway and progressing towards the midpoint
of construction.
Total New Zealand Developments A$105.20.084.520.75.7%
Total Developments in NZ$
3
249.97. 7213.036.95.6%
1
Excluding Land
2
Fully leased initial yield
3
A$ converted at 30 June 25 spot rate 0.9275
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
46
Glossary
AFFO
Adjusted Funds from Operations is an alternate measure used for assessing distributable income. Essentially adjusts net profit after tax for non-cash/non-recurring items (i.e. NDI) then makes adjustments for items such as
maintenance capex
CAGR
Compound Annual Growth Rate
Cap Rate
Capitalisation Rate. Generally calculated as net operating income / current market value of investment property
CPI
Consumer Price Index. An index that measures the change in the cost of a ‘basket’ of basic goods and services, showing how the cost-of-living changes over time. The most widely accepted indicator of inflation
DPU
Distribution per unit
DRP
Distribution Reinvestment Plan
EBITDAR
Earnings Before Interest, Tax, Depreciation, Amortisation, Rent
FX
An abbreviation for ‘foreign exchange’ used where there is a transaction in a currency other than the local currency
IFRS
International Financial Reporting Standards
M&A
Mergers and acquisitions
NPI
Net Property Income
NTA
Net Tangible Assets. The total assets of the Trust less total liabilities. NTA is normally divided by the number of units on issue and expressed as an annual amount per unit
NZX
New Zealand Stock Exchange
S&P
Standard & Poors, a credit rating agency
WAC R
Weighted Average Capitalisation Rate
WALE
Weighted Average Lease term to Expiry. The weighted average lease term remaining to expire across a portfolio, sometimes also referred to as WALT
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
47
Disclaimer
This document has been prepared by Northwest Healthcare Properties Management Limited (the Manager) as manager of the Vital
Healthcare Property Trust (the Trust). This document provides general information only and is not intended as investment, legal, tax, financial
product or financial advice or recommendation to any person and must not be relied on as such. You should obtain independent professional
advice prior to making any decision relating to your investment or financial needs.
All references to $ are to New Zealand dollars unless otherwise indicated.
This document may contain forward-looking statements. Forward-looking statements can include words such as “expect”, “intend”, “plan”,
“believe”, “continue” or similar words in connection with discussions of future operating or financial performance or conditions. Any indications
of, or guidance or outlook on, future earnings or financial position or performance and future distributions are also forward-looking
statements. The forward-looking statements are based on management's and directors’ current expectations and assumptions regarding the
Trust’s business, assets and performance and other future conditions, circumstances and results. As with any projection or forecast, forward-
looking statements are inherently susceptible to uncertainty and to any changes in circumstances. The Trust’s actual results may vary materially
from those expressed or implied in the forward-looking statements. The Manager, the Trust, and its or their directors, employees and/or
shareholders have no liability whatsoever to any person for any loss arising from this document or any information supplied in connection with
it. The Manager and the Trust are under no obligation to update this document or the information contained in it after it has been released.
Past performance is no indication of future performance.
The information in this document is of general background and does not purport to be complete. It should be read in conjunction with Vital’s
market announcements lodged with NZX, which are available at www.nzx.com/companies/VHP.
13 August 2025
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2025
|
48
Thank you
www.vhpt.co.nz
Wakefield Hospital, Wellington
---
Driving operational performance
Annual Report
Summary 2025
DISTRIBUTIONS PAID
TO UNIT HOLDERS
9. 75cpu
OCCUPANCY
98.6%
$2.47
NTA PER UNIT
Vital is pleased to report that distributions of 9.75cpu were paid to Unit
Holders in FY25, funded from an AFFO result of 10.41cpu. Good progress
was made on driving operational performance. New and renewal leasing
success lifted occupancy to 98.6% and the profitability of our diverse
underlying hospital tenants continued to improve. Vital’s strong balance sheet
was further enhanced during the final quarter of the year as improved terms
and pricing from a major $1.1b debt refinance were secured. Vital’s next debt
maturity is now not until March 2027.
Delivery of Vital’s major development projects continued the Stage 2
($91.5m) Wakefield Hospital (WGN) and the A$16.0m Maitland Private
Hospital (NSW) operationalised during the year. New opportunities
are being considered on a selective value adding basis and include the
commencement of a new $11.5m capacity expansion project at Wakefield
Hospital to meet demand. These initiatives, together with the continued focus
on actively curating the portfolio including its ESG resilience, position Vital to
offer enhanced Unit Holder returns over the medium term.
As part of our sustainability efforts, hard copy Annual Reports will no longer be mailed unless specifically requested by Unit Holders. Instead, this summary document
provides an overview of Vital’s key results for FY25. As with previous results, the full Annual Report will be emailed to Unit Holders and will be available on the NZX and
be posted on Vital’s website: https://www.vitalhealthcareproperty.co.nz/financial-results/. This initiative will save approximately 252,000 pages of printing per annum
and reduce our greenhouse gas emissions both through reducing printing and mailing.
Investors who would like to receive a printed Annual Report can request one by calling +64 9 488 8777, emailing enquiry@computershare.co.nz or mailing a request
to: Computershare Investor Services Limited, Private Bag 92119, Auckland 1142.
All values in this report are in NZ dollars unless stated otherwise.
$4.9m
LIKE-FOR-LIKE
NPI GROWTH
VITAL HEALTHCARE PROPERTY TRUST, MANAGED BY NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LTD | ANNUAL REPORT SUMMARY 2025 | 1
Financial results
Cash from operations measured by AFFO decreased by 3.5%
reflecting a higher tax expense and interest rate environment
partially offset by increased net property income.
Importantly, Vital was able to achieve distribution guidance
of 9.75cpu on a 93.6% payout ratio.
$148.8m
NET PROPERTY INCOME
Sustainability
Vital continues to prioritise sustainability throughout
its operations in line with Northwest’s global
sustainability strategy and framework.
PLACE GLOBALLY IN GRESB
FOR LISTED HEALTHCARE IN
DEVELOPMENTS
1s t
DEVELOPMENTS REGISTERED
TARGETING AT LEAST 5 STAR
GREEN STAR
Outlook
We believe the Vital business is well placed for FY26 and
beyond as we begin to see many of the headwinds that have
impacted healthcare property and the real estate sector
more generally begin to abate, including higher interest rates,
operator challenges in Australia and a risk off position from
investors. The recovery in New Zealand is further advanced
than Australia, with continued strong operator performance
and a stabilisation of property valuations and moderation in
construction costs observed. The continuation of this trend will
allow the fundamentals of the Vital business to again emerge,
Development update
Portfolio
overview
During FY25 two developments totalling $108.8m were
successfully operationalised, reducing the remaining committed
development spend to $36.9m.
Over 51,000sqm of space were leased, extended
or renewed during FY25, representing 22% of Vital’s
total income and 20% of the portfolios lettable area.
These strong leasing outcomes, including over
9,400sqm of new leasing, lifted portfolio occupancy
from 98.0% to 98.6% and increased weighted
average lease expiry (WALE) by 0.2 years to 18.5
years, despite the passage of time.
PORTFOLIO ($2.1B AUSTRALIA
& $1.1B NEW ZEALAND)
$3.2b
OCCUPANCY
98.6%
PIPELINE DEVELOPMENTS BEING
CONSIDERED FOR ACTIVATION
~$147.0m
SPENT ON CAPITAL WORKS IN
FY25 INCLUDING DEVELOPMENTS
$133.4m
COMMITTED DEVELOPMENT
SPEND REMAINING
$36.9m
WALE
18.5 year
DISTRIBUTION 10-YEAR CAGR
FY15 - FY25
2.0%
including strong demand for health services, an attractive
income return from a diversified tenant base and opportunities
to leverage the embedded value in the Vital portfolio. The Board
and management remain confident around Vital’s strategy
for delivering medium-long term returns for our Unit Holders.
Distributions totalling 9.75cpu (payable quarterly) are expected
to be paid for FY26.
We encourage you to join us and look forward to welcoming
you to our Annual General Meeting being held on
6 November 2025.
Ormiston Hospital Stage 1 Expansion, Auckland
Kawarau Park, Queenstown
Maitland Private Hospital, Maitland
AMBULATORY CARE
22%
SPECIALTY HOSPITALS
20%
ACUTE HOSPITALS
58%
TENANT DIVERSIFICATION
% OF RENT
Healthe Care 16.4%
Allevia 3.0%
Epworth HealthCare 13.7%
Evolution Healthcare 13.9%
Burnside 3.0%
Southern Cross 4.2%
GenesisCare 2.3%
Endoscopy Auckland
1
1.5%
Boulcott Hospital 1.7%
Other 21.9%
Aurora Healthcare 18.4%
BALANCE SHEET GEARING
42.1%
LIKE-FOR-LIKE NET PROPERTY INCOME GROWTH
3.7%
FY26 DISTRIBUTION
GUIDANCE
9.75cpu
9
WEIGHTED AVERAGE DEBT MATURITY
- NO MATURITY BEFORE MARCH 2027
3.8 years
1
Joint venture between Evolution Healthcare and Allevia
The recovery in New Zealand is further
advanced than Australia, with continued strong
operator performance and a stabilisation
of property valuations and moderation in
construction costs observed.
VITAL HEALTHCARE PROPERTY TRUST, MANAGED BY NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LTD | ANNUAL REPORT SUMMARY 2025 | 3VITAL HEALTHCARE PROPERTY TRUST, MANAGED BY NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LTD | ANNUAL REPORT SUMMARY 2025 | 2
Our
Board
Majority independent
board; directors
located in Auckland
(x2), Melbourne,
Sydney
*
& Toronto
vhpt.co.nz
Bios available at www.vitalhealthcareproperty.co.nz/board-management/
Disclaimer:
This document has been prepared by Northwest Healthcare Properties Management Limited (the Manager) as manager of the Vital Healthcare Property Trust (the Trust) and provides
high-level summary information only.
This document does not contain all the information in the Trust’s Annual Report which is available on www.nzx.com/companies/VHP and https://www.vitalhealthcareproperty.co.nz/
announcements/ and is not intended to replace the Annual Report.
This document is not intended as investment, legal, tax, financial product or financial advice or recommendation to any person and must not be relied on as such. You should obtain
independent professional advice prior to making any decision relating to your investment or financial needs.
All references to $ are to New Zealand dollars unless otherwise indicated.
This document may contain forward-looking statements. Forward-looking statements can include words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar words
in connection with discussions of future operating or financial performance or conditions. Any indications of, or guidance or outlook on, future earnings or financial position or
performance and future distributions are also forward-looking statements. The forward-looking statements are based on management’s and directors’ current expectations and
assumptions regarding the Trust’s business, assets and performance and other future conditions, circumstances and results. As with any projection or forecast, forward-looking
statements are inherently susceptible to uncertainty and to any changes in circumstances. The Trust’s actual results may vary materially from those expressed or implied in the forward-
looking statements. The Manager, the Trust, and its or their directors, employees and/or shareholders have no liability whatsoever to any person for any loss arising from this document
or any information supplied in connection with it. The Manager and the Trust are under no obligation to update this document or the information contained in it after it has been
released. Past performance is no indication of future performance.
The information in this document is of general background and does not purport to be complete. It should be read in conjunction with Vital’s market announcements lodged with NZX,
which are available at www.nzx.com/companies/VHP.
Craig Mitchell
Non-Executive Director
and Member of the Audit
Committee (Zachary
Vaughan replaced Craig
Mitchell on the Board
effective 12 August 2025)
Dr Michael
Stanford AM
Independent Director
and Chair of the Audit
Committee
Zachary Vaughan
Non-Independent
Director (Appointed
12 August 2025)
Graham Stuart
Independent Chair and
Member of the Audit
Committee
Angela Bull
Independent Director
and Member of the Audit
Committee
Mike Brady
Non-Independent
Director
Kirsty Bowyer
VP - Development
Chris Adams
Co-Head,
A/NZ Region
Alex Belcastro
SVP - Developments
and Precincts
Vanessa Flax
VP, Regional General
Counsel and Company
Secretary
Michael Groth
Chief Financial Officer
Richard Roos
Co-Head,
A/NZ Region
* As of 12 August 2025, with the
replacement of Craig Mitchell by
Zachary Vaughan, two directors
are based in Toronto and no
directors are based in Sydney
Executive
Team
Located across
New Zealand
and Australia
---
VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare
Properties Management Limited
Page 1 of 1
13 August 2025
Results for announcement to the market
Name of issuerVital Healthcare Property Trust
Reporting Period12 months to 30 June 2025
Previous Reporting Period12 months to 30 June 2024
CurrencyNZD
Amount (000s)Percentage change
Revenue from continuing operations$148,8343.0%
Total revenue$148,8343.0%
Net profit/(loss) from continuing
operations($51,220)52.4%
Total net profit/(loss)($51,220)52.4%
Interim/Final Dividend
Amount per Quoted Equity Security$0.02437500
Imputed amount per Quoted Equity
Security$0.00632664
Record Date4 September 2025
Distribution Payment Date18 September 2025
Current periodPrior comparable period
Net tangible assets per Quoted
Equity Security$2.47$2.69
A brief explanation of any of the
figures above necessary to enable
the figures to be understoodRefer announcement
Authority for this announcement
Name of person authorised to make
this announcementMichael Groth
Contact person for this
announcementMichael Groth
Contact phone number+61 409 936 104
Contact email addressMichael.Groth@nwhreit.com
Date of release through MAP13 August 2025
The Annual Report accompanies this announcement
RESULTS ANNOUNCEMENT
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.